
<html lang="en"     class="pb-page"  data-request-id="79abc973-32bf-4ccd-af5d-66e77285d202"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01460;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-2;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor" /></meta><meta name="dc.Creator" content="Julien  Lefranc" /></meta><meta name="dc.Creator" content="Volker Klaus  Schulze" /></meta><meta name="dc.Creator" content="Roman Christian  Hillig" /></meta><meta name="dc.Creator" content="Hans  Briem" /></meta><meta name="dc.Creator" content="Florian  Prinz" /></meta><meta name="dc.Creator" content="Anne  Mengel" /></meta><meta name="dc.Creator" content="Tobias  Heinrich" /></meta><meta name="dc.Creator" content="Jozsef  Balint" /></meta><meta name="dc.Creator" content="Srinivasan  Rengachari" /></meta><meta name="dc.Creator" content="Horst  Irlbacher" /></meta><meta name="dc.Creator" content="Detlef  Stöckigt" /></meta><meta name="dc.Creator" content="Ulf  Bömer" /></meta><meta name="dc.Creator" content="Benjamin  Bader" /></meta><meta name="dc.Creator" content="Stefan Nikolaus  Gradl" /></meta><meta name="dc.Creator" content="Carl Friedrich  Nising" /></meta><meta name="dc.Creator" content="Franz  von Nussbaum" /></meta><meta name="dc.Creator" content="Dominik  Mumberg" /></meta><meta name="dc.Creator" content="Daniel  Panne" /></meta><meta name="dc.Creator" content="Antje Margret  Wengner" /></meta><meta name="dc.Description" content="The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important ..." /></meta><meta name="Description" content="The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 20, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01460" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01460" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01460" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01460" /></link>
        
    
    

<title>Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01460" /></meta><meta property="og:title" content="Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0013.jpeg" /></meta><meta property="og:description" content="The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKKε inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01460"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01460">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01460&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01460&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01460&amp;href=/doi/10.1021/acs.jmedchem.9b01460" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 601-612</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01343" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01560" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Julien Lefranc</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julien Lefranc</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8ce6f9e0e5e9e2a2e0e9eafeede2efcceeedf5e9fea2efe3e1"><span class="__cf_email__" data-cfemail="ec869980858982c280898a9e8d828fac8e8d95899ec28f8381">[email protected]</span></a>. Phone: (+49)30468-194612.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julien++Lefranc">Julien Lefranc</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2116-9425" title="Orcid link">http://orcid.org/0000-0002-2116-9425</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Volker Klaus Schulze</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Volker Klaus Schulze</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Volker+Klaus++Schulze">Volker Klaus Schulze</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0158-1789" title="Orcid link">http://orcid.org/0000-0002-0158-1789</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roman Christian Hillig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roman Christian Hillig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roman+Christian++Hillig">Roman Christian Hillig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hans Briem</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hans Briem</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hans++Briem">Hans Briem</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florian Prinz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florian Prinz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Florian++Prinz">Florian Prinz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne Mengel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne Mengel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Mengel">Anne Mengel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tobias Heinrich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tobias Heinrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tobias++Heinrich">Tobias Heinrich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jozsef Balint</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jozsef Balint</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ASCA GmbH (Angewandte Synthesechemie Adlershof), 12489 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jozsef++Balint">Jozsef Balint</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Srinivasan Rengachari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Srinivasan Rengachari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leicester Institute of Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Lancaster Road, LE1 7RH Leicester, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Srinivasan++Rengachari">Srinivasan Rengachari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Horst Irlbacher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Horst Irlbacher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Horst++Irlbacher">Horst Irlbacher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Detlef Stöckigt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Detlef Stöckigt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Detlef++St%C3%B6ckigt">Detlef Stöckigt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulf Bömer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulf Bömer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++B%C3%B6mer">Ulf Bömer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin Bader</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin Bader</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Bader">Benjamin Bader</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Nikolaus Gradl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Nikolaus Gradl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+Nikolaus++Gradl">Stefan Nikolaus Gradl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carl Friedrich Nising</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carl Friedrich Nising</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carl+Friedrich++Nising">Carl Friedrich Nising</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Franz von Nussbaum</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Franz von Nussbaum</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Franz++von+Nussbaum">Franz von Nussbaum</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dominik Mumberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dominik Mumberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dominik++Mumberg">Dominik Mumberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Panne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Panne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leicester Institute of Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Lancaster Road, LE1 7RH Leicester, U.K.</div><div class="loa-info-affiliations-info">European Molecular Biology Laboratory, 38042 Grenoble, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Panne">Daniel Panne</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Antje Margret Wengner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antje Margret Wengner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceuticals, Research and Development, Bayer AG, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antje+Margret++Wengner">Antje Margret Wengner</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01460&amp;href=/doi/10.1021%2Facs.jmedchem.9b01460" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 601–612</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 20, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 September 2019</li><li><span class="item_label"><b>Published</b> online</span>20 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01460" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01460</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D601%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJulien%2BLefranc%252C%2BVolker%2BKlaus%2BSchulze%252C%2BRoman%2BChristian%2BHillig%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D2%26contentID%3Dacs.jmedchem.9b01460%26title%3DDiscovery%2Bof%2BBAY-985%252C%2Ba%2BHighly%2BSelective%2BTBK1%252FIKK%25CE%25B5%2BInhibitor%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D612%26publicationDate%3DJanuary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01460"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2744</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01460" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Julien&quot;,&quot;last_name&quot;:&quot;Lefranc&quot;},{&quot;first_name&quot;:&quot;Volker&quot;,&quot;last_name&quot;:&quot;Klaus Schulze&quot;},{&quot;first_name&quot;:&quot;Roman&quot;,&quot;last_name&quot;:&quot;Christian Hillig&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;Briem&quot;},{&quot;first_name&quot;:&quot;Florian&quot;,&quot;last_name&quot;:&quot;Prinz&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Mengel&quot;},{&quot;first_name&quot;:&quot;Tobias&quot;,&quot;last_name&quot;:&quot;Heinrich&quot;},{&quot;first_name&quot;:&quot;Jozsef&quot;,&quot;last_name&quot;:&quot;Balint&quot;},{&quot;first_name&quot;:&quot;Srinivasan&quot;,&quot;last_name&quot;:&quot;Rengachari&quot;},{&quot;first_name&quot;:&quot;Horst&quot;,&quot;last_name&quot;:&quot;Irlbacher&quot;},{&quot;first_name&quot;:&quot;Detlef&quot;,&quot;last_name&quot;:&quot;Stöckigt&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Bömer&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Bader&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Nikolaus Gradl&quot;},{&quot;first_name&quot;:&quot;Carl&quot;,&quot;last_name&quot;:&quot;Friedrich Nising&quot;},{&quot;first_name&quot;:&quot;Franz&quot;,&quot;last_name&quot;:&quot;von Nussbaum&quot;},{&quot;first_name&quot;:&quot;Dominik&quot;,&quot;last_name&quot;:&quot;Mumberg&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Panne&quot;},{&quot;first_name&quot;:&quot;Antje&quot;,&quot;last_name&quot;:&quot;Margret Wengner&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;601-612&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01460&quot;},&quot;abstract&quot;:&quot;The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKKε inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01460&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01460" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01460&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01460" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01460&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01460" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01460&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01460&amp;href=/doi/10.1021/acs.jmedchem.9b01460" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01460" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01460" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01460%26sid%3Dliteratum%253Aachs%26pmid%3D31859507%26genre%3Darticle%26aulast%3DLefranc%26date%3D2020%26atitle%3DDiscovery%2Bof%2BBAY-985%252C%2Ba%2BHighly%2BSelective%2BTBK1%252FIKK%25CE%25B5%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D2%26spage%3D601%26epage%3D612%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/jmcmar.2020.63.issue-2/20200123/jmcmar.2020.63.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKKε inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKKε are noncanonical members of the inhibitor of nuclear factor κB (IκB) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> IKKs are activated following engagement of pattern recognition receptors such as toll-like receptors, cytosolic DNA receptors, and retinoic acid inducible gene I-like receptors. Activated non-canonical IKKs phosphorylate interferon regulatory factors (IRFs) 3, 5, and 7, which then dimerize and enter the nucleus to induce expression of pro-inflammatory and antiviral genes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">TBK1 also plays an important role in autophagy,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> a quality control process in which the cell recycles proteins or disposes excessive or damaged organelles and which contributes to the clearance of intracellular pathogens.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9">(5−9)</a> Furthermore, TBK1 maintains T cell homeostasis and negatively regulates both autoimmunity and antitumor immunity by promoting immune tolerance in dendritic cells, likely by regulating a subset of type I interferon receptor-induced genes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">In view of its critical role in inflammatory signaling and oncology, TBK1 has attracted considerable interest as a potential target in cancer therapy. TBK1 is overexpressed and activated in bladder, lung, breast, and colon cancers.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Knockdown experiments have shown that TBK1 is crucial for cellular survival and synthetically lethal with mutated KRAS in lung cancer.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The RalB/Sec5 effector complex, downstream of KRAS signaling, directly recruits and activates TBK1, thus preventing induction of apoptosis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> TBK1 also regulates an autocrine circuit of CCL5/RANTES and interleukin 6 to promote KRAS-driven tumorigenesis.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> TBK1 is further thought to promote vascularization,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> to directly drive oncogenesis by phosphorylating and activating Akt1,<a onclick="showRef(event, 'ref11 ref17'); return false;" href="javascript:void(0);" class="ref ref11 ref17">(11,17)</a> and to regulate prostate cancer dormancy by inhibition of mTOR.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Although a number of studies suggest that TBK1 is a potentially interesting target in cancer therapy, recent data have challenged this view.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Considering that most studies were performed using relatively unselective TBK1 inhibitors or by protein depletion, it remains unclear if selective kinase inhibition of TBK1 is a viable therapeutic strategy. Clinical studies targeting TBK1 in KRAS-mutant cancers using momelotinib, a compound that inhibits both Janus kinases and TBK1, have been terminated early without release of further information.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Over the last decade, several attempts have been made to identify TBK1/IKKε inhibitors; however, it has become apparent that the identification of such highly selective inhibitors is very challenging.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a></div><div class="NLM_p last">TBK1 is an 84 kD, 729 amino acid protein comprising an N-terminal kinase domain, an ubiquitin-like domain (ULD), an α-helical scaffold dimerization domain (SDD), and a C-terminal adaptor-binding domain (CTD).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Depending on the context, cell type, and stimulus, the CTD binds to a number of different adaptors including TANK, NFκB activating kinase (NAK)-associated protein 1 (NAP1), similar to NAP1 TBK1 adaptor (SINTBAD), and optineurin.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> Thus, in addition to its enzymatic activity, TBK1 also has an important scaffolding function, and an unraveling of the relative contributions to cellular signaling is highly desirable. To that end, we have developed BAY-985, a highly potent and selective TBK1 inhibitor. BAY-985 has been donated as a probe molecule to the Structural Genomics Consortium (SGC) to enable access to the scientific community for future studies of TBK1 and its function. Similarly, selective inhibitors of other potential drug targets have proven to be valuable tool compounds for the scientific community,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and we anticipate that BAY-985 will broaden the understanding of the biology of TBK1.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> High-Throughput Screening</h3><div class="NLM_p">We first performed a TBK1 high-throughput screening (HTS) campaign using biochemical kinase assay as an entry point. Because of the limited set of compounds identified with this approach, we performed a second HTS, this time with TBK1-dependent cellular reporter gene assay. This second approach was expected to allow identification of compounds that inhibit TBK1 in its cellular environment, thus potentially revealing novel modes of action. The reporter cell line expressed luciferase under the control of multiple interferon-stimulated response elements (ISREs). Co-incubation with poly dA:dT stimulates TBK/IKKε-driven ISRE activation and hence luciferase expression. In the HTS, we screened 3.05 million compounds for their ability to inhibit the luciferase signal by more than 40%. Screening hits were tested for toxicity and unspecific luciferase or transcriptional/translational inhibition (see also <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>). They were further characterized using two different biochemical assays to measure TBK1 inhibition in vitro (referred to as “low ATP assay” and “high ATP assay”). These two assays varied in the ATP concentration (10 μM, low ATP assay; 1 mM, high ATP assay), where a high potency in the high ATP assay is desirable as this increased ATP concentration reflects more realistically the situation in the cell and in vivo. The cellular HTS campaign allowed us to identify compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) which was ATP-competitive in the biochemical assays.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Compound <b>1</b> identified during our cellular HTS and compound <b>2</b> as an early variant. (B) Crystal structure of TBK1 in complex with <b>2</b> (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR">6RSR</a>). Left: the overall view of one TBK1 monomer with the kinase domain in cyan (N-terminal lobe) and blue (C-terminal lobe), the ULD in yellow, and the SDD in green. Right: <b>2</b> bound to the hinge region within the ATP site of the kinase domain. The 3.1 Å resolution mF<sub>o</sub>–DF<sub>c</sub> electron density omit map contoured at 2 σ is shown in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> X-ray Crystallography and Initial Optimization</h3><div class="NLM_p">Starting from the HTS hit <b>1</b>, we explored the 6-position of the benzimidazole moiety with regard to potency and selectivity toward potential off-target kinases, most importantly, the CDK family of kinases. TBK1 contains a methionine (Met86, see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) at the so-called gatekeeper position, the residue immediately preceeding the hinge which connects the N- and C-terminal lobe of the kinase domain. This feature can be exploited to develop potentially selective inhibitors as CDKs contain a phenylalanine at this position. Guided by a co-complex crystal structure published for a similar 6-cyanobenzimidazole inhibitor binding to the ATP pocket of the kinase CK1γ, which also contains a methionine gatekeeper,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> we predicted that the cyano group of compound <b>1</b> would not interact with and modulate the side-chain conformation of the Met gatekeeper of TBK1. Potentially, this could explain the low selectivity of compound <b>1</b> toward kinases which feature a bulky Phe gatekeeper, such as CDKs (data not shown). As has been shown for JNK3 kinase inhibitors, selectivity can be improved by exploiting the high flexibility of a Met gatekeeper side chain.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> An appropriate substituent on the inhibitor is expected to push away the Met side chain and to open up the so-called “hydrophobic back pocket”, whereas a more rigid Phe side chain at the gatekeeper position, such as in CDKs, would restrict access to this back pocket. Based on this rationale, we synthesized compound <b>2</b> where the 6-cyano side chain of <b>1</b> was replaced by a bulkier <i>N</i>-cyclopropylmethyl amide group. While this substitution only modestly improved potency (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, TBK1 low ATP assay), it resulted in a surprisingly drastic improvement in selectivity toward the off-target kinase CDK9 (IC<sub>50</sub> = 5 nM for <b>1</b> vs >20000 nM for <b>2</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR at the Piperazine Ring (Targeting the Entrance of the ATP-Binding Site)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0008.gif" alt="" id="GRAPHIC-d7e515-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0009.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are reported as arithmetic means of several measurements (except stated otherwise); n.d.: not determined.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Single measurement.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> reported at the median value of several measurements.</p></div></div><div></div></div><div class="NLM_p">To understand the binding mode of this compound class, we co-crystallized three compounds with close to full-length TBK1S172E<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>, Table S4). TBK1 only crystallized when ATP site inhibitors were added prior to the crystal setup. The vast majority of crystals diffracted to a minimum Bragg spacing of 4–5 Å which required testing of 20–50 crystals/compound to identify a specimen that diffracted to better than 3.5 Å resolution. We collected a 3.15 Å data set for compound <b>2</b> and determined the structure by molecular replacement. Despite the modest resolution, omit maps of the ATP site of the kinase domain showed clear difference density, which allowed modeling of the ligand (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). The inhibitor inserts into the flat and mainly hydrophobic adenine pocket of the ATP-binding site at the hinge region, where the central conjugated biaromatic ring system is sandwiched between Leu15, Val23, and Ala33 at the roof of the ATP site, and Gly92 and Met142 at its floor. The inhibitor forms two hydrogen-bond interactions to Cys89 of the hinge region of TBK1, one via the central amino group (3.1 Å) and one via a nitrogen atom of the benzimidazole ring (3.5 Å). The piperazine moiety points toward the solvent, where the amide oxygen forms a 3.5 Å hydrogen bond to the side chain of Arg25. The cyclopropyl moiety inserts into the back pocket behind the ATP site and forms a hydrophobic contact with the gatekeeper residue Met86. The nitrogen atom of the adjacent amide group forms a hydrogen bond to Thr156 (2.7 Å). However, compound <b>2</b> does not interact with the conserved Lys38 at the back wall of the ATP site or with Asp157 (of the DFG motif at the start of the activation loop), two polar and conserved kinase residues which line this back pocket behind the ATP site (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).</div><div class="NLM_p">A comparison of the binding mode of <b>2</b> with the less-selective TBK1 inhibitor BX-795 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EUU">4EUU</a>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> revealed that, indeed, the gatekeeper Met86 of TBK1 can accommodate the cyclopropyl moiety of inhibitor <b>2</b> by adopting an alternative side-chain conformation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) relative to the one observed with BX-795 which does not occupy the back pocket.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Conformational flexibility of the TBK1 gatekeeper Met86. Superimposition of the kinase domains of TBK1 in complex with <b>2</b> (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR">6RSR</a>, green carbon atoms) and BX-795 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EUU">4EUU</a>, orange carbon atoms). View into the hinge region of the ATP-binding site. Hydrogen-bond interactions between the inhibitors and TBK1 shown as yellow dotted lines. The gatekeeper residue Met86 can accommodate back-pocket binders such as <b>2</b> by adopting a new side-chain conformation (red arrow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>1</b> and <b>2</b> showed low permeability and strong efflux in Caco-2 assays: <i>P</i><sub>app</sub> A–B = 32 nm/s, <i>P</i><sub>app</sub> B–A = 268 nm/s, ER = 8.3 and <i>P</i><sub>app</sub> A–B = 3.9 nm/s, <i>P</i><sub>app</sub> B–A = 155 nm/s, ER = 40, respectively. We further explored the 6-position of the benzimidazole moiety with the aim of improving selectivity and potency. We focused our attention on small heterocycles that could potentially be bioisosteric to an amide side chain. In addition to the desired shift of the Met86 gatekeeper side chain, computational design focused on the addition of a possible hydrogen bond with the catalytic Lys38, which is in close proximity to the gatekeeper (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). This led to the design of compound <b>3</b>, where the amide was replaced by its 1,2,4-oxadiazole bioisostere. This compound inhibited TBK1 and IKKε with IC<sub>50</sub> values of 129 nM (low ATP assay) and 168 nM, respectively (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>3</b> also showed improved permeability and efflux ratio in Caco-2 assay (<i>P</i><sub>app</sub> A–B = 42 nm/s, <i>P</i><sub>app</sub> B–A = 142 nm/s, ER = 3.4) compared to compound <b>1</b>.</div><div class="NLM_p">In parallel, we tested several of our more selective TBK1 inhibitors for antiproliferative activity in more than 100 cell lines. Contrary to results we had obtained in RNAi experiments (data not shown), most of the cell lines tested did not respond to these TBK1 inhibitors. Among the cell lines with higher sensitivity, we selected two cell lines, ACHN (CDKN2A mutated) and SK-MEL-2 (NRAS and TP53 mutated),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> as models to further determine the antiproliferative activity. Compound <b>3</b> showed micromolar antiproliferative activity in both cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">The selectivity of <b>3</b> was further assayed in an internal kinase panel and at 100 nM in the DiscoverX KINOME<i>scan</i> (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Table S1</a>). This analysis revealed low kinase selectivity, with eight other kinases in the panel being more potently inhibited than TBK1.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. DiscoverX KINOME trees for compound <b>3</b>, <b>24</b>, and <b>34</b> at 100 nM. The red dots highlight the kinases that show an inhibition of 65% or more (for more complete list of the kinases, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Tables S1–S3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Activity Relationship (SAR)</h3><div class="NLM_p">Starting from compound <b>3</b>, we investigated the amide substitution on the piperazine moiety (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Synthetic precursors of <b>3</b>, namely, compounds <b>4</b> and <b>5</b>, with a Boc protecting group or presenting an unsubstituted piperazine ring, were tested and showed reduced potency in the TBK1 and IKKε assays. Alkylation of the nitrogen also led to reduced potency compared to compound <b>3</b>: <i>N</i>-propyl as well as <i>N</i>-hydroxyethyl substitution (compounds <b>6</b> and <b>7</b>) resulted in only micromolar inhibition of TBK1 in both the low and high ATP assays. Compounds <b>8–10</b> with a fluorinated alkyl substituent were also assayed: <b>8</b> inhibited TBK1 at an IC<sub>50</sub> value of 281 nM in the low ATP assay and at 5290 nM in the high ATP assay; however, although <b>8</b> showed no antiproliferative activity in SK-MEL-2 cells, it inhibited proliferation in ACHN cells with an IC<sub>50</sub> of 350 nM. Compound <b>10</b> bearing a shorter trifluoromethylated side chain behaved similarly to <b>8</b> in the TBK1 assay, while difluoromethyl analogue <b>9</b> had slightly higher potency (IC<sub>50</sub> = 98 nM, low ATP assay) and a moderate antiproliferative activity, with an IC<sub>50</sub> of 1.6 μM in SK-MEL-2 cells. We further investigated amide substituents (compounds <b>11–14</b>). Aromatic amides such as furan analogue <b>14</b> showed reduced potency toward TBK1; however, compounds <b>11–13</b>, each bearing a small cycloalkyl substituent, proved to be as potent as compound <b>3</b> and did not show major differences with regard to Caco-2 permeability (<i>P</i><sub>app</sub> A–B = 68 nm/s, <i>P</i><sub>app</sub> B–A = 151 nm/s, ER = 2.2 for <b>11</b>, <i>P</i><sub>app</sub> A–B = 52 nm/s, <i>P</i><sub>app</sub> B–A = 124 nm/s, ER = 2.4 for compound <b>12</b>). Despite substantial efforts, no substituent superior to the initial trifluoroethylcarbonyl group was found; therefore, this group was retained throughout the rest of our investigations.</div><div class="NLM_p">Next, we investigated the benzylic position. The introduction of a methyl group at that position had a significant impact on potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). While racemic compound <b>15</b> had an IC<sub>50</sub> value of 34 nM in the TBK1 low ATP assay, testing of the separated enantiomers revealed that one antipode is superior: (S)-configured <b>16</b> inhibited TBK1 with an IC<sub>50</sub> value of 106 nM (low ATP assay), while (R)-configured <b>17</b> displayed a fivefold increase in potency (IC<sub>50</sub> = 19 nM, low ATP assay; 372 nM, high ATP assay). Compound <b>17</b> was also highly potent toward IKKε (IC<sub>50</sub> = 37 nM) and was active in our cellular mechanistic pIRF3 assay and SK-MEL-2 antiproliferation assay, with IC<sub>50</sub> values of 1.2 and 3.5 μM, respectively. An additional benefit of the introduction of a substituent at the benzylic position was the increased kinase selectivity relative to the unsubstituted analogue (see <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <b>17</b> vs <b>3</b>). In contrast, replacement of the benzylic methylene by a carbonyl group (compound <b>18</b>) significantly reduced potency toward both TBK1 and IKKε. Interestingly, compound <b>16</b> and <b>17</b> showed improved permeability compared to <b>3</b> in our Caco-2 assay with <i>P</i><sub>app</sub> A–B = 114 nm/s, <i>P</i><sub>app</sub> B–A = 79 nm/s, ER = 0.7 and <i>P</i><sub>app</sub> A–B = 108 nm/s, <i>P</i><sub>app</sub> B–A = 86 nm/s, ER = 0.8, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR at the Benzylic Position<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0010.gif" alt="" id="GRAPHIC-d7e896-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">TBK1 (low/high ATP)</th><th class="colsep0 rowsep0" align="center" char=".">IKKε</th><th class="colsep0 rowsep0" align="center" char=".">pIRF3</th><th class="colsep0 rowsep0" align="center">SK-MEL-2<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">ACHN</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">129/2270</td><td class="colsep0 rowsep0" align="char" char=".">168</td><td class="colsep0 rowsep0" align="char" char=".">2750</td><td class="colsep0 rowsep0" align="left">2180</td><td class="colsep0 rowsep0" align="left">9670</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Me (<i>rac</i>)</td><td class="colsep0 rowsep0" align="left">34/829</td><td class="colsep0 rowsep0" align="char" char=".">593</td><td class="colsep0 rowsep0" align="char" char=".">2270</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-Me</td><td class="colsep0 rowsep0" align="left">106/2490</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">3020</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-Me</td><td class="colsep0 rowsep0" align="left">19/372</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">1210</td><td class="colsep0 rowsep0" align="left">3530</td><td class="colsep0 rowsep0" align="left">8980</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">1210/>20000</td><td class="colsep0 rowsep0" align="char" char=".">3880</td><td class="colsep0 rowsep0" align="char" char=".">>10 000</td><td class="colsep0 rowsep0" align="left">>25 000</td><td class="colsep0 rowsep0" align="left">>30 000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are reported as arithmetic means of several measurements; n.d.: not determined.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> reported at the median value of several measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR at the 6-Position of the Benzimidazole Core (Targeting the Back Pocket)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0011.gif" alt="" id="GRAPHIC-d7e1101-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0012.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are reported as arithmetic means of several measurements (except stated otherwise); n.d.: not determined.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Single measurement.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Kd DiscoverX.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Eurofins IC<sub>50</sub> values.</p></div></div><div></div></div><div class="NLM_p">After some preliminary work on the benzimidazole core (data not shown), our further efforts were focused on the substituent at the 6-position, as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. We had previously established that the introduction of a methyl group at the benzylic position [with (<i>R</i>) configuration] improved the kinase selectivity profile of our compounds (cf. <b>3</b> and <b>17</b>); however, compound <b>17</b> still had micromolar off-target activity toward kinases such as CDK9 or RSK4, and also nanomolar activity toward FLT3 and DRAK1 (with IC<sub>50</sub> values of 30 and 10 nM, respectively). We hypothesized that a bulkier substituent on the oxadiazole ring might help to improve selectivity. Compound <b>19</b>, bearing a cyclopropyl group, and compound <b>20</b>, substituted with an isobutyl group, showed improved potency compared to <b>3</b> toward TBK1 in the low ATP assay (IC<sub>50</sub> = 58 and 72 nM, respectively); however, both <b>19</b> and <b>20</b> were inactive in the high ATP assay (see <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_p">Replacement of the oxadiazole moiety by an <i>N</i>-methylpyrazolyl group (<b>21</b>) resulted in a slight increase in potency in the low ATP assay (IC<sub>50</sub> = 55 nM, compared to 129 nM for <b>3</b>). We next introduced bulkier substituents at a pyrazole nitrogen: cyclopropylmethyl-substituted <b>23</b> showed a 10-fold increased potency toward TBK1 compared to the methyl and ethyl analogues (<b>21</b>/<b>22</b>). Our previous experience that the introduction of a methyl group at the benzylic position increased potency was confirmed with (R)-configured <b>24</b> which had a potency of 1 nM (IC<sub>50</sub>) and 6 nM in the TBK1 low ATP assay and the IKKε assay, respectively, and a very high potency (IC<sub>50</sub> = 18 nM) in the TBK1 high ATP assay. Unfortunately, the introduction of a pyrazole had a negative impact on Caco-2 permeability. Compounds <b>22</b>, <b>23</b>, and <b>24</b> showed lower permeability and higher efflux with <i>P</i><sub>app</sub> A–B = 17 nm/s, <i>P</i><sub>app</sub> B–A = 173 nm/s, ER = 10 for compound <b>22</b>, <i>P</i><sub>app</sub> A–B = 32 nm/s, <i>P</i><sub>app</sub> B–A = 125 nm/s, ER = 3.9 for <b>23</b> and <i>P</i><sub>app</sub> A–B = 16 nm/s, <i>P</i><sub>app</sub> B–A = 118 nm/s, ER = 7.5 for <b>24</b>.</div><div class="NLM_p">We obtained a co-crystal structure of TBK1 bound to compound <b>24</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>, Figure S1). As found for <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), compound <b>24</b> adopts an overall similar binding mode within the ATP-binding site, with two hydrogen-bond interactions to residue Cys89 in the hinge region of TBK1. The (R)-configured benzylic methyl group appears to improve the potency by stabilizing the outer piperazine moiety in a conformation which allows both insertion of the trifluoropropionyl amide moiety into a surface indentation above the entrance to the ATP site and formation of a hydrogen bond between a piperazine nitrogen and the backbone carbonyl oxygen of Pro90 (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>, Figure S1). This conformation also enables interaction of the propionyl amide with Arg25 and brings one of the fluoro atoms into a beneficial distance to the amide nitrogen of Ile14.</div><div class="NLM_p">Compound <b>24</b> was highly potent in the cellular mechanistic IRF3 phosphorylation assay and showed nanomolar antiproliferative activity in SK-MEL-2 cells but only a micromolar effect on ACHN cells (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Here as well, introduction of the benzylic substituent enhanced the selectivity profile. However, compared to the unsubstituted benzylic analogue <b>23</b> (with lower selectivity), <b>24</b> showed a twofold reduction in our SK-MEL-2 antiproliferation assay despite an almost threefold improvement in the cellular mechanistic pIRF3 assay, suggesting that some of the antiproliferative effect observed might not be only due to TBK1/IKKε inhibition but rather to inhibition of an as-yet-unidentified off-target kinase.</div><div class="NLM_p">Compound <b>24</b> was further profiled at 100 nM in the DiscoverX KINOME<i>scan</i> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Table S2</a>). In this assay, <b>24</b> showed an improved selectivity profile compared to <b>3</b>. Only two other kinases were inhibited more potently than TBK1 (DRAK1 and DRAK2) and two kinases (YSK4 and ULK1) were inhibited as potently as TBK1. Further attempts to improve the selectivity revealed that increasing the steric bulk of the substituent at the pyrazole nitrogen (compound <b>25</b>) led to a similar profile with improved selectivity toward FLT3 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_p">While compounds <b>26</b> and <b>27</b>, bearing a pyridyl substituent at the 6-position, retained potency toward TBK1, their selectivity was lower, especially regarding CDK9 and FLT3 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Relative to <b>26</b>, pyrimidinyl-substituted <b>28</b> displayed a moderate increase in potency in the biochemical TBK1 assay (low ATP). This compound, however, showed a different and improved selectivity toward CDK9 (IC<sub>50</sub> = 320 vs 71 nM for <b>26</b>). Again, the introduction of an (R)-configured benzylic methyl group improved potency and selectivity: compound <b>29</b> showed high potency toward both our targets, TBK1 and IKKε (IC<sub>50</sub> = 2 nM, low ATP assay, and 4 nM, respectively), and a potency of 140 nM (IC<sub>50</sub>) in the mechanistic pIRF3 assay. As this was the first time that selectivity toward ULK1 (50-fold) was observed, we investigated a broader set of pyrimidine derivatives. Introduction of a bulkier substituent on the pyrimidine moiety (compounds <b>30</b> and <b>31</b>) resulted in very high potency in our biochemical assays as well as in the pIRF3 assay, along with some antiproliferative effect on SK-MEL-2 cells. As seen before, however, the potency increase achieved did not translate into an antiproliferative effect on ACHN cells, therefore challenging the hypothesis that the antiproliferative effect observed was because of TBK1/IKKε inhibition. Despite the good selectivity profile of these compounds, they were still active toward FLT3 and DRAK1. We observed as well that the change from pyrazole to pyrimidines did not improve Caco-2 permeability with, for example, compound <b>30</b> showing low permeability and strong efflux (<i>P</i><sub>app</sub> A–B = 14 nm/s, <i>P</i><sub>app</sub> B–A = 218 nm/s, ER = 15). The introduction of an amino substituent on the pyrimidine moiety (compounds <b>32</b> and <b>33</b>) led to improved selectivity toward ULK1. The dimethylamino substituent (<b>33</b>) seemed to have a strong influence on FLT3 and DRAK1 potencies. Combining this substituent with an (<i>R</i>)-methyl group at the benzylic position led to the identification of BAY-985 (<b>34</b>). Compound <b>34</b> showed high potency toward TBK1 and IKKε (IC<sub>50</sub> = 2 nM, low ATP assay; 30 nM, high ATP assay), as well as high potency in the mechanistic pIRF3 assay (IC<sub>50</sub> = 74 nM) and an antiproliferative effect on SK-MEL-2 cells (IC<sub>50</sub> = 900 nM). Biochemically, <b>34</b> also displayed good selectivity toward FLT3 (60×), RSK4 (138×), DRAK1 (155×), and ULK1 (∼4000×) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). To confirm the improved selectivity of <b>34</b>, it was further profiled at 100 nM in the DiscoverX KINOME<i>scan</i> (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Table S3</a>). Compound <b>34</b> showed high selectivity with respect to all kinases tested in the panel, except YSK4. Compound 34 still showed low permeability and strong efflux in the Caco-2 assay (<i>P</i><sub>app</sub> A–B = 9 nm/s, <i>P</i><sub>app</sub> B–A = 146 nm/s, ER = 17).</div><div class="NLM_p">Further investigations on the pyrimidine family allowed us to also identify compound <b>35</b>, a close derivative of <b>34</b> in which the pyrimidine moiety is substituted with an isopropoxy group (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This compound showed high potency toward TBK1 but reduced selectivity, highlighting the importance of the dimethylamino substituent for the selectivity. Compound <b>36</b> bearing Cl on the pyrimidine ring turned out to be a lot less active. We were able to obtain a co-crystal structure of compound <b>35</b> with TBK1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In addition to the double hinge interaction of the aminobenzimidazole moiety to Cys89 of the hinge region, the new pyrimidine moiety enables formation of a hydrogen bond to the conserved lysine residue (Lys38) at the back wall of the ATP site. As observed for compound <b>24</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>, Figure S1), the (R)-configured benzylic methyl group helps to lock the outer piperazine moiety in a conformation which enables insertion of the trifluoropropionyl amide moiety into a surface pocket above the entrance to the ATP site, with hydrogen bonds to the side chain of Arg25, the backbone nitrogen of Ile14, and the carbonyl group of Pro90. Thus, compound <b>35</b> successfully combines both SAR insights from the previous optimization steps: the pyrimidine substituent is bulky enough to fully occupy the back pocket and push the Met86 side chain in a similar way as seen with compound <b>2</b>, which induces selectivity toward kinases with more bulky and rigid gatekeeper residues, such as CDKs; additionally, the pyrimidine is able to form a hydrogen bond to Lys38 in the back pocket (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Although compound <b>35</b> retains some residual CDK9 activity (IC<sub>50</sub> = 824 nM), the TBK1 affinity was further improved with respect to compound <b>2</b> (IC<sub>50</sub> = 2 vs 93 nM in lw ATP assay).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of TBK1 in complex with <b>35</b> (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RST">6RST</a>). Left: view into the ATP site of TBK1, with the protein shown in surface representation (transparent). Right: view rotated and surface omitted for clarity. mF<sub>o</sub>–DF<sub>c</sub> electron density omit map contoured at 2σ shown around the ligand. Hydrogen-bond interactions between the inhibitor <b>35</b> and TBK1 shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Pharmacokinetics</h3><div class="NLM_p">The in vitro metabolic clearance profile [CL<sub>b,in vitro</sub>(rat hepatocytes) = 1.7 L/h/kg, CL<sub>b,in vitro</sub>(human liver microsomes) = 0.50 L/h/kg] and CYP450 inhibition potential (CYP1A2, CYP2D6, CYP3A4; IC<sub>50</sub> > 20 μM) of compound <b>34</b> encouraged further in vivo evaluation. To this end, <b>34</b> was dosed iv/po at 0.30/0.30 mg/kg to male Wistar rats. Compound <b>34</b> demonstrated a high clearance (CL<sub>b</sub> = 4.0 L/h/kg, ca. 95% hepatic extraction) which was higher than predicted from both rat hepatocytes and rat liver microsomes (CL<sub>b,in vitro</sub> = 1.7 L/h/kg). The volume of distribution at steady state was large (<i>V</i><sub>ss</sub> = 2.9 L/kg) with a short terminal half-life (<i>t</i><sub>1/2</sub> = 0.79 h). Following oral administration, <b>34</b> showed low bioavailability (<i>F</i> = 11%), consistent with in vivo blood clearance (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overall profile for BAY-985 including pharmacological and physicochemical properties as well as in vitro DMPK properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Following administration of a single oral dose of <b>34</b> at 100 mg/kg to female NMRI nude mice, the exposure was low to moderate, without hints of accumulation after repeated q.d. (once daily) administration. Biochemical IC<sub>50,u</sub>(TBK1) and cell-based IC<sub>50,u</sub>(TBK1/IKKε) were covered by plasma exposure for 10 and 11 h, respectively. However, proliferative IC<sub>50,u</sub>(SK-MEL-2) was ca. threefold higher than <i>C</i><sub>max,u</sub>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Antitumor Efficacy Study</h3><div class="NLM_p">The in vivo efficacy and tolerability of <b>34</b> in the cell line-derived SK-MEL-2 human melanoma xenograft model in female NMRI nude mice was investigated. The maximal tolerated dose of <b>34</b> was 200 mg/kg applied twice daily (b.i.d.) continuously. Treatment resulted in weak antitumor efficacy with a <i>T</i>/<i>C</i><sub>rel.area</sub> ratio of 0.8 and <i>T</i>/<i>C</i><sub>tumor weight</sub> ratio of 0.6, as determined at the study termination (day 111 after tumor inoculation) after 35 treatment days (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B). The treatment was well tolerated, with a maximum body weight loss of less than 10% (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antitumor efficacy of <b>34</b> as monotherapy in the SK-MEL-2 human melanoma xenograft model in female NMRI nude mice. Treatment schedule: <b>34</b> (200 mg/kg) applied twice daily (b.i.d.) for 35 days. (A) Tumor area (<i>n</i> = 10 mice/group). (B) Tumor weight at study end (day 111). Tumor areas and weights given as mean ± SD. (C) Body weight change (defined as the percentage change of the actual mean body weight compared to the maximal mean body weight after start of treatment).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis of 34 (BAY-985)</h3><div class="NLM_p">The synthesis of <b>34</b> started with a Suzuki coupling between pinacol ester <b>36</b> (available in one step from the corresponding bromide) and chloropyrimidine <b>37</b> (available in one step from 4,6-dichloropyrimidine) using tetrakis(triphenylphosphine)palladium(0) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The resulting product <b>38</b> was converted into benzimidazole <b>40</b> in a two-step procedure: <b>38</b> was first reacted with 1,1′-thiocarbonyldiimidazole (TCDI) and amine <b>39</b> (available in five steps from commercially available reagents, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>) to provide a thiourea intermediate that was cyclized using <i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide (EDCI). Acid deprotection of the Boc group, followed by amide coupling with 3,3,3-trifluoropropanoic acid (using HATU), led to <b>34</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C; (b) 1<i>H</i>-imidazole, TCDI, DCM, 0 °C; (c) EDCI, DCM; (d) HCl, 1,4-dioxane, DCM; (e) 3,3,3-trifluoropropanoic acid, HATU, NaHCO<sub>3</sub>, DMF.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting from a HTS campaign, we identified a family of aryl-substituted benzimidazoles as highly potent TBK1/IKKε inhibitors. Early in our investigations, we observed that achieving a very high kinase selectivity will be challenging within this compound class. Using X-ray crystallography, we could confirm the aminobenzimidazole interaction at the hinge as well as identify the hydrogen bond interaction with the protein from the oxygen of the piperazine amide. With the help of computational chemistry, we hypothesized that bulky substituents addressing the back pocket of the protein could improve overall kinase selectivity.</div><div class="NLM_p">Addressing the back-pocket of the protein with different aromatic substituents turned out to be key in order to improve the selectivity profile of our compounds. Pyrazole-substituted benzimidazoles such as compound <b>24</b> displayed an improved overall kinase profile with TBK1 and IKKε being the most potently inhibited targets and with a limited number of off-targets inhibited. Finally, pyrimidine-substituted benzimidazoles appeared to have a superior selectivity profile. This observation resulted in the identification of compound <b>34</b> (BAY-985), a highly potent and selective ATP-competitive dual inhibitor of TBK1 and IKKε. Compound <b>34</b> was active in our cellular mechanistic assay and showed antiproliferative activity in a few cancer cell lines. However, we noticed that the antiproliferative activity observed on ACHN cells did not correlate with the potency on our targets and appeared to be weaker for compounds, showing a high selectivity. This result highlighted the fact that the antiproliferative activity observed early in our investigations might not be a consequence of TBK1/IKKε inhibition but is more likely resulting from off-target effects.</div><div class="NLM_p">The pharmacokinetic profile of compound <b>34</b> was then investigated and an efflux ratio of 17-fold was observed in the Caco-2 permeability assay.</div><div class="NLM_p">In vivo, compound <b>34</b> showed high clearance (CL<sub>b</sub> = 4.0 L/h/kg, ca. 95% hepatic extraction), large volume of distribution at the steady state (<i>V</i><sub>ss</sub> = 2.9 L/kg), and a short terminal half-life (<i>t</i><sub>1/2</sub> = 0.79 h).</div><div class="NLM_p">Despite the high potency of compound <b>34</b>, we observed only weak antitumor efficacy in the SK-MEL-2 human melanoma xenograft model, presumably because we did not reach sufficient exposure to cover the antiproliferative concentration of SK-MEL-2 cells. It is possible that we have not identified the appropriate cell line system characterized by specific oncogenic aberrations or certain biomarkers related to sensitization to TBK1/IKKε inhibition. Possibly, the use of combination treatments might be beneficial. Therefore, we have not devalidated TBK1/IKKε as anticancer targets but simply have not provided full (in vivo) evidence for it.</div><div class="NLM_p last">Compound <b>34</b> was recently accepted by the Structural Genomics Consortium as a dual TBK1/IKKε probe (along with the negative control BAY-440) and is now available to the scientific community via the SGC<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43">(35−43)</a> as a tool compound to aid the understanding of the pharmacology and potential therapeutic use of TBK1/IKKε pathway inhibition in tumors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Methods and Materials</h4><div class="NLM_p">Commercially available reagents and anhydrous solvents were used as supplied, without further purification. All air- and moisture-sensitive reactions were carried under an inert atmosphere of argon. Reactions were monitored by TLC and UPLC analysis with a Waters Acquity UPLC MS Single Quad system (see SI for methods details). Flash chromatography was carried out using a Biotage Isolera One system with 200–400 nm variable detector. Preparative HPLC was carried out with a Waters AutoPurification MS Single Quad system; column: Waters XBridge C18 5 μm, 100 × 30 mm; basic conditions: eluent A: H<sub>2</sub>O + 0.2 vol % aq NH<sub>3</sub> (32%), eluent B: MeCN; gradient: 0–0.5 min 5% B, flow: 25 mL/min; 0.51–5.50 min 10–100% B, flow: 70 mL/min; 5.51–6.5 min 100% B, flow: 70 mL/min; acidic conditions: eluent A: H<sub>2</sub>O + 0.1 vol % formic acid (99%), eluent B: MeCN; gradient: 0–0.5 min 5% B, flow: 25 mL/min; 0.51–5.50 min 10–100% B, flow: 70 mL/min; 5.51–6.5 min 100% B, flow: 70 mL/min; temperature: 25 °C; DAD scan: 210–400 nm. NMR spectra were recorded at ambient temperature (22 ± 1 °C), unless otherwise noted, on Bruker AVANCE III HD spectrometers. <sup>1</sup>H NMR spectra were obtained at 300, 400, 500, or 600 MHz, and referenced to the residual solvent signal (2.50 ppm for [D<sub>6</sub>]DMSO). <sup>13</sup>C NMR spectra were obtained at 125 MHz and also referenced to the residual solvent signal (39.52 ppm for [D<sub>6</sub>]DMSO). <sup>1</sup>H NMR data are reported as follows: chemical shift (δ) in ppm, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, and m = multiplet) and integration. Low-resolution mass spectra (electrospray ionization) were obtained via HPLC–MS (ESI) using a Waters Acquity UPLC system equipped with an SQ 3100 Mass Detector; column: Acquity UPLC BEH C18 1.7 μm, 50 × 2.1 mm; eluent A: H<sub>2</sub>O + 0.05% formic acid (99%), eluent B: MeCN + 0.05% formic acid (99%); gradient: 0–0.5 min 5% B, 0.5–2.5 min 5–100% B, 2.5–4.5 min 100% B; total run time: 5 min; flow: 0.5 mL/min. Melting points were determined with a Büchi B-540 melting point apparatus. Optical rotations were recorded on a JASCO P-2000 polarimeter. The purity of all target compounds was at least 95%, as determined by <sup>1</sup>H NMR spectroscopy and UPLC analysis. Compound names were generated using ICS software.</div><div class="NLM_p last">Only the synthesis of compound <b>34</b> (BAY-985) is described in this section. For all other compounds, please see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of <b>34</b> (BAY-985)</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 6-Chloro-<i>N</i>,<i>N</i>-dimethylpyrimidin-4-amine (<b>38</b>)</h4><div class="NLM_p last">4,6-Dichloropyrimidine (50.0 g, 336 mmol), dimethylamine (180 mL, 2.0 M in THF, 369 mmol), and K<sub>2</sub>CO<sub>3</sub> (51.0 g, 369 mmol) were stirred in 1,4-dioxane (400 mL) for 14 h at reflux. Then, the reaction mixture was cooled to rt and diluted with water. The aqueous phase was extracted with DCM. The organic layer was dried over a silicone filter and concentrated under reduced pressure to provide <b>38</b> (53.7 g), which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.06 (br s, 6H), 6.75 (d, <i>J</i> = 1.01 Hz, 1H), 8.31 (d, <i>J</i> = 1.01 Hz, 1H). LC–MS (method 2, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>): <i>t</i><sub>R</sub> (min) 0.76. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 158 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-[6-(Dimethylamino)pyrimidin-4-yl]benzene-1,2-diamine (<b>39</b>)</h4><div class="NLM_p last">4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzene-1,2-diamine (<b>37</b>; 20.0 g, 85.4 mmol) and crude chloropyrimidine <b>38</b> (16.2 g) were dissolved in 1,4-dioxane (500 mL), and Na<sub>2</sub>CO<sub>3</sub> (130 mL, 2.0 M in water, 260 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (9.87 g, 8.54 mmol) were added. The mixture was stirred for 2 h at 90 °C; then, additional Pd(PPh<sub>3</sub>)<sub>4</sub> (2.0 g, 1.73 mmol) was added and stirring continued overnight at 90 °C. The mixture was cooled to rt and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by flash chromatography (hexane/EtOAc → EtOAc/EtOH) to give <b>39</b>. Yield 15.4 g (74% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.09 (s, 6H), 4.55 (s, 2H), 4.92 (s, 2H), 6.54 (d, <i>J</i> = 8.36 Hz, 1H), 6.79 (d, <i>J</i> = 1.01 Hz, 1H), 7.24 (dd, <i>J</i> = 8.11, 2.03 Hz, 1H), 7.37 (d, <i>J</i> = 2.03 Hz, 1H), 8.41 (d, <i>J</i> = 1.01 Hz, 1H). LC–MS (method 2, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>): <i>t</i><sub>R</sub> (min) = 0.68. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 230 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl 4-{(1<i>R</i>)-1-[2-({6-[6-(Dimethylamino)pyrimidin-4-yl]-1<i>H</i>-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazine-1-carboxylate (<b>41</b>)</h4><div class="NLM_p">Step 1: 1<i>H</i>-Imidazole (989 mg, 14.5 mmol), TCDI (15.5 g, 87.2 mmol), and <i>tert</i>-butyl 4-[(1<i>R</i>)-1-(2-aminopyridin-4-yl)ethyl]piperazine-1-carboxylate (<b>40</b>; 24.5 g, 79.9 mmol) were dissolved in DCM (836 mL), and the mixture was stirred at 0 °C for 30 min and then stored in a freezer at −20 °C for 36 h. Benzene-1,2-diamine <b>39</b> (16.6 g, 72.6 mmol) dissolved in DCM (100 mL) was added, and the mixture was stirred at rt for 2 h. Then, it was diluted with water and extracted with DCM (3×). The combined organic layers were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated under reduced pressure.</div><div class="NLM_p last">Step 2: The crude material (44.8 g) was dissolved in DCM (700 mL), and EDCI hydrochloride (14.9 g, 77.6 mmol) was added. The mixture was stirred for 2 d under the argon atmosphere and then concentrated under reduced pressure. The crude product was purified by flash chromatography (EtOAc/EtOH) to give <b>41</b>. Yield 16.25 g (42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.29 (d, <i>J</i> = 6.59 Hz, 3H), 1.38 (s, 9H), 2.25–2.31 (m, 2H), 2.36–2.43 (m, 2H), 3.15 (s, 6H), 3.27–3.32 (m, 4H), 3.40–3.48 (m, 1H), 6.95 (br s, 1H), 7.03–7.13 (m, 1H), 7.17 (s, 1H), 7.36–7.55 (m, 1H), 7.84–7.93 (m, 1H), 8.14–8.33 (m, 2H), 8.52 (d, <i>J</i> = 1.01 Hz, 1H), 10.68 (br s, 1H), 12.09–12.33 (br m, 1H). LC–MS (method 2, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>): <i>t</i><sub>R</sub> (min) = 1.24. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 544 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-[6-(Dimethylamino)pyrimidin-4-yl]-<i>N</i>-{4-[(1<i>R</i>)-1-(piperazin-1-yl)ethyl]pyridin-2-yl}-1<i>H</i>-benzimidazol-2-amine Hydrochloride (<b>42</b>)</h4><div class="NLM_p last">Boc-protected benzimidazole <b>41</b> (21.5 g, 39.6 mmol) was dissolved in DCM (300 mL) and MeOH (150 mL), and HCl (149 mL, 4.0 M in 1,4-dioxane, 594 mmol) was added. The mixture was stirred for 4 h at rt and then concentrated to give hydrochloride <b>42</b> (25.3 g), which was used without further purification. LC–MS (method 2, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>): <i>t</i><sub>R</sub> (min) = 0.92. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 444 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(4-{(1<i>R</i>)-1-[2-({6-[6-(Dimethylamino)pyrimidin-4-yl]-1<i>H</i>-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one (<b>34</b>, BAY-985)</h4><div class="NLM_p last">Hydrochloride <b>42</b> (19.3 g, crude material) was dissolved in DMF (310 mL), and 3,3,3-trifluoropropanoic acid (4.6 mL, 52 mmol), NaHCO<sub>3</sub> (17.6 g, 209 mmol), and HATU (19.9 g, 52.4 mmol) were added. The mixture was stirred for 2 h at rt and then filtered. The filtrate was poured into half-saturated NaHCO<sub>3</sub> solution. The suspension was filtered, and the solids were washed with water and dried under reduced pressure at 60 °C to give <b>34</b>. Yield 11.89 g (100% purity by UPLC–MS). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.30 (d, <i>J</i> = 6.59 Hz, 3H), 2.32–2.47 (m, 4H), 3.15 (s, 6H), 3.41–3.52 (m, 5H), 3.56–3.67 (m, 2H), 6.95 (br d, <i>J</i> = 4.82 Hz, 1H), 7.03–7.13 (m, 1H), 7.18 (s, 1H), 7.37–7.59 (m, 1H), 7.85–7.93 (m, 1H), 8.15 (br s, 0.5H), 8.27 (d, <i>J</i> = 5.32 Hz, 1H), 8.31 (br s, 0.5H), 8.52 (d, <i>J</i> = 1.01 Hz, 1H), 10.70 (br d, <i>J</i> = 12.93 Hz, 1H), 12.22 (br d, <i>J</i> = 17.24 Hz, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.5, 161.8, 157.6, 154.4, 153.7, 147.0, 132.9, 129.0, 125.1, 115.5, 115.0, 109.7, 96.6, 62.6, 49.9, 43.4, 36.9, 36.7, 18.1. LC–MS (method 2, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Supporting Information</a>): <i>t</i><sub>R</sub> (min) = 1.06. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 554 [M + H]<sup>+</sup>. HRMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 554.2607 [M + H] (calcd <i>m</i>/<i>z</i>: 553.2525 [M]).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01460" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01460?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01460</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Detailed descriptions of methods for the HTS; all biochemical and cellular assays, pharmacokinetics assays; synthesis of compounds <b>1</b> to <b>36</b>; crystallization and structure determination; tables containing IC<sub>50</sub> values with standard deviation; kinase selectivity results; crystallographic data collection and refinement statistics; and additional crystallography result figure (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_001.csv">jm9b01460_si_001.csv (6.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf">jm9b01460_si_002.pdf (710.1 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors for the described crystal structures have been deposited with the Protein Data Bank (PDB). The PDB accession codes are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR">6RSR</a> (compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RST">6RST</a> (compound <b>24</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSU">6RSU</a> (compound <b>35</b>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01460" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julien Lefranc</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2116-9425" title="Orcid link">http://orcid.org/0000-0002-2116-9425</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#305a455c59555e1e5c555642515e537052514955421e535f5d"><span class="__cf_email__" data-cfemail="e18b948d88848fcf8d848793808f82a18380988493cf828e8c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Volker Klaus Schulze</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0158-1789" title="Orcid link">http://orcid.org/0000-0002-0158-1789</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roman Christian Hillig</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans Briem</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florian Prinz</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Mengel</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tobias Heinrich</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jozsef Balint</span> - <span class="hlFld-Affiliation affiliation">ASCA
GmbH (Angewandte Synthesechemie Adlershof), 12489 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srinivasan Rengachari</span> - <span class="hlFld-Affiliation affiliation">Leicester
Institute of Structural and Chemical Biology, Department of Molecular
and Cell Biology, University of Leicester, Lancaster Road, LE1 7RH Leicester, U.K.</span>; 
    <span>Present Address:
                        Max Planck Institute for Biophysical Chemistry, Department of Molecular Biology, Göttingen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Horst Irlbacher</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Detlef Stöckigt</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Bömer</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Bader</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Nikolaus Gradl</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carl Friedrich Nising</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franz von Nussbaum</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominik Mumberg</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Panne</span> - <span class="hlFld-Affiliation affiliation">Leicester
Institute of Structural and Chemical Biology, Department of Molecular
and Cell Biology, University of Leicester, Lancaster Road, LE1 7RH Leicester, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">European
Molecular Biology Laboratory, 38042 Grenoble, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antje Margret Wengner</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals,
Research and Development, Bayer AG, 13353 Berlin, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank S. Böttcher, L. Ehresmann, J. Fischer, M. Keifler, A. Klinner, C. Kröber, S. Osterberg, V. Raschke, S. Schulze, P. Stollberg, G. Piechowiak, F. Probst, and D. Wolleh for technical support, the staff at beamline ID30A-1 at the European Synchrotron Radiation Facility (ESRF) in Grenoble for access to synchrotron radiation and support during data collection, and DiscoverX and Eurofins for performing the kinase selectivity studies. We would like to thank K. Greenfield for support with writing the manuscript as well as J. Fischer and K. Deja for their help with compiling the experimental part.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">TBK1</td><td class="NLM_def"><p class="first last">TANK-binding kinase 1</p></td></tr><tr><td class="NLM_term">IKKε</td><td class="NLM_def"><p class="first last">inhibitor of nuclear factor κ-B kinase subunit ε</p></td></tr><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">CK1γ</td><td class="NLM_def"><p class="first last">casein kinase 1</p></td></tr><tr><td class="NLM_term">JNK3</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio (in Caco-2 assay)</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">RSK4</td><td class="NLM_def"><p class="first last">ribosomal S6 kinase 4</p></td></tr><tr><td class="NLM_term">DRAK1</td><td class="NLM_def"><p class="first last">death-associated protein kinase-related apoptosis-inducing kinase 1</p></td></tr><tr><td class="NLM_term">YSK4</td><td class="NLM_def"><p class="first last">yeast Sps1/Ste20-related kinase 4 (also called MAP3K19)</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">CL<sub>b</sub></td><td class="NLM_def"><p class="first last">blood clearance</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxy carbonyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhirter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faia, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniatis, T.</span></span> <span> </span><span class="NLM_article-title">IKKε and TBK1 are essential components of the IRF3 signaling pathway</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1038/ni921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1038%2Fni921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=12692549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlakt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=491-496&author=K.+A.+Fitzgeraldauthor=S.+M.+McWhirterauthor=K.+L.+Faiaauthor=D.+C.+Roweauthor=E.+Latzauthor=D.+T.+Golenbockauthor=A.+J.+Coyleauthor=S.-M.+Liaoauthor=T.+Maniatis&title=IKK%CE%B5+and+TBK1+are+essential+components+of+the+IRF3+signaling+pathway&doi=10.1038%2Fni921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">IKKε and TBK1 are essential components of the IRF3 signaling pathway</span></div><div class="casAuthors">Fitzgerald, Katherine A.; McWhirter, Sarah M.; Faia, Kerrie L.; Rowe, Daniel C.; Latz, Eicke; Golenbock, Douglas T.; Coyle, Anthony J.; Liao, Sha-Mei; Maniatis, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transcription factors interferon regulatory factor 3 (IRF3) and NF-κB are required for the expression of many genes involved in the innate immune response.  Viral infection, or the binding of double-stranded RNA to Toll-like receptor 3, results in the coordinate activation of IRF3 and NF-κB.  Activation of IRF3 requires signal-dependent phosphorylation, but little is known about the signaling pathway or kinases involved.  Here the authors report that the noncanonical IκB kinase homologs, IκB kinase-ε (IKKε) and TANK-binding kinase-1 (TBK1), which were previously implicated in NF-κB activation, are also essential components of the IRF3 signaling pathway.  Thus, IKKε and TBK1 have a pivotal role in coordinating the activation of IRF3 and NF-κB in the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptsqPVRs3ofrVg90H21EOLACvtfcHk0ljdyfgFvmRN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlakt7k%253D&md5=57ed4331a366ca6e1fff2af8e8505967</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni921%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DMcWhirter%26aufirst%3DS.%2BM.%26aulast%3DFaia%26aufirst%3DK.%2BL.%26aulast%3DRowe%26aufirst%3DD.%2BC.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DCoyle%26aufirst%3DA.%2BJ.%26aulast%3DLiao%26aufirst%3DS.-M.%26aulast%3DManiatis%26aufirst%3DT.%26atitle%3DIKK%25CE%25B5%2520and%2520TBK1%2520are%2520essential%2520components%2520of%2520the%2520IRF3%2520signaling%2520pathway%26jtitle%3DNat.%2520Immunol.%26date%3D2003%26volume%3D4%26spage%3D491%26epage%3D496%26doi%3D10.1038%2Fni921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">tenOever, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandvaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiscott, J.</span></span> <span> </span><span class="NLM_article-title">Triggering the interferon antiviral response through an IKK-related pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">1148</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1126/science.1081315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1126%2Fscience.1081315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=12702806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=1148-1151&author=S.+Sharmaauthor=B.+R.+tenOeverauthor=N.+Grandvauxauthor=G.-P.+Zhouauthor=R.+Linauthor=J.+Hiscott&title=Triggering+the+interferon+antiviral+response+through+an+IKK-related+pathway&doi=10.1126%2Fscience.1081315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Triggering the Interferon Antiviral Response Through an IKK-Related Pathway</span></div><div class="casAuthors">Sharma, Sonia; ten Oever, Benjamin R.; Grandvaux, Nathalie; Zhou, Guo-Ping; Lin, Rongtuan; Hiscott, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">5622</span>),
    <span class="NLM_cas:pages">1148-1152</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Rapid induction of type I interferon expression, a central event in establishing the innate antiviral response, requires cooperative activation of numerous transcription factors.  Although signaling pathways that activate the transcription factors nuclear factor κB and ATF-2/c-Jun have been well characterized, activation of the interferon regulatory factors IRF-3 and IRF-7 has remained a crit. missing link in understanding interferon signaling.  We report here that the IκB kinase (IKK)-related kinases IKKε and TANK-binding kinase 1 (TBK1) are components of the virus-activated kinase that phosphorylate IRF-3 and IRF-7.  These studies illustrate an essential role for an IKK-related kinase pathway in triggering the host antiviral response to viral infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDrWALVOqi4rVg90H21EOLACvtfcHk0ljdyfgFvmRN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGqtrs%253D&md5=239b55b61cedd911d80348f0bc822cb0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1081315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1081315%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DtenOever%26aufirst%3DB.%2BR.%26aulast%3DGrandvaux%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DG.-P.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DHiscott%26aufirst%3DJ.%26atitle%3DTriggering%2520the%2520interferon%2520antiviral%2520response%2520through%2520an%2520IKK-related%2520pathway%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D1148%26epage%3D1151%26doi%3D10.1126%2Fscience.1081315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholefield, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIver, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S.</span></span> <span> </span><span class="NLM_article-title">TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e50672</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0050672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1371%2Fjournal.pone.0050672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=23209807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A.+C.+Newmanauthor=C.+L.+Scholefieldauthor=A.+J.+Kempauthor=M.+Newmanauthor=E.+G.+McIverauthor=A.+Kamalauthor=S.+Wilkinson&title=TBK1+kinase+addiction+in+lung+cancer+cells+is+mediated+via+autophagy+of+Tax1bp1%2FNdp52+and+non-canonical+NF-%CE%BAB+signalling&doi=10.1371%2Fjournal.pone.0050672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling</span></div><div class="casAuthors">Newman, Alice C.; Scholefield, Caroline L.; Kemp, Alain J.; Newman, Michelle; McIver, Edward G.; Kamal, Ahmad; Wilkinson, Simon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e50672</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">K-Ras dependent non-small cell lung cancer (NSCLC) cells are 'addicted' to basal autophagy that reprograms cellular metab. in a lysosomal-sensitive manner.  Here we demonstrate that the xenophagy-assocd. kinase TBK1 drives basal autophagy, consistent with its known requirement in K-Ras-dependent NSCLC proliferation.  Furthermore, basal autophagy in this context is characterised by sequestration of the xenophagy cargo receptor Ndp52 and its paralogue Tax1bp1, which we demonstrate here to be a bona fide cargo receptor.  Autophagy of these cargo receptors promotes non-canonical NF-κB signalling.  We propose that this TBK1-dependent mechanism for NF-κB signalling contributes to autophagy addiction in K-Ras driven NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4GOMvvYu1HLVg90H21EOLACvtfcHk0ljdyfgFvmRN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqsb%252FN&md5=fc67d5a03c51b7c79b9ab599a39b03d2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0050672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0050672%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BC.%26aulast%3DScholefield%26aufirst%3DC.%2BL.%26aulast%3DKemp%26aufirst%3DA.%2BJ.%26aulast%3DNewman%26aufirst%3DM.%26aulast%3DMcIver%26aufirst%3DE.%2BG.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DWilkinson%26aufirst%3DS.%26atitle%3DTBK1%2520kinase%2520addiction%2520in%2520lung%2520cancer%2520cells%2520is%2520mediated%2520via%2520autophagy%2520of%2520Tax1bp1%252FNdp52%2520and%2520non-canonical%2520NF-%25CE%25BAB%2520signalling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0050672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arko-Mensah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponpuak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Master, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornatowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradfute, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruun, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deretic, V.</span></span> <span> </span><span class="NLM_article-title">TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.immuni.2012.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=22921120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GksbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=223-234&author=M.+Pilliauthor=J.+Arko-Mensahauthor=M.+Ponpuakauthor=E.+Robertsauthor=S.+Masterauthor=M.+A.+Mandellauthor=N.+Dupontauthor=W.+Ornatowskiauthor=S.+Jiangauthor=S.+B.+Bradfuteauthor=J.-A.+Bruunauthor=T.+E.+Hansenauthor=T.+Johansenauthor=V.+Deretic&title=TBK-1+promotes+autophagy-mediated+antimicrobial+defense+by+controlling+autophagosome+maturation&doi=10.1016%2Fj.immuni.2012.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">TBK-1 Promotes Autophagy-Mediated Antimicrobial Defense by Controlling Autophagosome Maturation</span></div><div class="casAuthors">Pilli, Manohar; Arko-Mensah, John; Ponpuak, Marisa; Roberts, Esteban; Master, Sharon; Mandell, Michael A.; Dupont, Nicolas; Ornatowski, Wojciech; Jiang, Shanya; Bradfute, Steven B.; Bruun, Jack-Ansgar; Hansen, Tom Egil; Johansen, Terje; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-234</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Autophagy is a fundamental biol. process of the eukaryotic cell contributing to diverse cellular and physiol. functions including cell-autonomous defense against intracellular pathogens.  Here, we screened the Rab family of membrane trafficking regulators for effects on autophagic elimination of Mycobacterium tuberculosis var. bovis BCG and found that Rab8b and its downstream interacting partner, innate immunity regulator TBK-1, are required for autophagic elimination of mycobacteria in macrophages.  TBK-1 was necessary for autophagic maturation.  TBK-1 coordinated assembly and function of the autophagic machinery and phosphorylated the autophagic adaptor p62 (sequestosome 1) on Ser-403, a residue essential for its role in autophagic clearance.  A key proinflammatory cytokine, IL-1β, induced autophagy leading to autophagic killing of mycobacteria in macrophages, and this IL-1β activity was dependent on TBK-1.  Thus, TBK-1 is a key regulator of immunol. autophagy and is responsible for the maturation of autophagosomes into lytic bactericidal organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpa-L6h6ibrVg90H21EOLACvtfcHk0lhJlr8Sv94y3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GksbfN&md5=2bdcb1d8b65ca833a15c3f1fd48b0553</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DPilli%26aufirst%3DM.%26aulast%3DArko-Mensah%26aufirst%3DJ.%26aulast%3DPonpuak%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DMaster%26aufirst%3DS.%26aulast%3DMandell%26aufirst%3DM.%2BA.%26aulast%3DDupont%26aufirst%3DN.%26aulast%3DOrnatowski%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DBradfute%26aufirst%3DS.%2BB.%26aulast%3DBruun%26aufirst%3DJ.-A.%26aulast%3DHansen%26aufirst%3DT.%2BE.%26aulast%3DJohansen%26aufirst%3DT.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DTBK-1%2520promotes%2520autophagy-mediated%2520antimicrobial%2520defense%2520by%2520controlling%2520autophagosome%2520maturation%26jtitle%3DImmunity%26date%3D2012%26volume%3D37%26spage%3D223%26epage%3D234%26doi%3D10.1016%2Fj.immuni.2012.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span> <span> </span><span class="NLM_article-title">Autophagy in antimicrobial immunity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.molcel.2014.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24766886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=224-233&author=L.+C.+Gomesauthor=I.+Dikic&title=Autophagy+in+antimicrobial+immunity&doi=10.1016%2Fj.molcel.2014.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in Antimicrobial Immunity</span></div><div class="casAuthors">Gomes, Ligia C.; Dikic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-233</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Autophagy plays a key role in cellular homeostasis, responding to various environmental stresses.  In particular, pathogen invasion leads to rapid induction of autophagy, which is crit. for both innate and adaptive immune responses.  In this review, we focus on the emerging mol. mechanisms of pathogen elimination by autophagy (a process known as xenophagy) and on the strategies developed by pathogens to subvert autophagy.  We also address other functions of autophagy proteins in restricting pathogen invasion, independent of the formation of a canonical double-membrane autophagosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6oYcDQ219vrVg90H21EOLACvtfcHk0lhJlr8Sv94y3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGhtr0%253D&md5=5064824755c4175fac744640f19a4445</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DL.%2BC.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DAutophagy%2520in%2520antimicrobial%2520immunity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D224%26epage%3D233%26doi%3D10.1016%2Fj.molcel.2014.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, E.-L.</span></span> <span> </span><span class="NLM_article-title">Autophagy: Supporting cellular and organismal homeostasis by self-eating</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2019.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.biocel.2019.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=30940605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvFSntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2019&pages=1-10&author=E.-L.+Eskelinen&title=Autophagy%3A+Supporting+cellular+and+organismal+homeostasis+by+self-eating&doi=10.1016%2Fj.biocel.2019.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: Supporting cellular and organismal homeostasis by self-eating</span></div><div class="casAuthors">Eskelinen, Eeva-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Autophagy is a conserved catabolic process that delivers cytoplasmic components and organelles to lysosomes for degrdn. and recycling.  This pathway serves to degrade nonfunctional organelles and aggregate-prone proteins, as well as to produce substrates for energy prodn. and biosynthesis.  Autophagy is esp. important for the maintenance of stem cells, and for the survival and homeostasis of post-mitotic cells like neurons.  Functional autophagy promotes longevity in several model organisms.  Autophagy regulates immunity and inflammation at several levels and has both anti- and pro-tumorigenic roles in cancer.  This review provides a concise overview of autophagy and its importance in cellular and organismal homeostasis, with emphasis on aging, stem cells, neuronal cells, immunity, inflammation, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHCCCyu3Uh7Vg90H21EOLACvtfcHk0lhJlr8Sv94y3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvFSntLw%253D&md5=06421829fb82b19eb024660a78a0708c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2019.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2019.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DEskelinen%26aufirst%3DE.-L.%26atitle%3DAutophagy%253A%2520Supporting%2520cellular%2520and%2520organismal%2520homeostasis%2520by%2520self-eating%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2019%26volume%3D111%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.biocel.2019.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span> <span> </span><span class="NLM_article-title">The roles of autophagy in cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3466</span>, <span class="refDoi"> DOI: 10.3390/ijms19113466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.3390%2Fijms19113466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVKksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3466&author=C.+Yunauthor=S.+Lee&title=The+roles+of+autophagy+in+cancer&doi=10.3390%2Fijms19113466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of autophagy in cancer</span></div><div class="casAuthors">Yun, Chul Won; Lee, Sang Hun</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3466/1-3466/18</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Autophagy is an intracellular degradative process that occurs under several stressful conditions, including organelle damage, the presence of abnormal proteins, and nutrient deprivation.  The mechanism of autophagy initiates the formation of autophagosomes that capture degraded components and then fuse with lysosomes to recycle these components.  The modulation of autophagy plays dual roles in tumor suppression and promotion in many cancers.  In addn., autophagy regulates the properties of cancer stem-cells by contributing to the maintenance of stemness, the induction of recurrence, and the development of resistance to anticancer reagents.  Although some autophagy modulators, such as rapamycin and chloroquine, are used to regulate autophagy in anticancer therapy, since this process also plays roles in both tumor suppression and promotion, the precise mechanism of autophagy in cancer requires further study.  In this review, we will summarize the mechanism of autophagy under stressful conditions and its roles in tumor suppression and promotion in cancer and in cancer stem-cells.  Furthermore, we discuss how autophagy is a promising potential therapeutic target in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq15OqSo4-izLVg90H21EOLACvtfcHk0liEnV8wusGpNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVKksb0%253D&md5=f390920f25a16b47d16d0978b3b180e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fijms19113466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19113466%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DThe%2520roles%2520of%2520autophagy%2520in%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3466%26doi%3D10.3390%2Fijms19113466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacevic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungblut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terzic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1242/jcs.114926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1242%2Fjcs.114926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=23178947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntleksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=580-592&author=J.+Koracauthor=V.+Schaefferauthor=I.+Kovacevicauthor=A.+M.+Clementauthor=B.+Jungblutauthor=C.+Behlauthor=J.+Terzicauthor=I.+Dikic&title=Ubiquitin-independent+function+of+optineurin+in+autophagic+clearance+of+protein+aggregates&doi=10.1242%2Fjcs.114926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates</span></div><div class="casAuthors">Korac, Jelena; Schaeffer, Veronique; Kovacevic, Igor; Clement, Albrecht M.; Jungblut, Benno; Behl, Christian; Terzic, Janos; Dikic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">580-592</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Aggregation of misfolded proteins and the assocd. loss of neurons are considered a hallmark of numerous neurodegenerative diseases.  Optineurin is present in protein inclusions obsd. in various neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Huntington's disease, Alzheimer's disease, Parkinson's disease, Creutzfeld-Jacob disease and Pick's disease.  Optineurin deletion mutations have also been described in ALS patients.  However, the role of optineurin in mechanisms of protein aggregation remains unclear.  In this report, we demonstrate that optineurin recognizes various protein aggregates via its C-terminal coiled-coil domain in a ubiquitin-independent manner.  We also show that optineurin depletion significantly increases protein aggregation in HeLa cells and that morpholino-silencing of the optineurin ortholog in zebrafish causes the motor axonopathy phenotype similar to a zebrafish model of ALS.  A more severe phenotype is obsd. when optineurin is depleted in zebrafish carrying ALS mutations.  Furthermore, TANK1 binding kinase 1 (TBK1) is colocalized with optineurin on protein aggregates and is important in clearance of protein aggregates through the autophagy-lysosome pathway.  TBK1 phosphorylates optineurin at serine 177 and regulates its ability to interact with autophagy modifiers.  This study provides evidence for a ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates as well as addnl. relevance for TBK1 as an upstream regulator of the autophagic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdIVcoNUmRxbVg90H21EOLACvtfcHk0liEnV8wusGpNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntleksLc%253D&md5=db386195406da3463d536e9ad4f95f8d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1242%2Fjcs.114926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.114926%26sid%3Dliteratum%253Aachs%26aulast%3DKorac%26aufirst%3DJ.%26aulast%3DSchaeffer%26aufirst%3DV.%26aulast%3DKovacevic%26aufirst%3DI.%26aulast%3DClement%26aufirst%3DA.%2BM.%26aulast%3DJungblut%26aufirst%3DB.%26aulast%3DBehl%26aufirst%3DC.%26aulast%3DTerzic%26aufirst%3DJ.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DUbiquitin-independent%2520function%2520of%2520optineurin%2520in%2520autophagic%2520clearance%2520of%2520protein%2520aggregates%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2013%26volume%3D126%26spage%3D580%26epage%3D592%26doi%3D10.1242%2Fjcs.114926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span> <span> </span><span class="NLM_article-title">Common traits spark the mitophagy/xenophagy interplay</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1172</span>, <span class="refDoi"> DOI: 10.3389/fphys.2018.01172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.3389%2Ffphys.2018.01172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=30294276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A280%3ADC%252BB3czms1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1172&author=A.+Singhauthor=S.+L.+Kendallauthor=M.+Campanella&title=Common+traits+spark+the+mitophagy%2Fxenophagy+interplay&doi=10.3389%2Ffphys.2018.01172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Common Traits Spark the Mitophagy/Xenophagy Interplay</span></div><div class="casAuthors">Singh Aarti; Campanella Michelangelo; Kendall Sharon L; Campanella Michelangelo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1172</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">Selective autophagy contributes to the wellbeing of eukaryotic cells by recycling cellular components, disposing damaged organelles, and removing pathogens, amongst others.  Both the quality control process of selective mitochondrial autophagy (Mitophagy) and the defensive process of intracellular pathogen-engulfment (Xenophagy) are facilitated via protein assemblies which have shared molecules, a prime example being the Tank-Binding Kinase 1 (TBK1).  TBK1 plays a central role in the immunity response driven by Xenophagy and was recently shown to be an amplifying mechanism in Mitophagy, bring to attention the potential cross talk between the two processes.  Here we draw parallels between Xenophagy and Mitophagy, speculating on the inhibitory mechanisms of specific proteins (e.g., the 18 kDa protein TSPO), how the preferential sequestering toward one of the two pathways may undermine the other, and in this way impair cellular response to pathogens and cellular immunity.  We believe that an in depth understanding of the commonalities may present an opportunity to design novel therapeutic strategies targeted at both the autonomous and non-autonomous processes of selective autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSa3S_UovOd7WPgL4LrC-0VfW6udTcc2eZkmWy5BLyTmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czms1KnsQ%253D%253D&md5=fe34d3e87bacf70edc89a5f0044a4a5a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2018.01172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2018.01172%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKendall%26aufirst%3DS.%2BL.%26aulast%3DCampanella%26aufirst%3DM.%26atitle%3DCommon%2520traits%2520spark%2520the%2520mitophagy%252Fxenophagy%2520interplay%26jtitle%3DFront.%2520Physiol.%26date%3D2018%26volume%3D9%26spage%3D1172%26doi%3D10.3389%2Ffphys.2018.01172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watowich, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1084/jem.20161524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1084%2Fjem.20161524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=28356390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2017&pages=1493-1507&author=Y.+Xiaoauthor=Q.+Zouauthor=X.+Xieauthor=T.+Liuauthor=H.+S.+Liauthor=Z.+Jieauthor=J.+Jinauthor=H.+Huauthor=G.+Manyamauthor=L.+Zhangauthor=X.+Chengauthor=H.+Wangauthor=I.+Marieauthor=D.+E.+Levyauthor=S.+S.+Watowichauthor=S.-C.+Sun&title=The+kinase+TBK1+functions+in+dendritic+cells+to+regulate+T+cell+homeostasis%2C+autoimmunity%2C+and+antitumor+immunity&doi=10.1084%2Fjem.20161524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity</span></div><div class="casAuthors">Xiao, Yichuan; Zou, Qiang; Xie, Xiaoping; Liu, Ting; Li, Haiyan S.; Jie, Zuliang; Jin, Jin; Hu, Hongbo; Manyam, Ganiraju; Zhang, Li; Cheng, Xuhong; Wang, Hui; Marie, Isabelle; Levy, David E.; Watowich, Stephanie S.; Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1493-1507</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">1540-9538</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Dendritic cells (DCs) are crucial for mediating immune responses but, when deregulated, also contribute to immunol. disorders, such as autoimmunity.  The mol. mechanism underlying the function of DCs is incompletely understood.  In this study, we have identified TANK-binding kinase 1 (TBK1), a master innate immune kinase, as an important regulator of DC function.  DC-specific deletion of Tbk1 causes T cell activation and autoimmune symptoms and also enhances antitumor immunity in animal models of cancer immunotherapy.  The TBK1-deficient DCs have up-regulated expression of co-stimulatory mols. and increased T cell-priming activity.  We further demonstrate that TBK1 neg. regulates the induction of a subset of genes by type I interferon receptor (IFNAR).  Deletion of IFNAR1 could largely prevent aberrant T cell activation and autoimmunity in DC-conditional Tbk1 knockout mice.  These findings identify a DC-specific function of TBK1 in the maintenance of immune homeostasis and tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKZsWUz77p-LVg90H21EOLACvtfcHk0lijG-495E5P3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7jJ&md5=974f9b22ad3a2a1574452fa5151c9b27</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1084%2Fjem.20161524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20161524%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%2BS.%26aulast%3DJie%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DManyam%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMarie%26aufirst%3DI.%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DWatowich%26aufirst%3DS.%2BS.%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DThe%2520kinase%2520TBK1%2520functions%2520in%2520dendritic%2520cells%2520to%2520regulate%2520T%2520cell%2520homeostasis%252C%2520autoimmunity%252C%2520and%2520antitumor%2520immunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2017%26volume%3D214%26spage%3D1493%26epage%3D1507%26doi%3D10.1084%2Fjem.20161524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span> <span> </span><span class="NLM_article-title">TBK1 promote bladder cancer cell proliferation and migration via Akt signaling</span>. <i>J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1892</span>– <span class="NLM_lpage">1899</span>, <span class="refDoi"> DOI: 10.7150/jca.17638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.7150%2Fjca.17638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=28819387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A280%3ADC%252BC1cfpsVyqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1892-1899&author=W.+Chenauthor=K.+Luoauthor=Z.+Keauthor=B.+Kuaiauthor=S.+Heauthor=W.+Jiangauthor=W.+Huangauthor=Z.+Cai&title=TBK1+promote+bladder+cancer+cell+proliferation+and+migration+via+Akt+signaling&doi=10.7150%2Fjca.17638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling</span></div><div class="casAuthors">Chen Wei; Luo Kewang; Ke Zhiyi; He Shiyang; Jiang Wei; Huang Weiren; Cai Zhiming; Kuai Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1892-1899</span>
        ISSN:<span class="NLM_cas:issn">1837-9664</span>.
    </div><div class="casAbstract">Bladder cancer is a challenging and fatal malignancy and the improvement in prognosis is limited over years.  Deep understanding the mechanism of bladder cancer tumorigenesis and progression will help to discover novel and effective treatment strategies.  In this study, we identify non-canonical IkB kinase TBK1 is up-regulated in bladder cancer tissue and cell lines.  Knockdown of TBK1 markedly inhibits cell proliferation and migration.  Inhibition of TBK1 kinase activity by BX795 significantly attenuates bladder cancer cell proliferation and migration.  Mechanistic study shows that overexpression of TBK1 promoted the phosphorylation of Akt, whereas knockdown of TBK1 reverses this action.  Taken together, our data suggest that TBK1 modulates the malignant behaviors of bladder cancer cell via Akt signaling, revealing new insights in discovering new therapy target for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7Wv3q1vQF3UEgZCMqtRBifW6udTcc2easc6esIiRqXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfpsVyqsw%253D%253D&md5=8e71b429a5de279267f6a44fcda95479</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.7150%2Fjca.17638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fjca.17638%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DK.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DKuai%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DZ.%26atitle%3DTBK1%2520promote%2520bladder%2520cancer%2520cell%2520proliferation%2520and%2520migration%2520via%2520Akt%2520signaling%26jtitle%3DJ.%2520Cancer%26date%3D2017%26volume%3D8%26spage%3D1892%26epage%3D1899%26doi%3D10.7150%2Fjca.17638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, X.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span> <span> </span><span class="NLM_article-title">Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">E601</span>– <span class="NLM_lpage">E610</span>, <span class="refDoi"> DOI: 10.1073/pnas.1316255111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.1316255111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24449872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E601-E610&author=C.+Weiauthor=Y.+Caoauthor=X.+Yangauthor=Z.+Zhengauthor=K.+Guanauthor=Q.+Wangauthor=Y.+Taiauthor=Y.+Zhangauthor=S.+Maauthor=Y.+Caoauthor=X.+Geauthor=C.+Xuauthor=J.+Liauthor=H.+Yanauthor=Y.+Lingauthor=T.+Songauthor=L.+Zhuauthor=B.+Zhangauthor=Q.+Xuauthor=C.+Huauthor=X.-w.+Bianauthor=X.+Heauthor=H.+Zhong&title=Elevated+expression+of+TANK-binding+kinase+1+enhances+tamoxifen+resistance+in+breast+cancer&doi=10.1073%2Fpnas.1316255111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer</span></div><div class="casAuthors">Wei, Congwen; Cao, Yuan; Yang, Xiaoli; Zheng, Zirui; Guan, Kai; Wang, Qiang; Tai, Yanhong; Zhang, Yanhong; Ma, Shengli; Cao, Ye; Ge, Xiaoxing; Xu, Changzhi; Li, Jia; Yan, Hui; Ling, Youguo; Song, Ting; Zhu, Lin; Zhang, Buchang; Xu, Quanbin; Hu, Chengjin; Bian, Xiu-wu; He, Xiang; Zhong, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">E601-E610</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Resistance to antiestrogens is one of the major challenges in breast cancer treatment.  Although phosphorylation of estrogen receptor α (ERα) is an important factor in endocrine resistance, the contributions of specific kinases in endocrine resistance are still not fully understood.  Here, we report that an important innate immune response kinase, the IκB kinase-related TANK-binding kinase 1 (TBK1), is a crucial determinant of resistance to tamoxifen therapies.  We show that TBK1 increases ERα transcriptional activity through phosphorylation modification of ERα at the Ser-305 site.  Ectopic TBK1 expression impairs the responsiveness of breast cancer cells to tamoxifen.  By studying the specimens from patients with breast cancer, we find a strong pos. correlation of TBK1 with ERα, ERα Ser-305, and cyclin D1.  Notably, patients with tumors highly expressing TBK1 respond poorly to tamoxifen treatment and show high potential for relapse.  Therefore, our findings suggest that TBK1 contributes to tamoxifen resistance in breast cancer via phosphorylation modification of ERα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7g9UakTBLG7Vg90H21EOLACvtfcHk0lhSSDTPJL0n0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyis7k%253D&md5=aab3413f2df8313a5425f67f94b1dfb9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1316255111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1316255111%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DGuan%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DTai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DBian%26aufirst%3DX.-w.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DH.%26atitle%3DElevated%2520expression%2520of%2520TANK-binding%2520kinase%25201%2520enhances%2520tamoxifen%2520resistance%2520in%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3DE601%26epage%3DE610%26doi%3D10.1073%2Fpnas.1316255111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korherr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig-Hoffmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixelius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egland, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, U.</span></span> <span> </span><span class="NLM_article-title">Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">4240</span>– <span class="NLM_lpage">4245</span>, <span class="refDoi"> DOI: 10.1073/pnas.0511319103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.0511319103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=16537515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFWhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=4240-4245&author=C.+Korherrauthor=H.+Gilleauthor=R.+Schaferauthor=K.+Koenig-Hoffmannauthor=J.+Dixeliusauthor=K.+A.+Eglandauthor=I.+Pastanauthor=U.+Brinkmann&title=Identification+of+proangiogenic+genes+and+pathways+by+high-throughput+functional+genomics%3A+TBK1+and+the+IRF3+pathway&doi=10.1073%2Fpnas.0511319103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway</span></div><div class="casAuthors">Korherr, Christian; Gille, Hendrik; Schaefer, Rolf; Koenig-Hoffmann, Kerstin; Dixelius, Johan; Egland, Kristi A.; Pastan, Ira; Brinkmann, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4240-4245</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A genome-wide phenotype screen was used to identify factors and pathways that induce proliferation of human umbilical vein endothelial cells (HUVEC).  HUVEC proliferation is a recognized marker for factors that modulate vascularization.  Screening "hits" included known proangiogenic factors, such as VEGF, FGF1, and FGF2 and addnl. factors for which a direct assocn. with angiogenesis was not previously described.  These include the kinase TBK1 as well as Toll-like receptor adaptor mol. and IFN regulatory factor 3.  All three proteins belong to one signaling pathway that mediates induction of gene expression, including a mixt. of secreted factors, which, in concert, mediate proliferative activity toward endothelial cells.  TBK1 as the "trigger" of this pathway is induced under hypoxic conditions and expressed at significant levels in many solid tumors.  This pattern of expression and the decreased expression of angiogenic factors in cultured cells upon RNA-interference-mediated ablation suggests that TBK1 is important for vascularization and subsequent tumor growth and a target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5bnKzf81bcbVg90H21EOLACvtfcHk0lhSSDTPJL0n0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFWhsro%253D&md5=fac047c47cff388a9ef7e25bb5c8c7c9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0511319103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0511319103%26sid%3Dliteratum%253Aachs%26aulast%3DKorherr%26aufirst%3DC.%26aulast%3DGille%26aufirst%3DH.%26aulast%3DSchafer%26aufirst%3DR.%26aulast%3DKoenig-Hoffmann%26aufirst%3DK.%26aulast%3DDixelius%26aufirst%3DJ.%26aulast%3DEgland%26aufirst%3DK.%2BA.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DBrinkmann%26aufirst%3DU.%26atitle%3DIdentification%2520of%2520proangiogenic%2520genes%2520and%2520pathways%2520by%2520high-throughput%2520functional%2520genomics%253A%2520TBK1%2520and%2520the%2520IRF3%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D4240%26epage%3D4245%26doi%3D10.1073%2Fpnas.0511319103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbie, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meylan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiling, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadlow, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoersch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittner, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1038/nature08460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1038%2Fnature08460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=19847166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=108-112&author=D.+A.+Barbieauthor=P.+Tamayoauthor=J.+S.+Boehmauthor=S.+Y.+Kimauthor=S.+E.+Moodyauthor=I.+F.+Dunnauthor=A.+C.+Schinzelauthor=P.+Sandyauthor=E.+Meylanauthor=C.+Schollauthor=S.+Fr%C3%B6hlingauthor=E.+M.+Chanauthor=M.+L.+Sosauthor=K.+Michelauthor=C.+Mermelauthor=S.+J.+Silverauthor=B.+A.+Weirauthor=J.+H.+Reilingauthor=Q.+Shengauthor=P.+B.+Guptaauthor=R.+C.+Wadlowauthor=H.+Leauthor=S.+Hoerschauthor=B.+S.+Wittnerauthor=S.+Ramaswamyauthor=D.+M.+Livingstonauthor=D.+M.+Sabatiniauthor=M.+Meyersonauthor=R.+K.+Thomasauthor=E.+S.+Landerauthor=J.+P.+Mesirovauthor=D.+E.+Rootauthor=D.+G.+Gillilandauthor=T.+Jacksauthor=W.+C.+Hahn&title=Systematic+RNA+interference+reveals+that+oncogenic+KRAS-driven+cancers+require+TBK1&doi=10.1038%2Fnature08460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span></div><div class="casAuthors">Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Sandy, Peter; Meylan, Etienne; Scholl, Claudia; Froehling, Stefan; Chan, Edmond M.; Sos, Martin L.; Michel, Kathrin; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Reiling, Jan H.; Sheng, Qing; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Hoersch, Sebastian; Wittner, Ben S.; Ramaswamy, Sridhar; Livingston, David M.; Sabatini, David M.; Meyerson, Matthew; Thomas, Roman K.; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7269</span>),
    <span class="NLM_cas:pages">108-112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to std. therapies.  Although the identification of specific oncogenes has led to the development of clin. effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach.  A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele.  Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IκB kinase TBK1 was selectively essential in cells that contain mutant KRAS.  Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression.  In these cells, TBK1 activated NF-κB anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction.  These observations indicate that TBK1 and NF-κB signaling are essential in KRAS mutant tumors, and establish a general approach for the rational identification of co-dependent pathways in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlw2rhGywK0bVg90H21EOLACvtfcHk0lgW3z144sSQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL&md5=aab467de18805a08c3b1484f432ea64a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature08460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08460%26sid%3Dliteratum%253Aachs%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DDunn%26aufirst%3DI.%2BF.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMeylan%26aufirst%3DE.%26aulast%3DScholl%26aufirst%3DC.%26aulast%3DFr%25C3%25B6hling%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DMichel%26aufirst%3DK.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DSilver%26aufirst%3DS.%2BJ.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DReiling%26aufirst%3DJ.%2BH.%26aulast%3DSheng%26aufirst%3DQ.%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DWadlow%26aufirst%3DR.%2BC.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DHoersch%26aufirst%3DS.%26aulast%3DWittner%26aufirst%3DB.%2BS.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DSystematic%2520RNA%2520interference%2520reveals%2520that%2520oncogenic%2520KRAS-driven%2520cancers%2520require%2520TBK1%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D108%26epage%3D112%26doi%3D10.1038%2Fnature08460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumeister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakireva, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopelovich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeaman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camonis, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span> <span> </span><span class="NLM_article-title">RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.cell.2006.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17018283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSitrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=157-170&author=Y.+Chienauthor=S.+Kimauthor=R.+Bumeisterauthor=Y.-M.+Looauthor=S.+W.+Kwonauthor=C.+L.+Johnsonauthor=M.+G.+Balakirevaauthor=Y.+Romeoauthor=L.+Kopelovichauthor=M.+Galeauthor=C.+Yeamanauthor=J.+H.+Camonisauthor=Y.+Zhaoauthor=M.+A.+White&title=RalB+GTPase-mediated+activation+of+the+I%CE%BAB+family+kinase+TBK1+couples+innate+immune+signaling+to+tumor+cell+survival&doi=10.1016%2Fj.cell.2006.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival</span></div><div class="casAuthors">Chien, Yuchen; Kim, Sungchan; Bumeister, Ron; Loo, Yueh-Ming; Kwon, Sung Won; Johnson, Cynthia L.; Balakireva, Mirey G.; Romeo, Yves; Kopelovich, Levy; Gale, Michael, Jr.; Yeaman, Charles; Camonis, Jacques H.; Zhao, Yingming; White, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-170</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The monomeric RalGTPases, RalA and RalB are recognized as components of a regulatory framework supporting tumorigenic transformation.  Specifically, RalB is required to suppress apoptotic checkpoint activation, the mechanistic basis of which is unknown.  Reported effector proteins of RalB include the Sec5 component of the exocyst, an octameric protein complex implicated in tethering of vesicles to membranes.  Surprisingly, the authors find that the RalB/Sec5 effector complex directly recruits and activates the atypical IκB kinase family member TBK1.  In cancer cells, constitutive engagement of this pathway, via chronic RalB activation, restricts initiation of apoptotic programs typically engaged in the context of oncogenic stress.  Although dispensable for survival in a nontumorigenic context, this pathway helps mount an innate immune response to virus exposure.  These observations define the mechanistic contribution of RalGTPases to cancer cell survival and reveal the RalB/Sec5 effector complex as a component of TBK1-dependent innate immune signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsXgw7MqPab7Vg90H21EOLACvtfcHk0lgW3z144sSQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSitrzM&md5=b9c529423b1f96deec9c7069aa6964a9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DBumeister%26aufirst%3DR.%26aulast%3DLoo%26aufirst%3DY.-M.%26aulast%3DKwon%26aufirst%3DS.%2BW.%26aulast%3DJohnson%26aufirst%3DC.%2BL.%26aulast%3DBalakireva%26aufirst%3DM.%2BG.%26aulast%3DRomeo%26aufirst%3DY.%26aulast%3DKopelovich%26aufirst%3DL.%26aulast%3DGale%26aufirst%3DM.%26aulast%3DYeaman%26aufirst%3DC.%26aulast%3DCamonis%26aufirst%3DJ.%2BH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DRalB%2520GTPase-mediated%2520activation%2520of%2520the%2520I%25CE%25BAB%2520family%2520kinase%2520TBK1%2520couples%2520innate%2520immune%2520signaling%2520to%2520tumor%2520cell%2520survival%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D157%26epage%3D170%26doi%3D10.1016%2Fj.cell.2006.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aref, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohoon, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbie, T. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfrey, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silkworth, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labowsky, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozhansky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillanders, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacohen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbie, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.cd-13-0646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1158%2F2159-8290.cd-13-0646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24444711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFSmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=452-465&author=Z.+Zhuauthor=A.+R.+Arefauthor=T.+J.+Cohoonauthor=T.+U.+Barbieauthor=Y.+Imamuraauthor=S.+Yangauthor=S.+E.+Moodyauthor=R.+R.+Shenauthor=A.+C.+Schinzelauthor=T.+C.+Thaiauthor=J.+B.+Reibelauthor=P.+Tamayoauthor=J.+T.+Godfreyauthor=Z.+R.+Qianauthor=A.+N.+Pageauthor=K.+Maciagauthor=E.+M.+Chanauthor=W.+Silkworthauthor=M.+T.+Labowskyauthor=L.+Rozhanskyauthor=J.+P.+Mesirovauthor=W.+E.+Gillandersauthor=S.+Oginoauthor=N.+Hacohenauthor=S.+Gaudetauthor=M.+J.+Eckauthor=J.+A.+Engelmanauthor=R.+B.+Corcoranauthor=K.-K.+Wongauthor=W.+C.+Hahnauthor=D.+A.+Barbie&title=Inhibition+of+KRAS-driven+tumorigenicity+by+interruption+of+an+autocrine+cytokine+circuit&doi=10.1158%2F2159-8290.cd-13-0646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of KRAS-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit</span></div><div class="casAuthors">Zhu, Zehua; Aref, Amir R.; Cohoon, Travis J.; Barbie, Thanh U.; Imamura, Yu; Yang, Shenghong; Moody, Susan E.; Shen, Rhine R.; Schinzel, Anna C.; Thai, Tran C.; Reibel, Jacob B.; Tamayo, Pablo; Godfrey, Jason T.; Qian, Zhi Rong; Page, Asher N.; Maciag, Karolina; Chan, Edmond M.; Silkworth, Whitney; Labowsky, Mary T.; Rozhansky, Lior; Mesirov, Jill P.; Gillanders, William E.; Ogino, Shuji; Hacohen, Nir; Gaudet, Suzanne; Eck, Michael J.; Engelman, Jeffrey A.; Corcoran, Ryan B.; Wong, Kwok-Kin; Hahn, William C.; Barbie, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">452-465</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the roles of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling in KRAS-driven tumorigenesis are well established, KRAS activates addnl. pathways required for tumor maintenance, the inhibition of which are likely to be necessary for effective KRAS-directed therapy.  Here, we show that the IκB kinase (IKK)- related kinases Tank-binding kinase-1 (TBK1) and IKKε promote KRAS-driven tumorigenesis by regulating autocrine CCL5 and interleukin (IL)-6 and identify CYT387 as a potent JAK/TBK1/IKKε inhibitor.  CYT387 treatment ablates RAS-assocd. cytokine signaling and impairs Kras-driven murine lung cancer growth.  Combined CYT387 treatment and MAPK pathway inhibition induces regression of aggressive murine lung adenocarcinomas driven by Kras mutation and p53 loss.  These observations reveal that TBK1/IKKε promote tumor survival by activating CCL5 and IL-6 and identify concurrent inhibition of TBK1/IKKε, Janus-activated kinase (JAK), and MEK signaling as an effective approach to inhibit the actions of oncogenic KRAS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHKh9hy-iqZ7Vg90H21EOLACvtfcHk0ljnEi3h_YtsMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFSmu70%253D&md5=e218c1228786d6b72e122a349007964a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.cd-13-0646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.cd-13-0646%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DAref%26aufirst%3DA.%2BR.%26aulast%3DCohoon%26aufirst%3DT.%2BJ.%26aulast%3DBarbie%26aufirst%3DT.%2BU.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DShen%26aufirst%3DR.%2BR.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DThai%26aufirst%3DT.%2BC.%26aulast%3DReibel%26aufirst%3DJ.%2BB.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DGodfrey%26aufirst%3DJ.%2BT.%26aulast%3DQian%26aufirst%3DZ.%2BR.%26aulast%3DPage%26aufirst%3DA.%2BN.%26aulast%3DMaciag%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DSilkworth%26aufirst%3DW.%26aulast%3DLabowsky%26aufirst%3DM.%2BT.%26aulast%3DRozhansky%26aufirst%3DL.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DGillanders%26aufirst%3DW.%2BE.%26aulast%3DOgino%26aufirst%3DS.%26aulast%3DHacohen%26aufirst%3DN.%26aulast%3DGaudet%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520KRAS-driven%2520tumorigenicity%2520by%2520interruption%2520of%2520an%2520autocrine%2520cytokine%2520circuit%26jtitle%3DCancer%2520Discovery%26date%3D2014%26volume%3D4%26spage%3D452%26epage%3D465%26doi%3D10.1158%2F2159-8290.cd-13-0646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formstecher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polverino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span> <span> </span><span class="NLM_article-title">TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.molcel.2011.01.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=21329883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Ggsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=458-470&author=Y.-H.+Ouauthor=M.+Torresauthor=R.+Ramauthor=E.+Formstecherauthor=C.+Rolandauthor=T.+Chengauthor=R.+Brekkenauthor=R.+Wurzauthor=A.+Taskerauthor=T.+Polverinoauthor=S.-L.+Tanauthor=M.+A.+White&title=TBK1+directly+engages+Akt%2FPKB+survival+signaling+to+support+oncogenic+transformation&doi=10.1016%2Fj.molcel.2011.01.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic Transformation</span></div><div class="casAuthors">Ou, Yi-Hung; Torres, Michael; Ram, Rosalyn; Formstecher, Etienne; Roland, Christina; Cheng, Tzuling; Brekken, Rolf; Wurz, Ryan; Tasker, Andrew; Polverino, Tony; Tan, Seng-Lai; White, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-470</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The innate immune-signaling kinase, TBK1, couples pathogen surveillance to induction of host defense mechanisms.  Pathol. activation of TBK1 in cancer can overcome programmed cell death cues, enabling cells to survive oncogenic stress.  The mechanistic basis of TBK1 prosurvival signaling, however, has been enigmatic.  Here, we show that TBK1 directly activates AKT by phosphorylation of the canonical activation loop and hydrophobic motif sites independently of PDK1 and mTORC2.  Upon mitogen stimulation, triggering of the innate immune response, re-exposure to glucose, or oncogene activation, TBK1 is recruited to the exocyst, where it activates AKT.  In cells lacking TBK1, insulin activates AKT normally, but AKT activation by exocyst-dependent mechanisms is impaired.  Discovery and characterization of a 6-aminopyrazolopyrimidine deriv., as a selective low-nanomolar TBK1 inhibitor, indicates that this regulatory arm can be pharmacol. perturbed independently of canonical PI3K/PDK1 signaling.  Thus, AKT is a direct TBK1 substrate that connects TBK1 to prosurvival signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMc_xy4O_x6rVg90H21EOLACvtfcHk0ljnEi3h_YtsMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Ggsb8%253D&md5=0a85a5612ab6e13b899081994679abc9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DY.-H.%26aulast%3DTorres%26aufirst%3DM.%26aulast%3DRam%26aufirst%3DR.%26aulast%3DFormstecher%26aufirst%3DE.%26aulast%3DRoland%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DBrekken%26aufirst%3DR.%26aulast%3DWurz%26aufirst%3DR.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DPolverino%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DS.-L.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DTBK1%2520directly%2520engages%2520Akt%252FPKB%2520survival%2520signaling%2520to%2520support%2520oncogenic%2520transformation%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D41%26spage%3D458%26epage%3D470%26doi%3D10.1016%2Fj.molcel.2011.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebsbach, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiozawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taichman, R. S.</span></span> <span> </span><span class="NLM_article-title">TBK1 regulates prostate cancer dormancy through mTOR inhibition</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1593/neo.13402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1593%2Fneo.13402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24027431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1064-1074&author=J.+K.+Kimauthor=Y.+Jungauthor=J.+Wangauthor=J.+Josephauthor=A.+Mishraauthor=E.+E.+Hillauthor=P.+H.+Krebsbachauthor=K.+J.+Pientaauthor=Y.+Shiozawaauthor=R.+S.+Taichman&title=TBK1+regulates+prostate+cancer+dormancy+through+mTOR+inhibition&doi=10.1593%2Fneo.13402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 regulates prostate cancer dormancy through mTOR inhibition</span></div><div class="casAuthors">Kim, Jin Koo; Jung, Younghun; Wang, Jingcheng; Joseph, Jeena; Mishra, Anjali; Hill, Elliott E.; Krebsbach, Paul H.; Pienta, Kenneth J.; Shiozawa, Yusuke; Taichman, Russell S.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1064-1074</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">The mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are well established and are largely dependent on signals emanating from the HSC niche.  Recently, we found that prostate cancer (PCa) cells target the HSC niche in mouse bone marrow (BM) during metastasis.  Little is known, however, as to how the HSC niche may regulate dormancy in cancer cells.  In this study, we investigated the effects of TANK binding kinase 1 (TBK1) on PCa dormancy in the BM niche.  We found that binding with niche osteoblasts induces the expression of TBK1 in PCa cells PC3 and C4-2B.  Interestingly, TBK1 interacts with mammalian target of rapamycin (mTOR) and inhibits its function.  Rapamycin, an mTOR inhibitor, induces cell cycle arrest of PCa cells and enhances chemotherapeutic resistance of PCa cells.  As a result, the knockdown of TBK1 decreases PCa stem-like cells and drug resistance in vitro and in vivo.  Taken together, these results strongly indicate that TBK1 plays an important role in the dormancy and drug resistance of PCa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDMSl7htIPXrVg90H21EOLACvtfcHk0ljnEi3h_YtsMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCnur8%253D&md5=1f1f2327dae079362bed0c1463bcf8ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1593%2Fneo.13402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.13402%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DE.%2BE.%26aulast%3DKrebsbach%26aufirst%3DP.%2BH.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DShiozawa%26aufirst%3DY.%26aulast%3DTaichman%26aufirst%3DR.%2BS.%26atitle%3DTBK1%2520regulates%2520prostate%2520cancer%2520dormancy%2520through%2520mTOR%2520inhibition%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D1064%26epage%3D1074%26doi%3D10.1593%2Fneo.13402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muvaffak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolinski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strack, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jánne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel-Dugan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschmeier, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Evaluating TBK1 as a therapeutic target in cancers with activated IRF3</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.mcr-13-0642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1158%2F1541-7786.mcr-13-0642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24752990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1055-1066&author=A.+Muvaffakauthor=Q.+Panauthor=H.+Yanauthor=R.+Fernandezauthor=J.+Limauthor=B.+Dolinskiauthor=T.+T.+Nguyenauthor=P.+Strackauthor=S.+Wuauthor=R.+Chungauthor=W.+Zhangauthor=C.+Hultonauthor=S.+Ripleyauthor=H.+Hirschauthor=K.+Nagashimaauthor=K.-K.+Wongauthor=P.+A.+J%C3%A1nneauthor=C.+Seidel-Duganauthor=L.+Zawelauthor=P.+T.+Kirschmeierauthor=R.+E.+Middletonauthor=E.+J.+Morrisauthor=Y.+Wang&title=Evaluating+TBK1+as+a+therapeutic+target+in+cancers+with+activated+IRF3&doi=10.1158%2F1541-7786.mcr-13-0642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3</span></div><div class="casAuthors">Muvaffak, Asli; Pan, Qi; Yan, Haiyan; Fernandez, Rafael; Lim, Jongwon; Dolinski, Brian; Nguyen, Thi T.; Strack, Peter; Wu, Stephen; Chung, Rossana; Zhang, Weiqun; Hulton, Chris; Ripley, Steven; Hirsch, Heather; Nagashima, Kumiko; Wong, Kwok-Kin; Janne, Pasi A.; Seidel-Dugan, Cynthia; Zawel, Leigh; Kirschmeier, Paul T.; Middleton, Richard E.; Morris, Erick J.; Wang, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1055-1066</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">TBK1 (TANK-binding kinase 1) is a noncanonical IκB protein kinase that phosphorylates and activates downstream targets such as IRF3 and c-Rel and, mediates NF-κB activation in cancer.  Previous reports demonstrated synthetic lethality of TBK1 with mutant KRAS in non-small cell lung cancer (NSCLC); thus, TBK1 could be a novel target for treatment of KRAS-mutant NSCLC.  Here, the effect of TBK1 on proliferation in a panel of cancer cells by both genetic and pharmacol. approaches was evaluated.  In KRAS-mutant cancer cells, redn. of TBK1 activity by knockdown or treatment with TBK1 inhibitors did not correlate with reduced proliferation in a two-dimensional viability assay.  Verification of target engagement via reduced phosphorylation of S386 of IRF3 (pIRF3S386) was difficult to assess in NSCLC cells due to low protein expression.  However, several cell lines were identified with high pIRF3S386 levels after screening a large panel of cell lines, many of which also harbor KRAS mutations.  Specifically, a large subset of KRAS-mutant pancreatic cancer cell lines was uncovered with high constitutive pIRF3S386 levels, which correlated with high levels of phosphorylated S172 of TBK1 (pTBK1S172).  Finally, TBK1 inhibitors dose-dependently inhibited pIRF3S386 in these cell lines, but this did not correlate with inhibition of cell growth.  Taken together, these data demonstrate that the regulation of pathways important for cell proliferation in some NSCLC, pancreatic, and colorectal cell lines is not solely dependent on TBK1 activity.  Implications: TBK1 has therapeutic potential under certain contexts and phosphorylation of its downstream target IRF3 is a biomarker of TBK1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1SJhITnpZLVg90H21EOLACvtfcHk0liYu7lqkehTFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbjJ&md5=556bb9b1f3a33fc7a84f5ba3b8485acd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.mcr-13-0642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.mcr-13-0642%26sid%3Dliteratum%253Aachs%26aulast%3DMuvaffak%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DDolinski%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DStrack%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DHulton%26aufirst%3DC.%26aulast%3DRipley%26aufirst%3DS.%26aulast%3DHirsch%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DJ%25C3%25A1nne%26aufirst%3DP.%2BA.%26aulast%3DSeidel-Dugan%26aufirst%3DC.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DKirschmeier%26aufirst%3DP.%2BT.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMorris%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEvaluating%2520TBK1%2520as%2520a%2520therapeutic%2520target%2520in%2520cancers%2520with%2520activated%2520IRF3%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2014%26volume%3D12%26spage%3D1055%26epage%3D1066%26doi%3D10.1158%2F1541-7786.mcr-13-0642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebrenik, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamman, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neklesa, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of von Hippel-Lindau-recruiting proteolysis targeting chimeras (PROTACs) of TANK-binding kinase 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFelu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=583-598&author=A.+P.+Crewauthor=K.+Rainaauthor=H.+Dongauthor=Y.+Qianauthor=J.+Wangauthor=D.+Vigilauthor=Y.+V.+Serebrenikauthor=B.+D.+Hammanauthor=A.+Morganauthor=C.+Ferraroauthor=K.+Siuauthor=T.+K.+Neklesaauthor=J.+D.+Winklerauthor=K.+G.+Colemanauthor=C.+M.+Crews&title=Identification+and+characterization+of+von+Hippel-Lindau-recruiting+proteolysis+targeting+chimeras+%28PROTACs%29+of+TANK-binding+kinase+1&doi=10.1021%2Facs.jmedchem.7b00635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1</span></div><div class="casAuthors">Crew, Andrew P.; Raina, Kanak; Dong, Hanqing; Qian, Yimin; Wang, Jing; Vigil, Dominico; Serebrenik, Yevgeniy V.; Hamman, Brian D.; Morgan, Alicia; Ferraro, Caterina; Siu, Kam; Neklesa, Taavi K.; Winkler, James D.; Coleman, Kevin G.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">583-598</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteolysis Targeting Chimeras (PROTACs) are bifunctional mols. that recruit an E3 ligase to a target protein to facilitate ubiquitination and subsequent degrdn. of that protein.  While the field of targeted degraders is still relatively young, the potential for this modality to become a differentiated and therapeutic reality is strong, such that both academic and pharmaceutical institutions are now entering this interesting area of research.  In this paper, the authors describe a broadly applicable process for identifying degrader hits based around the serine/threonine kinase TANK-binding kinase 1 (TBK1), and have generalized the key structural elements assocd. with degrdn. activities.  Compd. I is a potent hit (TBK1 DC50 = 12 nM, Dmax = 96%) with excellent selectivity against a related kinase IKKε, which was further used as a chem. tool to assess TBK1 as a target in mutant K-Ras cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJWCnFncQRLVg90H21EOLACvtfcHk0lhU6hI1jOgMvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFelu7rK&md5=41c3627e05ca31aee3ba85815685fcb2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00635%26sid%3Dliteratum%253Aachs%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DSerebrenik%26aufirst%3DY.%2BV.%26aulast%3DHamman%26aufirst%3DB.%2BD.%26aulast%3DMorgan%26aufirst%3DA.%26aulast%3DFerraro%26aufirst%3DC.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DNeklesa%26aufirst%3DT.%2BK.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DColeman%26aufirst%3DK.%2BG.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520von%2520Hippel-Lindau-recruiting%2520proteolysis%2520targeting%2520chimeras%2520%2528PROTACs%2529%2520of%2520TANK-binding%2520kinase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D583%26epage%3D598%26doi%3D10.1021%2Facs.jmedchem.7b00635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span> <span> </span><span class="NLM_article-title">Assessment of TANK-binding kinase 1 as a therapeutic target in cancer</span>. <i>J. Cell. Commun. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1007/s12079-017-0438-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1007%2Fs12079-017-0438-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=29218456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A280%3ADC%252BC1M3pt1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=83-90&author=V.+H.+Cruzauthor=R.+A.+Brekken&title=Assessment+of+TANK-binding+kinase+1+as+a+therapeutic+target+in+cancer&doi=10.1007%2Fs12079-017-0438-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of TANK-binding kinase 1 as a therapeutic target in cancer</span></div><div class="casAuthors">Cruz Victoria H; Brekken Rolf A; Brekken Rolf A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cell communication and signaling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-90</span>
        ISSN:<span class="NLM_cas:issn">1873-9601</span>.
    </div><div class="casAbstract">TANK-binding kinase 1 (TBK1) is central to multiple biological processes that promote tumorigenesis including cell division, autophagy, innate immune response and AKT-pro survival signaling.  TBK1 is well studied and most known for its function in innate immunity.  However, the serine threonine protein kinase received significant attention as a synthetic lethal partner and effector of the major oncogene, RAS.  This review summarizes newly identified cancer promoting functions of TBK1 and evaluates the therapeutic potential of targeting TBK1 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQR8mq8uPtuWXl8icjszYl0fW6udTcc2eZ472D3IuaGGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3pt1Kktg%253D%253D&md5=563940aeb57006e79070bfac8e4e0419</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs12079-017-0438-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12079-017-0438-y%26sid%3Dliteratum%253Aachs%26aulast%3DCruz%26aufirst%3DV.%2BH.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26atitle%3DAssessment%2520of%2520TANK-binding%2520kinase%25201%2520as%2520a%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Commun.%2520Signal.%26date%3D2018%26volume%3D12%26spage%3D83%26epage%3D90%26doi%3D10.1007%2Fs12079-017-0438-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeckel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duempelfeld, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanjulu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesiridis, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muelbaier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of GSK8612, a highly selective and potent TBK1 inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFensr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=780-785&author=D.+W.+Thomsonauthor=D.+Poeckelauthor=N.+Zinnauthor=C.+Rauauthor=K.+Strohmerauthor=A.+J.+Wagnerauthor=A.+P.+Gravesauthor=J.+Perrinauthor=M.+Bantscheffauthor=B.+Duempelfeldauthor=V.+Kasparcovaauthor=J.+M.+Ramanjuluauthor=G.+S.+Pesiridisauthor=M.+Muelbaierauthor=G.+Bergamini&title=Discovery+of+GSK8612%2C+a+highly+selective+and+potent+TBK1+inhibitor&doi=10.1021%2Facsmedchemlett.9b00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor</span></div><div class="casAuthors">Thomson, Douglas W.; Poeckel, Daniel; Zinn, Nico; Rau, Christina; Strohmer, Katrin; Wagner, Anne J.; Graves, Alan P.; Perrin, Jessica; Bantscheff, Marcus; Duempelfeld, Birgit; Kasparcova, Viera; Ramanjulu, Joshi M.; Pesiridis, G. Scott; Muelbaier, Marcel; Bergamini, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">780-785</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The serine/threonine protein kinase TBK1 (Tank-binding Kinase-1) is a noncanonical member of the IkB kinase (IKK) family.  This kinase regulates signaling pathways in innate immunity, oncogenesis, energy homeostasis, autophagy, and neuroinflammation.  Herein, we report the discovery and characterization of a novel potent and highly selective TBK1 inhibitor, GSK8612.  In cellular assays, this small mol. inhibited Toll-like receptor (TLR)3-induced interferon regulatory factor (IRF)3 phosphorylation in Ramos cells and type I interferon (IFN) secretion in primary human mononuclear cells.  In THP1 cells, GSK8612 was able to inhibit secretion of interferon beta (IFNβ) in response to dsDNA and cGAMP, the natural ligand for STING.  GSK8612 is a TBK1 small mol. inhibitor displaying an excellent selectivity profile and therefore represents an ideal probe to further dissect the biol. of TBK1 in models of immunity, neuroinflammation, obesity, or cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSGssfttyOLVg90H21EOLACvtfcHk0lhU6hI1jOgMvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFensr0%253D&md5=d9b3a1d565707a6c0cfb9f8a78a178e2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00027%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DPoeckel%26aufirst%3DD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DStrohmer%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDuempelfeld%26aufirst%3DB.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DRamanjulu%26aufirst%3DJ.%2BM.%26aulast%3DPesiridis%26aufirst%3DG.%2BS.%26aulast%3DMuelbaier%26aufirst%3DM.%26aulast%3DBergamini%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520GSK8612%252C%2520a%2520highly%2520selective%2520and%2520potent%2520TBK1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D780%26epage%3D785%26doi%3D10.1021%2Facsmedchemlett.9b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. Y.</span></span> <span> </span><span class="NLM_article-title">TBK1 inhibitors: a review of patent literature (2011 - 2014)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1385</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1517/13543776.2015.1081168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1517%2F13543776.2015.1081168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=26293650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVajsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1385-1396&author=T.+Yuauthor=Y.+Yangauthor=D.+Q.+Yinauthor=S.+Hongauthor=Y.-J.+Sonauthor=J.-H.+Kimauthor=J.+Y.+Cho&title=TBK1+inhibitors%3A+a+review+of+patent+literature+%282011+-+2014%29&doi=10.1517%2F13543776.2015.1081168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 inhibitors: a review of patent literature (2011 - 2014)</span></div><div class="casAuthors">Yu, Tao; Yang, Yanyan; Yin, De Qing; Hong, Sungyoul; Son, Young-Jin; Kim, Jong-Hoon; Cho, Jae Youl</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1385-1396</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">TANK-binding kinase 1 (TBK1) is a noncanonical IκB kinase family member that regulates the innate immune response.  Misregulation of TBK1 activity can promote inflammatory disorders and oncogenesis; therefore, TBK1 inhibitors are considered a promising therapy for inflammation and cancer.  In this review, the authors provide information on the role of TBK1 in human health and on recently developed inhibitors from patents granted from 2011 to 2014.  The reader will gain an understanding of the mechanisms of TBK1 function as well as the structure and biol. activity of recently developed TBK1 inhibitors.  Google and NCBI search engines were used to find relevant patents and clin. information using "TBK1 inhibitor" as the search term.  The role of TBK1 in various diseases has prompted the further investigation of significant targets.  Although research on TBK1 inhibitors has increased over the last few years, only a few inhibitors of this kinase have been identified.  In addn., almost all of the chem. inhibitors are modified from different scaffolds and/or chemotypes of pyrimidine.  Specifically, compd. BX795 is the representative one, which was first patented as a potent TBK1 inhibitor.  Even though some compds. have displayed interesting potential inhibition and selectivity of TBK1 in vitro and in in vivo trials, the development of more efficient and selective TBK1 inhibitors is still required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsxegMOo9h-LVg90H21EOLACvtfcHk0lgy86oDjxbzAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVajsrbF&md5=19c818f20a1b43c64d056da910398a80</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F13543776.2015.1081168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2015.1081168%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DD.%2BQ.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DSon%26aufirst%3DY.-J.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26atitle%3DTBK1%2520inhibitors%253A%2520a%2520review%2520of%2520patent%2520literature%2520%25282011%2520-%25202014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26spage%3D1385%26epage%3D1396%26doi%3D10.1517%2F13543776.2015.1081168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larabi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Round, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniatis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panne, D.</span></span> <span> </span><span class="NLM_article-title">Crystal structure and mechanism of activation of TANK-binding kinase 1</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.celrep.2013.01.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=23453971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlyrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=734-746&author=A.+Larabiauthor=J.+M.+Devosauthor=S.-L.+Ngauthor=M.+H.+Nanaoauthor=A.+Roundauthor=T.+Maniatisauthor=D.+Panne&title=Crystal+structure+and+mechanism+of+activation+of+TANK-binding+kinase+1&doi=10.1016%2Fj.celrep.2013.01.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure and Mechanism of Activation of TANK-Binding Kinase 1</span></div><div class="casAuthors">Larabi, Amede; Devos, Juliette M.; Ng, Sze-Ling; Nanao, Max H.; Round, Adam; Maniatis, Tom; Panne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">734-746</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tank-binding kinase I (TBK1) plays a key role in the innate immune system by integrating signals from pattern-recognition receptors.  Here, we report the x-ray crystal structures of inhibitor-bound inactive and active TBK1 detd. to 2.6 Å and 4.0 Å resoln., resp.  The structures reveal a compact dimer made up of trimodular subunits contg. an N-terminal kinase domain (KD), a ubiquitin-like domain (ULD), and an α-helical scaffold dimerization domain (SDD).  Activation rearranges the KD into an active conformation while maintaining the overall dimer conformation.  Low-resoln. SAXS studies reveal that the missing C-terminal domain (CTD) extends away from the main body of the kinase dimer.  Mutants that interfere with TBK1 dimerization show significantly reduced trans-autophosphorylation but retain the ability to bind adaptor proteins through the CTD.  Our results provide detailed insights into the architecture of TBK1 and the mol. mechanism of activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp47I973peWE7Vg90H21EOLACvtfcHk0lgy86oDjxbzAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlyrsro%253D&md5=aacfaf521342d3f642cac21a4f92c60e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DLarabi%26aufirst%3DA.%26aulast%3DDevos%26aufirst%3DJ.%2BM.%26aulast%3DNg%26aufirst%3DS.-L.%26aulast%3DNanao%26aufirst%3DM.%2BH.%26aulast%3DRound%26aufirst%3DA.%26aulast%3DManiatis%26aufirst%3DT.%26aulast%3DPanne%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520and%2520mechanism%2520of%2520activation%2520of%2520TANK-binding%2520kinase%25201%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D734%26epage%3D746%26doi%3D10.1016%2Fj.celrep.2013.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, M.</span></span> <span> </span><span class="NLM_article-title">Identification of NAP1, a regulatory subunit of IκB kinase-related kinases that potentiates NF-κB signaling</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7780</span>– <span class="NLM_lpage">7793</span>, <span class="refDoi"> DOI: 10.1128/mcb.23.21.7780-7793.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1128%2Fmcb.23.21.7780-7793.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=14560022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7780-7793&author=F.+Fujitaauthor=Y.+Taniguchiauthor=T.+Katoauthor=Y.+Naritaauthor=A.+Furuyaauthor=T.+Ogawaauthor=H.+Sakuraiauthor=T.+Johauthor=M.+Itohauthor=M.+Delhaseauthor=M.+Karinauthor=M.+Nakanishi&title=Identification+of+NAP1%2C+a+regulatory+subunit+of+I%CE%BAB+kinase-related+kinases+that+potentiates+NF-%CE%BAB+signaling&doi=10.1128%2Fmcb.23.21.7780-7793.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NAP1, a regulatory subunit of IκB kinase-related kinases that potentiates NF-κB signaling</span></div><div class="casAuthors">Fujita, Fumitaka; Taniguchi, Yuko; Kato, Takashi; Narita, Yasuko; Furuya, Akiko; Ogawa, Tatsuhiro; Sakurai, Hiroaki; Joh, Takashi; Itoh, Makoto; Delhase, Mireille; Karin, Michael; Nakanishi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7780-7793</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The IκB kinase (IKK)-related kinase NAK (also known as TBK or T2K) contributes to the activation of NF-κB-dependent gene expression.  Here we identify NAP1 (for NAK-assocd. protein 1), a protein that interacts with NAK and its relative IKKε (also known as IKKi).  NAP1 activates NAK and facilitates its oligomerization.  Interestingly, the NAK-NAP1 complex itself effectively phosphorylated serine 536 of the p65/RelA subunit of NF-κB, and this activity was stimulated by tumor necrosis factor alpha (TNF-α).  Overexpression of NAP1 specifically enhanced cytokine induction of an NF-κB-dependent, but not an AP-1-dependent, reporter.  Depletion of NAP1 reduced NF-κB-dependent reporter gene expression and sensitized cells to TNF-α-induced apoptosis.  These results define NAP1 as an activator of IKK-related kinases and suggest that the NAK-NAP1 complex may protect cells from TNF-α-induced apoptosis by promoting NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRPtpVJzwFfLVg90H21EOLACvtfcHk0lgy86oDjxbzAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOgt7g%253D&md5=dc35c4a46a7dee37d2d73de7520c680c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2Fmcb.23.21.7780-7793.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmcb.23.21.7780-7793.2003%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DNarita%26aufirst%3DY.%26aulast%3DFuruya%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DH.%26aulast%3DJoh%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DM.%26aulast%3DDelhase%26aufirst%3DM.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NAP1%252C%2520a%2520regulatory%2520subunit%2520of%2520I%25CE%25BAB%2520kinase-related%2520kinases%2520that%2520potentiates%2520NF-%25CE%25BAB%2520signaling%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D7780%26epage%3D7793%26doi%3D10.1128%2Fmcb.23.21.7780-7793.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatot, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gioia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, T.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrascu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Close, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapelle, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraille, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebenlist, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejardin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chariot, A.</span></span> <span> </span><span class="NLM_article-title">Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKε-dependent Lys<sup>63</sup>-linked polyubiquitination and phosphorylation of TANK/I-TRAF</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">31131</span>– <span class="NLM_lpage">31146</span>, <span class="refDoi"> DOI: 10.1074/jbc.m701690200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1074%2Fjbc.m701690200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17823124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFykurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=31131-31146&author=J.-S.+Gatotauthor=R.+Gioiaauthor=T.-L.+Chauauthor=F.+Patrascuauthor=M.+Warnierauthor=P.+Closeauthor=J.-P.+Chapelleauthor=E.+Murailleauthor=K.+Brownauthor=U.+Siebenlistauthor=J.+Pietteauthor=E.+Dejardinauthor=A.+Chariot&title=Lipopolysaccharide-mediated+interferon+regulatory+factor+activation+involves+TBK1-IKK%CE%B5-dependent+Lys63-linked+polyubiquitination+and+phosphorylation+of+TANK%2FI-TRAF&doi=10.1074%2Fjbc.m701690200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide-mediated Interferon Regulatory Factor Activation Involves TBK1-IKKε-dependent Lys63-linked Polyubiquitination and Phosphorylation of TANK/I-TRAF</span></div><div class="casAuthors">Gatot, Jean-Stephane; Gioia, Romain; Chau, Tieu-Lan; Patrascu, Felicia; Warnier, Michael; Close, Pierre; Chapelle, Jean-Paul; Muraille, Eric; Brown, Keith; Siebenlist, Ulrich; Piette, Jacques; Dejardin, Emmanuel; Chariot, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">31131-31146</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Type I interferon gene induction relies on IKK-related kinase TBK1 and IKKε-mediated phosphorylations of IRF3/7 through the Toll-like receptor-dependent signaling pathways.  The scaffold proteins that assemble these kinase complexes are poorly characterized.  We show here that TANK/I-TRAF is required for the TBK1- and IKKε-mediated IRF3/7 phosphorylations through some Toll-like receptor-dependent pathways and is part of a TRAF3-contg. complex.  Moreover, TANK is dispensable for the early phase of double-stranded RNA-mediated IRF3 phosphorylation.  Interestingly, TANK is heavily phosphorylated by TBK1-IKKε upon lipopolysaccharide stimulation and is also subject to lipopolysaccharide- and TBK1-IKKε-mediated Lys63-linked polyubiquitination, a mechanism that does not require TBK1-IKKε kinase activity.  Thus, we have identified TANK as a scaffold protein that assembles some but not all IRF3/7-phosphorylating TBK1-IKKε complexes and demonstrated that these kinases possess two functions, namely the phosphorylation of both IRF3/7 and TANK as well as the recruitment of an E3 ligase for Lys63-linked polyubiquitination of their scaffold protein, TANK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7yx4SPWko1LVg90H21EOLACvtfcHk0liTJX1SJdebjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFykurrO&md5=10cb598f48055bb2ffc97a2f4bbd7c4d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m701690200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m701690200%26sid%3Dliteratum%253Aachs%26aulast%3DGatot%26aufirst%3DJ.-S.%26aulast%3DGioia%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DT.-L.%26aulast%3DPatrascu%26aufirst%3DF.%26aulast%3DWarnier%26aufirst%3DM.%26aulast%3DClose%26aufirst%3DP.%26aulast%3DChapelle%26aufirst%3DJ.-P.%26aulast%3DMuraille%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DSiebenlist%26aufirst%3DU.%26aulast%3DPiette%26aufirst%3DJ.%26aulast%3DDejardin%26aufirst%3DE.%26aulast%3DChariot%26aufirst%3DA.%26atitle%3DLipopolysaccharide-mediated%2520interferon%2520regulatory%2520factor%2520activation%2520involves%2520TBK1-IKK%25CE%25B5-dependent%2520Lys63-linked%2520polyubiquitination%2520and%2520phosphorylation%2520of%2520TANK%252FI-TRAF%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D31131%26epage%3D31146%26doi%3D10.1074%2Fjbc.m701690200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryzhakov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randow, F.</span></span> <span> </span><span class="NLM_article-title">SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3180</span>– <span class="NLM_lpage">3190</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1038%2Fsj.emboj.7601743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17568778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFejtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3180-3190&author=G.+Ryzhakovauthor=F.+Randow&title=SINTBAD%2C+a+novel+component+of+innate+antiviral+immunity%2C+shares+a+TBK1-binding+domain+with+NAP1+and+TANK&doi=10.1038%2Fsj.emboj.7601743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK</span></div><div class="casAuthors">Ryzhakov, Grigory; Randow, Felix</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3180-3190</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The expression of antiviral genes during infection is controlled by inducible transcription factors such as IRF3 (interferon regulatory factor).  Activation of IRF3 requires its phosphorylation by TBK1 (TANK-binding kinase) or IKKi (inhibitor of nuclear factor κB kinase, inducible).  The authors have identified a new and essential component of this pathway, the adaptor protein SINTBAD (similar to NAP1 TBK1 adaptor).  SINTBAD constitutively binds TBK1 and IKKi but not related kinases.  Upon infection with Sendai virus, SINTBAD is essential for the efficient induction of IRF-dependent transcription, as are two further TBK1 adaptors, TANK and NAP1.  The authors identified a conserved TBK1/IKKi-binding domain (TBD) in the three adaptors, predicted to form an α-helix with residues essential for kinase binding clustering on one side.  Isolated TBDs compete with adaptor binding to TBK1 and prevent poly(I:C)-induced IRF-dependent transcription.  The results suggest that efficient signal transduction upon viral infection requires SINTBAD, TANK and NAP1 because they link TBK1 and IKKi to virus-activated signaling cascades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-HD2rNbqMBrVg90H21EOLACvtfcHk0liTJX1SJdebjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFejtr4%253D&md5=35fbfb07c129d1c555dc7307aed62ae5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601743%26sid%3Dliteratum%253Aachs%26aulast%3DRyzhakov%26aufirst%3DG.%26aulast%3DRandow%26aufirst%3DF.%26atitle%3DSINTBAD%252C%2520a%2520novel%2520component%2520of%2520innate%2520antiviral%2520immunity%252C%2520shares%2520a%2520TBK1-binding%2520domain%2520with%2520NAP1%2520and%2520TANK%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D3180%26epage%3D3190%26doi%3D10.1038%2Fsj.emboj.7601743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackloo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baryza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttcher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damerell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dötsch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh Saikatendu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, A. Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span> <span> </span><span class="NLM_article-title">Donated chemical probes for open science</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e34311</span> <span class="refDoi"> DOI: 10.7554/elife.34311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.7554%2Felife.34311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=29676732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSisr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=S.+M%C3%BCllerauthor=S.+Acklooauthor=C.+H.+Arrowsmithauthor=M.+Bauserauthor=J.+L.+Baryzaauthor=J.+Blaggauthor=J.+B%C3%B6ttcherauthor=C.+Bountraauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=A.+J.+Carterauthor=D.+Damerellauthor=V.+D%C3%B6tschauthor=D.+H.+Drewryauthor=A.+M.+Edwardsauthor=J.+Edwardsauthor=J.+M.+Elkinsauthor=C.+Fischerauthor=S.+V.+Fryeauthor=A.+Gollnerauthor=C.+E.+Grimshawauthor=A.+IJzermanauthor=T.+Hankeauthor=I.+V.+Hartungauthor=S.+Hitchcockauthor=T.+Howeauthor=T.+V.+Hughesauthor=S.+Lauferauthor=V.+M.+J.+Liauthor=S.+Lirasauthor=B.+D.+Marsdenauthor=H.+Matsuiauthor=J.+Mathiasauthor=R.+C.+O%E2%80%99Haganauthor=D.+R.+Owenauthor=V.+Pandeauthor=D.+Rauhauthor=S.+H.+Rosenbergauthor=B.+L.+Rothauthor=N.+S.+Schneiderauthor=C.+Scholtenauthor=K.+Singh+Saikatenduauthor=A.+Simeonovauthor=M.+Takizawaauthor=C.+Tseauthor=P.+R.+Thompsonauthor=D.+K.+Treiberauthor=A.+Y.+I.+Vianaauthor=C.+I.+Wellsauthor=T.+M.+Willsonauthor=W.+J.+Zuercherauthor=S.+Knappauthor=A.+Mueller-Fahrnow&title=Donated+chemical+probes+for+open+science&doi=10.7554%2Felife.34311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Donated chemical probes for open science</span></div><div class="casAuthors">Mueller, Susanne; Ackloo, Suzanne; Arrowsmith, Cheryl H.; Bauser, Marcus; Baryza, Jeremy L.; Blagg, Julian; Boettcher, Jark; Bountra, Chas; Brown, Peter J.; Bunnage, Mark E.; Carter, Adrian J.; Damerell, David; Doetsch, Volker; Drewry, David H.; Edwards, Aled M.; Edwards, James; Elkins, Jon M.; Fischer, Christian; Frye, Stephen V.; Gollner, Andreas; Grimshaw, Charles E.; Ijzerman, Adriaan; Hanke, Thomas; Hartung, Ingo V.; Hitchcock, Steve; Howe, Trevor; Hughes, Terry V.; Laufer, Stefan; Li, Volkhart MJ; Liras, Spiros; Marsden, Brian D.; Matsui, Hisanori; Mathias, John; O'Hagan, Ronan C.; Owen, Dafydd R.; Pande, Vineet; Rauh, Daniel; Rosenberg, Saul H.; Roth, Bryan L.; Schneider, Natalie S.; Scholten, Cora; Saikatendu, Kumar Singh; Simeonov, Anton; Takizawa, Masayuki; Tse, Chris; Thompson, Paul R.; Treiber, Daniel K.; Viana, Amelia YI; Wells, Carrow I.; Willson, Timothy M.; Zuercher, William J.; Knapp, Stefan; Mueller-Fahrnow, Anke</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e34311/1-e34311/15</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Potent, selective and broadly characterized small mol. modulators of protein function (chem. probes) are powerful research reagents.  The pharmaceutical industry has generated many high-quality chem. probes and several of these have been made available to academia.  However, probe-assocd. data and control compds., such as inactive structurally related mols. and their assocd. data, are generally not accessible.  The lack of data and guidance makes it difficult for researchers to decide which chem. tools to choose.  Several pharmaceutical companies (AbbVie, Bayer, Boehringer Ingelheim, Janssen, MSD, Pfizer, and Takeda) have therefore entered into a pre-competitive collaboration to make available a large no. of innovative high-quality probes, including all probe-assocd. data, control compds. and recommendations on use.  Here we describe the chem. tools and target-related knowledge that have been made available, and encourage others to join the project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRaiuCjk4Ny7Vg90H21EOLACvtfcHk0liL9yB1jFtURA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSisr3F&md5=18e66627d15b9fa650b83bb96564757c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.7554%2Felife.34311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252Felife.34311%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DAckloo%26aufirst%3DS.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBaryza%26aufirst%3DJ.%2BL.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DDamerell%26aufirst%3DD.%26aulast%3DD%25C3%25B6tsch%26aufirst%3DV.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGollner%26aufirst%3DA.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DIJzerman%26aufirst%3DA.%26aulast%3DHanke%26aufirst%3DT.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DT.%2BV.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DV.%2BM.%2BJ.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%2BD.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMathias%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPande%26aufirst%3DV.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSchneider%26aufirst%3DN.%2BS.%26aulast%3DScholten%26aufirst%3DC.%26aulast%3DSingh%2BSaikatendu%26aufirst%3DK.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DTakizawa%26aufirst%3DM.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DP.%2BR.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DViana%26aufirst%3DA.%2BY.%2BI.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26atitle%3DDonated%2520chemical%2520probes%2520for%2520open%2520science%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26doi%3D10.7554%2Felife.34311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercede, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. W.</span></span> <span> </span><span class="NLM_article-title">2-Phenylamino-6-cyano-1<i>H</i>-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5392</span>– <span class="NLM_lpage">5395</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.bmcl.2012.07.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=22877629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGhtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5392-5395&author=Z.+Huaauthor=X.+Huangauthor=H.+Bregmanauthor=N.+Chakkaauthor=E.+F.+DiMauroauthor=E.+M.+Dohertyauthor=J.+Goldsteinauthor=H.+Gunaydinauthor=H.+Huangauthor=S.+Mercedeauthor=J.+Newcombauthor=V.+F.+Patelauthor=S.+M.+Turciauthor=J.+Yanauthor=C.+Wilsonauthor=M.+W.+Martin&title=2-Phenylamino-6-cyano-1H-benzimidazole-based+isoform+selective+casein+kinase+1+gamma+%28CK1%CE%B3%29+inhibitors&doi=10.1016%2Fj.bmcl.2012.07.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">2-(Phenylamino)-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors</span></div><div class="casAuthors">Hua, Zihao; Huang, Xin; Bregman, Howard; Chakka, Nagasree; DiMauro, Erin F.; Doherty, Elizabeth M.; Goldstein, Jon; Gunaydin, Hakan; Huang, Hongbing; Mercede, Stephanie; Newcomb, John; Patel, Vinod F.; Turci, Susan M.; Yan, Jie; Wilson, Cindy; Martin, Matthew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5392-5395</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Screening of the amgen compd. library led to the identification of 2-(phenylamino)-6-cyano-1H-benzimidazole, I, as a potential CK1 gamma inhibitor (CK1γ) with excellent kinase selectivity and unprecedented CK1 isoform selectivity.  Further structure-based optimization of this series resulted in the discovery of II, which possessed good enzymic and cellular potency, excellent CK1 isoform and kinase selectivity, and acceptable pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HobtFUhBBLVg90H21EOLACvtfcHk0liBpgz-FsB8zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGhtb%252FL&md5=05de8c976d9a1cb21c5d1a0f6cc2ea75</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.046%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDoherty%26aufirst%3DE.%2BM.%26aulast%3DGoldstein%26aufirst%3DJ.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMercede%26aufirst%3DS.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26atitle%3D2-Phenylamino-6-cyano-1H-benzimidazole-based%2520isoform%2520selective%2520casein%2520kinase%25201%2520gamma%2520%2528CK1%25CE%25B3%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5392%26epage%3D5395%26doi%3D10.1016%2Fj.bmcl.2012.07.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plobeck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.11.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.bmcl.2005.11.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=16337120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28Xosl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1397-1401&author=B.-M.+Swahnauthor=Y.+Xueauthor=E.+Arzelauthor=E.+Kallinauthor=A.+Magnusauthor=N.+Plobeckauthor=J.+Viklund&title=Design+and+synthesis+of+2%E2%80%B2-anilino-4%2C4%E2%80%B2-bipyridines+as+selective+inhibitors+of+c-Jun+N-terminal+kinase-3&doi=10.1016%2Fj.bmcl.2005.11.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3</span></div><div class="casAuthors">Swahn, Britt-Marie; Xue, Yafeng; Arzel, Erwan; Kallin, Elisabet; Magnus, Angelika; Plobeck, Niklas; Viklund, Jenny</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1397-1401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The design and synthesis of a new series of c-Jun N-terminal kinase-3 (JNK3) inhibitors with selectivity against JNK1 are reported.  Substituted 2'-anilino-4,4'-bipyridines I (R1 = R2 = 4-FC6H4, 2-MeOC6H4, 3-F3CC6H4, etc.; R1 = Ph, 4-FC6H4, R2 = MeOCH2CH2CO, 4-methoxycyclohexylcarbonyl, nicotinoyl, 2-furoyl, etc.) were designed based on a combination of hits from high throughput screening and X-ray crystal structure information of compds. crystd. into the JNK3 ATP binding active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxU6m3U6EDrVg90H21EOLACvtfcHk0liBpgz-FsB8zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xosl2gtw%253D%253D&md5=ddb516dc2c8b520c119c52ef3e8aac27</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.11.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.11.039%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DArzel%26aufirst%3DE.%26aulast%3DKallin%26aufirst%3DE.%26aulast%3DMagnus%26aufirst%3DA.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DViklund%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202%25E2%2580%25B2-anilino-4%252C4%25E2%2580%25B2-bipyridines%2520as%2520selective%2520inhibitors%2520of%2520c-Jun%2520N-terminal%2520kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1397%26epage%3D1401%26doi%3D10.1016%2Fj.bmcl.2005.11.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichy-Knight, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hightower, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkakorpi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrave, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.bmcl.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17194588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1296-1301&author=R.+M.+Angellauthor=F.+L.+Atkinsonauthor=M.+J.+Brownauthor=T.+T.+Chuangauthor=J.+A.+Christopherauthor=M.+Cichy-Knightauthor=A.+K.+Dunnauthor=K.+E.+Hightowerauthor=S.+Malkakorpiauthor=J.+R.+Musgraveauthor=M.+Neuauthor=P.+Rowlandauthor=R.+L.+Sheaauthor=J.+L.+Smithauthor=D.+O.+Somersauthor=S.+A.+Thomasauthor=G.+Thompsonauthor=R.+Wang&title=N-%283-Cyano-4%2C5%2C6%2C7-tetrahydro-1-benzothien-2-yl%29amides+as+potent%2C+selective%2C+inhibitors+of+JNK2+and+JNK3&doi=10.1016%2Fj.bmcl.2006.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3</span></div><div class="casAuthors">Angell, Richard M.; Atkinson, Francis L.; Brown, Murray J.; Chuang, Tsu Tshen; Christopher, John A.; Cichy-Knight, Maria; Dunn, Allison K.; Hightower, Kendra E.; Malkakorpi, Susanna; Musgrave, James R.; Neu, Margarete; Rowland, Paul; Shea, Robyn L.; Smith, Jeffery L.; Somers, Donald O.; Thomas, Sonia A.; Thompson, Gladstone; Wang, Ruolan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1296-1301</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The identification and exploration of a novel, potent and selective series of N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amide inhibitors of JNK2 and JNK3 kinases is described.  Compds. 5a and 11a were identified as potent inhibitors of JNK3 (pIC50 6.7 and 6.6, resp.), with essentially equal potency against JNK2 (pIC50 6.5).  Selectivity within the mitogen-activated protein kinase (MAPK) family, against JNK1, p38α and ERK2, was obsd. for the series.  X-ray crystallog. of 5e and 8a in JNK3 revealed a unique binding mode, with the 3-cyano substituent forming an H-bond acceptor interaction with the hinge region of the ATP-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr271b_UF6qQLVg90H21EOLACvtfcHk0liP4Gsw3sjqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsbk%253D&md5=2c9f4aaea1a10f2c2fd143555f756f2c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAtkinson%26aufirst%3DF.%2BL.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26aulast%3DChuang%26aufirst%3DT.%2BT.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DCichy-Knight%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DA.%2BK.%26aulast%3DHightower%26aufirst%3DK.%2BE.%26aulast%3DMalkakorpi%26aufirst%3DS.%26aulast%3DMusgrave%26aufirst%3DJ.%2BR.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DR.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DThomas%26aufirst%3DS.%2BA.%26aulast%3DThompson%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DN-%25283-Cyano-4%252C5%252C6%252C7-tetrahydro-1-benzothien-2-yl%2529amides%2520as%2520potent%252C%2520selective%252C%2520inhibitors%2520of%2520JNK2%2520and%2520JNK3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1296%26epage%3D1301%26doi%3D10.1016%2Fj.bmcl.2006.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frackowiak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">12853</span>– <span class="NLM_lpage">12861</span>, <span class="refDoi"> DOI: 10.1074/jbc.m809430200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1074%2Fjbc.m809430200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=19261605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlemsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=12853-12861&author=T.+Kameneckaauthor=J.+Habelauthor=D.+Duckettauthor=W.+Chenauthor=Y.+Y.+Lingauthor=B.+Frackowiakauthor=R.+Jiangauthor=Y.+Shinauthor=X.+Songauthor=P.+LoGrasso&title=Structure-activity+relationships+and+X-ray+structures+describing+the+selectivity+of+aminopyrazole+inhibitors+for+c-Jun+N-terminal+kinase+3+%28JNK3%29+over+p38&doi=10.1074%2Fjbc.m809430200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38</span></div><div class="casAuthors">Kamenecka, Ted; Habel, Jeff; Duckett, Derek; Chen, Weimin; Ling, Yuan Yuan; Frackowiak, Bozena; Jiang, Rong; Shin, Youseung; Song, Xinyi; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12853-12861</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">C-Jun N-terminal kinase 3α1 (JNK3α1) is a mitogen-activated protein kinase family member expressed primarily in the brain that phosphorylates protein transcription factors, including c-Jun and activating transcription factor-2 (ATF-2) upon activation by a variety of stress-based stimuli.  In this study, we set out to design JNK3-selective inhibitors that had >1000-fold selectivity over p38, another closely related mitogen-activated protein kinase family member.  To do this we employed traditional medicinal chem. principles coupled with structure-based drug design.  Inhibitors from the aminopyrazole class, such as SR-3576, were found to be very potent JNK3 inhibitors (IC50 = 7 nM) with >2800-fold selectivity over p38 (p38 IC50 > 20 μM) and had cell-based potency of ∼1 μM.  In contrast, indazole-based inhibitors exemplified by SR-3737 were potent inhibitors of both JNK3 (IC50 = 12 nM) and p38 (IC50 = 3 nM).  These selectivity differences between the indazole class and the aminopyrazole class came despite nearly identical binding (root mean square deviation = 0.33 Å) of these two compd. classes to JNK3.  The structural features within the compds. giving rise to the selectivity in the aminopyrazole class include the highly planar nature of the pyrazole, N-linked Ph structures, which better occupied the smaller active site of JNK3 compared with the larger active site of p38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAnr4BDk9xp7Vg90H21EOLACvtfcHk0liP4Gsw3sjqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlemsrs%253D&md5=fe7a266891521ca6526dd8738441fcee</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m809430200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m809430200%26sid%3Dliteratum%253Aachs%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DHabel%26aufirst%3DJ.%26aulast%3DDuckett%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLing%26aufirst%3DY.%2BY.%26aulast%3DFrackowiak%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DStructure-activity%2520relationships%2520and%2520X-ray%2520structures%2520describing%2520the%2520selectivity%2520of%2520aminopyrazole%2520inhibitors%2520for%2520c-Jun%2520N-terminal%2520kinase%25203%2520%2528JNK3%2529%2520over%2520p38%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D12853%26epage%3D12861%26doi%3D10.1074%2Fjbc.m809430200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helgason, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueber, E. C.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">9378</span>– <span class="NLM_lpage">9383</span>, <span class="refDoi"> DOI: 10.1073/pnas.1121552109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.1121552109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=22619329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptlaiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=9378-9383&author=X.+Maauthor=E.+Helgasonauthor=Q.+T.+Phungauthor=C.+L.+Quanauthor=R.+S.+Iyerauthor=M.+W.+Leeauthor=K.+K.+Bowmanauthor=M.+A.+Starovasnikauthor=E.+C.+Dueber&title=Molecular+basis+of+Tank-binding+kinase+1+activation+by+transautophosphorylation&doi=10.1073%2Fpnas.1121552109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation</span></div><div class="casAuthors">Ma, Xiaolei; Helgason, Elizabeth; Phung, Qui T.; Quan, Clifford L.; Lyer, Rekha S.; Lee, Michelle W.; Bowman, Krista K.; Starovasnik, Melissa A.; Dueber, Erin C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9378-9383, S9378/1-S9378/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tank-binding kinase (TBK)1 plays a central role in innate immunity; it serves as an integrator of multiple signals induced by receptor-mediated pathogen detection and as a modulator of IFN levels.  Efforts to better understand the biol. of this key immunol. factor have intensified recently as growing evidence implicates aberrant TBK1 activity in a variety of autoimmune diseases and cancers.  Nevertheless, key mol. details of TBK1 regulation and substrate selection remain unanswered.  Here, structures of phosphorylated and unphosphorylated human TBK1 kinase domain (KD) and ubiquitin-like domain (ULD), combined with biochem. studies, indicate a mol. mechanism of activation via transautophosphorylation.  These TBK1 structures are consistent with the tripartite architecture obsd. recently for the related kinase IKKβ, but domain contributions toward target recognition appear to differ for the two enzymes.  In particular, both TBK1 autoactivation and substrate specificity are likely driven by signal-dependent colocalization events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHhXS8bOS9LVg90H21EOLACvtfcHk0ljXEoghucKISA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptlaiurc%253D&md5=fa6ff15e25a04066c1a54f5d5072d651</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121552109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121552109%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHelgason%26aufirst%3DE.%26aulast%3DPhung%26aufirst%3DQ.%2BT.%26aulast%3DQuan%26aufirst%3DC.%2BL.%26aulast%3DIyer%26aufirst%3DR.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BW.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DDueber%26aufirst%3DE.%2BC.%26atitle%3DMolecular%2520basis%2520of%2520Tank-binding%2520kinase%25201%2520activation%2520by%2520transautophosphorylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D9378%26epage%3D9383%26doi%3D10.1073%2Fpnas.1121552109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikediobi, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarius, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barthorpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brackenbury, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicks, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hills, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmidou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mironenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tofts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhold, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futreal, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooster, R.</span></span> <span> </span><span class="NLM_article-title">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2606</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-06-0433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1158%2F1535-7163.mct-06-0433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17088437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2606-2612&author=O.+N.+Ikediobiauthor=H.+Daviesauthor=G.+Bignellauthor=S.+Edkinsauthor=C.+Stevensauthor=S.+O%E2%80%99Mearaauthor=T.+Santariusauthor=T.+Avisauthor=S.+Barthorpeauthor=L.+Brackenburyauthor=G.+Buckauthor=A.+Butlerauthor=J.+Clementsauthor=J.+Coleauthor=E.+Dicksauthor=S.+Forbesauthor=K.+Grayauthor=K.+Hallidayauthor=R.+Harrisonauthor=K.+Hillsauthor=J.+Hintonauthor=C.+Hunterauthor=A.+Jenkinsonauthor=D.+Jonesauthor=V.+Kosmidouauthor=R.+Luggauthor=A.+Menziesauthor=T.+Mironenkoauthor=A.+Parkerauthor=J.+Perryauthor=K.+Raineauthor=D.+Richardsonauthor=R.+Shepherdauthor=A.+Smallauthor=R.+Smithauthor=H.+Solomonauthor=P.+Stephensauthor=J.+Teagueauthor=C.+Toftsauthor=J.+Varianauthor=T.+Webbauthor=S.+Westauthor=S.+Widaaauthor=A.+Yatesauthor=W.+Reinholdauthor=J.+N.+Weinsteinauthor=M.+R.+Strattonauthor=P.+A.+Futrealauthor=R.+Wooster&title=Mutation+analysis+of+24+known+cancer+genes+in+the+NCI-60+cell+line+set&doi=10.1158%2F1535-7163.mct-06-0433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span></div><div class="casAuthors">Ikediobi, Ogechi N.; Davies, Helen; Bignell, Graham; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Santarius, Thomas; Avis, Tim; Barthorpe, Syd; Brackenbury, Lisa; Buck, Gemma; Butler, Adam; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kristian; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jonathan; Hunter, Chris; Jenkinson, Andy; Jones, David; Kosmidou, Vivienne; Lugg, Richard; Menzies, Andrew; Mironenko, Tatiana; Parker, Adrian; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alex; Smith, Raffaella; Solomon, Helen; Stephens, Philip; Teague, Jon; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Reinhold, William; Weinstein, John N.; Stratton, Michael R.; Futreal, P. Andrew; Wooster, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2606-2612</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer Institute for anticancer drug discovery is a widely used resource.  The NCI-60 has been characterized pharmacol. and at the mol. level more extensively than any other set of cell lines.  However, no systematic mutation anal. of genes causally implicated in oncogenesis has been reported.  This study reports the sequence anal. of 24 known cancer genes in the NCI-60 and an assessment of 4 of the 24 genes for homozygous deletions.  One hundred thirty-seven oncogenic mutations were identified in 14 (APC, BRAF, CDKN2, CTNNB1, HRAS, KRAS, NRAS, SMAD4, PIK3CA, PTEN, RB1, STK11, TP53, and VHL) of the 24 genes.  All lines have at least one mutation among the cancer genes examd., with most lines (73%) having more than one.  Identification of those cancer genes mutated in the NCI-60, in combination with pharmacol. and mol. profiles of the cells, will allow for more informed interpretation of anticancer agent screening and will enhance the use of the NCI-60 cell lines for molecularly targeted screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1IovOJtJWDbVg90H21EOLACvtfcHk0ljXEoghucKISA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK&md5=f943d16d3e147357815de0ec3c29c30d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-06-0433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-06-0433%26sid%3Dliteratum%253Aachs%26aulast%3DIkediobi%26aufirst%3DO.%2BN.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DBignell%26aufirst%3DG.%26aulast%3DEdkins%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DS.%26aulast%3DSantarius%26aufirst%3DT.%26aulast%3DAvis%26aufirst%3DT.%26aulast%3DBarthorpe%26aufirst%3DS.%26aulast%3DBrackenbury%26aufirst%3DL.%26aulast%3DBuck%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DA.%26aulast%3DClements%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DJ.%26aulast%3DDicks%26aufirst%3DE.%26aulast%3DForbes%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DHalliday%26aufirst%3DK.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHills%26aufirst%3DK.%26aulast%3DHinton%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DC.%26aulast%3DJenkinson%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKosmidou%26aufirst%3DV.%26aulast%3DLugg%26aufirst%3DR.%26aulast%3DMenzies%26aufirst%3DA.%26aulast%3DMironenko%26aufirst%3DT.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DRaine%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DR.%26aulast%3DSmall%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DSolomon%26aufirst%3DH.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DTofts%26aufirst%3DC.%26aulast%3DVarian%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWidaa%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DA.%26aulast%3DReinhold%26aufirst%3DW.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26atitle%3DMutation%2520analysis%2520of%252024%2520known%2520cancer%2520genes%2520in%2520the%2520NCI-60%2520cell%2520line%2520set%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2606%26epage%3D2612%26doi%3D10.1158%2F1535-7163.mct-06-0433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meibom, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbeck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrenga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittendorf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schamberger, J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective human neutrophil elastase inhibitors with novel equatorial ring topology: in vivo efficacy of the polar pyrimidopyridazine BAY-8040 in a pulmonary arterial hypertension rat model</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1002%2Fcmdc.201500269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=26333652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGntL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=199-206&author=F.+von%0ANussbaumauthor=V.+M.+Liauthor=D.+Meibomauthor=S.+Anlaufauthor=M.+Bechemauthor=M.+Delbeckauthor=M.+Gerischauthor=A.+Harrengaauthor=D.+Karthausauthor=D.+Langauthor=K.+Lustigauthor=J.+Mittendorfauthor=M.+Sch%C3%A4ferauthor=S.+Sch%C3%A4ferauthor=J.+Schamberger&title=Potent+and+selective+human+neutrophil+elastase+inhibitors+with+novel+equatorial+ring+topology%3A+in+vivo+efficacy+of+the+polar+pyrimidopyridazine+BAY-8040+in+a+pulmonary+arterial+hypertension+rat+model&doi=10.1002%2Fcmdc.201500269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat Model</span></div><div class="casAuthors">von Nussbaum, Franz; Li, Volkhart M.; Meibom, Daniel; Anlauf, Sonja; Bechem, Martin; Delbeck, Martina; Gerisch, Michael; Harrenga, Axel; Karthaus, Dagmar; Lang, Dieter; Lustig, Klemens; Mittendorf, Joachim; Schaefer, Martina; Schaefer, Stefan; Schamberger, Jens</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Human neutrophil elastase (HNE) is a key driver of inflammation in many cardiopulmonary and systemic inflammatory and autoimmune conditions.  Overshooting high HNE activity is the consequence of a disrupted protease-antiprotease balance.  Accordingly, there has been an intensive search for potent and selective HNE inhibitors with suitable pharmacokinetics that would allowing oral administration in patients.  Based on the chem. probe BAY-678 and the clin. candidate BAY 85-8501 we explored further ring topologies along the equator of the parent pyrimidinone lead series.  Novel ring systems were annulated in the east, yielding imidazolo-, triazolo-, and tetrazolopyrimidines in order to ensure addnl. inhibitor-HNE contacts beyond the S1 and the S2 pocket of HNE.  The western annulation of pyridazines led to the polar pyrimidopyridazine BAY-8040, which combines excellent potency and selectivity with a promising pharmacokinetic profile.  In vivo efficacy with regard to decreasing cardiac remodeling and amelioration of cardiac function was shown in a monocrotaline-induced rat model for pulmonary arterial hypertension.  This demonstrated in vivo proof of concept in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_7hken5xnLVg90H21EOLACvtfcHk0lg87YivjRtXgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGntL3I&md5=a649307980cdcb9f1994e6675ff9d509</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500269%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DV.%2BM.%26aulast%3DMeibom%26aufirst%3DD.%26aulast%3DAnlauf%26aufirst%3DS.%26aulast%3DBechem%26aufirst%3DM.%26aulast%3DDelbeck%26aufirst%3DM.%26aulast%3DGerisch%26aufirst%3DM.%26aulast%3DHarrenga%26aufirst%3DA.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DLustig%26aufirst%3DK.%26aulast%3DMittendorf%26aufirst%3DJ.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26aulast%3DSchamberger%26aufirst%3DJ.%26atitle%3DPotent%2520and%2520selective%2520human%2520neutrophil%2520elastase%2520inhibitors%2520with%2520novel%2520equatorial%2520ring%2520topology%253A%2520in%2520vivo%2520efficacy%2520of%2520the%2520polar%2520pyrimidopyridazine%2520BAY-8040%2520in%2520a%2520pulmonary%2520arterial%2520hypertension%2520rat%2520model%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D199%26epage%3D206%26doi%3D10.1002%2Fcmdc.201500269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brumby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ter Laak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Montalvan, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsyte-Lovejoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhakumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellfeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stresemann, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a highly potent and selective aminopyrazoline-based in vivo probe (BAY-598) for the protein lysine methyltransferase SMYD2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4578</span>– <span class="NLM_lpage">4600</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01890</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4578-4600&author=E.+Eggertauthor=R.+C.+Hilligauthor=S.+Koehrauthor=D.+St%C3%B6ckigtauthor=J.+Weiskeauthor=N.+Barakauthor=J.+Mowatauthor=T.+Brumbyauthor=C.+D.+Christauthor=A.+ter+Laakauthor=T.+Langauthor=A.+E.+Fernandez-Montalvanauthor=V.+Badockauthor=H.+Weinmannauthor=I.+V.+Hartungauthor=D.+Barsyte-Lovejoyauthor=M.+Szewczykauthor=S.+Kennedyauthor=F.+Liauthor=M.+Vedadiauthor=P.+J.+Brownauthor=V.+Santhakumarauthor=C.+H.+Arrowsmithauthor=T.+Stellfeldauthor=C.+Stresemann&title=Discovery+and+characterization+of+a+highly+potent+and+selective+aminopyrazoline-based+in+vivo+probe+%28BAY-598%29+for+the+protein+lysine+methyltransferase+SMYD2&doi=10.1021%2Facs.jmedchem.5b01890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2</span></div><div class="casAuthors">Eggert, Erik; Hillig, Roman C.; Koehr, Silke; Stoeckigt, Detlef; Weiske, Joerg; Barak, Naomi; Mowat, Jeffrey; Brumby, Thomas; Christ, Clara D.; ter Laak, Antonius; Lang, Tina; Fernandez-Montalvan, Amaury E.; Badock, Volker; Weinmann, Hilmar; Hartung, Ingo V.; Barsyte-Lovejoy, Dalia; Szewczyk, Magdalena; Kennedy, Steven; Li, Fengling; Vedadi, Masoud; Brown, Peter J.; Santhakumar, Vijayaratnam; Arrowsmith, Cheryl H.; Stellfeld, Timo; Stresemann, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4578-4600</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein lysine methyltransferases have recently emerged as a new target class for the development of inhibitors that modulate gene transcription or signaling pathways.  SET and MYND domain contg. protein 2 (SMYD2) is a catalytic SET domain contg. methyltransferase reported to monomethylate lysine residues on histone and nonhistone proteins.  Although several studies have uncovered an important role of SMYD2 in promoting cancer by protein methylation, the biol. of SMYD2 is far from being fully understood.  Utilization of highly potent and selective chem. probes for target validation has emerged as a concept which circumvents possible limitations of knockdown expts. and, in particular, could result in an improved exploration of drug targets with a complex underlying biol.  Here, we report the development of a potent, selective, and cell-active, substrate-competitive inhibitor of SMYD2, which is the first reported inhibitor suitable for in vivo target validation studies in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuNehWDd3N7Vg90H21EOLACvtfcHk0lifueHFz4xovw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsLc%253D&md5=d0944b0a6870b9790f9f4c429290f81e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01890%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DE.%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DKoehr%26aufirst%3DS.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DBarak%26aufirst%3DN.%26aulast%3DMowat%26aufirst%3DJ.%26aulast%3DBrumby%26aufirst%3DT.%26aulast%3DChrist%26aufirst%3DC.%2BD.%26aulast%3Dter%2BLaak%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DT.%26aulast%3DFernandez-Montalvan%26aufirst%3DA.%2BE.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DSzewczyk%26aufirst%3DM.%26aulast%3DKennedy%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSanthakumar%26aufirst%3DV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DStellfeld%26aufirst%3DT.%26aulast%3DStresemann%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520potent%2520and%2520selective%2520aminopyrazoline-based%2520in%2520vivo%2520probe%2520%2528BAY-598%2529%2520for%2520the%2520protein%2520lysine%2520methyltransferase%2520SMYD2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4578%26epage%3D4600%26doi%3D10.1021%2Facs.jmedchem.5b01890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouché, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Montalván, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ter Laak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Sáez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siejka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pütter, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haendler, B.</span></span> <span> </span><span class="NLM_article-title">Benzoisoquinolinediones as potent and selective inhibitors of BRPF2 and TAF1/TAF1L bromodomains</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4002</span>– <span class="NLM_lpage">4022</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4002-4022&author=L.+Bouch%C3%A9author=C.+D.+Christauthor=S.+Siegelauthor=A.+E.+Fern%C3%A1ndez-Montalv%C3%A1nauthor=S.+J.+Holtonauthor=O.+Fedorovauthor=A.+ter+Laakauthor=T.+Sugawaraauthor=D.+St%C3%B6ckigtauthor=C.+Tallantauthor=J.+Bennettauthor=O.+Monteiroauthor=L.+D%C3%ADaz-S%C3%A1ezauthor=P.+Siejkaauthor=J.+Meierauthor=V.+P%C3%BCtterauthor=J.+Weiskeauthor=S.+M%C3%BCllerauthor=K.+V.+M.+Huberauthor=I.+V.+Hartungauthor=B.+Haendler&title=Benzoisoquinolinediones+as+potent+and+selective+inhibitors+of+BRPF2+and+TAF1%2FTAF1L+bromodomains&doi=10.1021%2Facs.jmedchem.7b00306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains</span></div><div class="casAuthors">Bouche, Lea; Christ, Clara D.; Siegel, Stephan; Fernandez-Montalvan, Amaury E.; Holton, Simon J.; Fedorov, Oleg; ter Laak, Antonius; Sugawara, Tatsuo; Stoeckigt, Detlef; Tallant, Cynthia; Bennett, James; Monteiro, Octovia; Diaz-Saez, Laura; Siejka, Paulina; Meier, Julia; Puetter, Vera; Weiske, Joerg; Mueller, Susanne; Huber, Kilian V. M.; Hartung, Ingo V.; Haendler, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4002-4022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains (BD) are readers of lysine acetylation marks present in numerous proteins assocd. with chromatin.  Here we describe a dual inhibitor of the bromodomain and PHD finger (BRPF) family member BRPF2 and the TATA box binding protein-assocd. factors TAF1 and TAF1L.  These proteins are found in large chromatin complexes and play important roles in transcription regulation.  The substituted benzoisoquinolinedione series was identified by high-throughput screening, and subsequent structure-activity relationship optimization allowed generation of low nanomolar BRPF2 BD inhibitors with strong selectivity against BRPF1 and BRPF3 BDs.  In addn., a strong inhibition of TAF1/TAF1L BD2 was measured for most derivs.  The best compd. of the series was BAY-299, which is a very potent, dual inhibitor with an IC50 of 67 nM for BRPF2 BD, 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2.  Importantly, no activity was measured for BRD4 BDs.  Furthermore, cellular activity was evidenced using a BRPF2- or TAF1-histone H3.3 or H4 interaction assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWg-Bg5eiC-bVg90H21EOLACvtfcHk0lifueHFz4xovw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvFWhsLk%253D&md5=3012fd7ce265b23bfc6c354425112e2a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00306%26sid%3Dliteratum%253Aachs%26aulast%3DBouch%25C3%25A9%26aufirst%3DL.%26aulast%3DChrist%26aufirst%3DC.%2BD.%26aulast%3DSiegel%26aufirst%3DS.%26aulast%3DFern%25C3%25A1ndez-Montalv%25C3%25A1n%26aufirst%3DA.%2BE.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3Dter%2BLaak%26aufirst%3DA.%26aulast%3DSugawara%26aufirst%3DT.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DMonteiro%26aufirst%3DO.%26aulast%3DD%25C3%25ADaz-S%25C3%25A1ez%26aufirst%3DL.%26aulast%3DSiejka%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DJ.%26aulast%3DP%25C3%25BCtter%26aufirst%3DV.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DHaendler%26aufirst%3DB.%26atitle%3DBenzoisoquinolinediones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520BRPF2%2520and%2520TAF1%252FTAF1L%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4002%26epage%3D4022%26doi%3D10.1021%2Facs.jmedchem.7b00306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Montalván, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuropka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puetter, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ter Laak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troast, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodeschini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Sáez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorjánácz, M.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective ATAD2 chemical probe with novel chemical structure and unusual mode of action</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2730</span>– <span class="NLM_lpage">2736</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2730-2736&author=A.+E.+Fern%C3%A1ndez-Montalv%C3%A1nauthor=M.+Bergerauthor=B.+Kuropkaauthor=S.+J.+Kooauthor=V.+Badockauthor=J.+Weiskeauthor=V.+Puetterauthor=S.+J.+Holtonauthor=D.+St%C3%B6ckigtauthor=A.+ter+Laakauthor=P.+A.+Centrellaauthor=M.+A.+Clarkauthor=C.+E.+Dumelinauthor=E.+A.+Sigelauthor=H.+H.+Soutterauthor=D.+M.+Troastauthor=Y.+Zhangauthor=J.+W.+Cuozzoauthor=A.+D.+Keefeauthor=D.+Rocheauthor=V.+Rodeschiniauthor=A.+Chaikuadauthor=L.+D%C3%ADaz-S%C3%A1ezauthor=J.+M.+Bennettauthor=O.+Fedorovauthor=K.+V.+M.+Huberauthor=J.+H%C3%BCbnerauthor=H.+Weinmannauthor=I.+V.+Hartungauthor=M.+Gorj%C3%A1n%C3%A1cz&title=Isoform-selective+ATAD2+chemical+probe+with+novel+chemical+structure+and+unusual+mode+of+action&doi=10.1021%2Facschembio.7b00708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action</span></div><div class="casAuthors">Fernandez-Montalvan, Amaury E.; Berger, Markus; Kuropka, Benno; Koo, Seong Joo; Badock, Volker; Weiske, Joerg; Puetter, Vera; Holton, Simon J.; Stoeckigt, Detlef; ter Laak, Antonius; Centrella, Paolo A.; Clark, Matthew A.; Dumelin, Christoph E.; Sigel, Eric A.; Soutter, Holly H.; Troast, Dawn M.; Zhang, Ying; Cuozzo, John W.; Keefe, Anthony D.; Roche, Didier; Rodeschini, Vincent; Chaikuad, Apirat; Diaz-Saez, Laura; Bennett, James M.; Fedorov, Oleg; Huber, Kilian V. M.; Huebner, Jan; Weinmann, Hilmar; Hartung, Ingo V.; Gorjanacz, Matyas</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2730-2736</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types.  Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells.  These features qualify BAY-850 as a chem. probe to explore ATAD2 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCB3nyG9YvubVg90H21EOLACvtfcHk0livoqYt9OYsbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrrL&md5=1f09000a7d7e60e30540fbbae117acfe</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00708%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Montalv%25C3%25A1n%26aufirst%3DA.%2BE.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DKuropka%26aufirst%3DB.%26aulast%3DKoo%26aufirst%3DS.%2BJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DPuetter%26aufirst%3DV.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3Dter%2BLaak%26aufirst%3DA.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DSigel%26aufirst%3DE.%2BA.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DTroast%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26aulast%3DRoche%26aufirst%3DD.%26aulast%3DRodeschini%26aufirst%3DV.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DD%25C3%25ADaz-S%25C3%25A1ez%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DJ.%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DGorj%25C3%25A1n%25C3%25A1cz%26aufirst%3DM.%26atitle%3DIsoform-selective%2520ATAD2%2520chemical%2520probe%2520with%2520novel%2520chemical%2520structure%2520and%2520unusual%2520mode%2520of%2520action%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D2730%26epage%3D2736%26doi%3D10.1021%2Facschembio.7b00708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmann, B.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2271</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1002%2Fcmdc.201600276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=27552707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2261-2271&author=H.+Siebeneicherauthor=A.+Cleveauthor=H.+Rehwinkelauthor=R.+Neuhausauthor=I.+Heislerauthor=T.+M%C3%BCllerauthor=M.+Bauserauthor=B.+Buchmann&title=Identification+and+optimization+of+the+first+highly+selective+GLUT1+inhibitor+BAY-876&doi=10.1002%2Fcmdc.201600276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876</span></div><div class="casAuthors">Siebeneicher, Holger; Cleve, Arwed; Rehwinkel, Hartmut; Neuhaus, Roland; Heisler, Iring; Mueller, Thomas; Bauser, Marcus; Buchmann, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2261-2271</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite the long-known fact that the facilitative glucose transporter GLUT1 is one of the key players safeguarding the increase in glucose consumption of many tumor entities even under conditions of normal oxygen supply (known as the Warburg effect), only few endeavors have been undertaken to find a GLUT1-selective small-mol. inhibitor.  Because other transporters of the GLUT1 family are involved in crucial processes, these transporters should not be addressed by such an inhibitor.  A high-throughput screen against a library of ∼3 million compds. was performed to find a small mol. with this challenging potency and selectivity profile.  The N-(1H-pyrazol-4-yl)quinoline-4-carboxamides were identified as an excellent starting point for further compd. optimization.  After extensive structure-activity relationship explorations, single-digit nanomolar inhibitors with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4 were obtained.  The most promising compd., BAY-876 [N4-[1-(4-cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide], showed good metabolic stability in vitro and high oral bioavailability in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnF7Pnmxup7Vg90H21EOLACvtfcHk0lj1n5T2Gzw95A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L&md5=bcad707900882f937d137dc3925862a7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600276%26sid%3Dliteratum%253Aachs%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DCleve%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520the%2520first%2520highly%2520selective%2520GLUT1%2520inhibitor%2520BAY-876%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2261%26epage%3D2271%26doi%3D10.1002%2Fcmdc.201600276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trésaugues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talagas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Sáez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panagakou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siejka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorjánácz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, M.</span></span> <span> </span><span class="NLM_article-title">Creation of a novel class of potent and selective MutT homologue 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2533</span>– <span class="NLM_lpage">2551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2533-2551&author=F.+Rahmauthor=J.+Viklundauthor=L.+Tr%C3%A9sauguesauthor=M.+Ellermannauthor=A.+Gieseauthor=U.+Ericssonauthor=R.+Forsblomauthor=T.+Ginmanauthor=J.+G%C3%BCntherauthor=K.+Hallbergauthor=J.+Lindstr%C3%B6mauthor=L.+B.+Perssonauthor=C.+Silvanderauthor=A.+Talagasauthor=L.+D%C3%ADaz-S%C3%A1ezauthor=O.+Fedorovauthor=K.+V.+M.+Huberauthor=I.+Panagakouauthor=P.+Siejkaauthor=M.+Gorj%C3%A1n%C3%A1czauthor=M.+Bauserauthor=M.+Andersson&title=Creation+of+a+novel+class+of+potent+and+selective+MutT+homologue+1+%28MTH1%29+inhibitors+using+fragment-based+screening+and+structure-based+drug+design&doi=10.1021%2Facs.jmedchem.7b01884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design</span></div><div class="casAuthors">Rahm, Fredrik; Viklund, Jenny; Tresaugues, Lionel; Ellermann, Manuel; Giese, Anja; Ericsson, Ulrika; Forsblom, Rickard; Ginman, Tobias; Gunther, Judith; Hallberg, Kenth; Lindstroem, Johan; Persson, Lars Boukharta; Silvander, Camilla; Talagas, Antoine; Diaz-Saez, Laura; Fedorov, Oleg; Huber, Kilian V. M.; Panagakou, Ioanna; Siejka, Paulina; Gorjanacz, Matyas; Bauser, Marcus; Andersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2533-2551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent literature has both suggested and questioned MTH1 as a novel cancer target.  BAY-707 was just published as a target validation small mol. probe for assessing the effects of pharmacol. inhibition of MTH1 on tumor cell survival, both in vitro and in vivo.  In this report, the authors describe the medicinal chem. program creating BAY-707, where fragment-based methods were used to develop a series of highly potent and selective MTH1 inhibitors.  Using structure-based drug design and rational medicinal chem. approaches, the potency was increased over 10,000 times from the fragment starting point while maintaining high ligand efficiency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7pMr__ory7Vg90H21EOLACvtfcHk0lj1n5T2Gzw95A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D&md5=5500fe330efef6fdbe5eae95b3d88ab1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01884%26sid%3Dliteratum%253Aachs%26aulast%3DRahm%26aufirst%3DF.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DTr%25C3%25A9saugues%26aufirst%3DL.%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DA.%26aulast%3DEricsson%26aufirst%3DU.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DG%25C3%25BCnther%26aufirst%3DJ.%26aulast%3DHallberg%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPersson%26aufirst%3DL.%2BB.%26aulast%3DSilvander%26aufirst%3DC.%26aulast%3DTalagas%26aufirst%3DA.%26aulast%3DD%25C3%25ADaz-S%25C3%25A1ez%26aufirst%3DL.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DPanagakou%26aufirst%3DI.%26aulast%3DSiejka%26aufirst%3DP.%26aulast%3DGorj%25C3%25A1n%25C3%25A1cz%26aufirst%3DM.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DM.%26atitle%3DCreation%2520of%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520MutT%2520homologue%25201%2520%2528MTH1%2529%2520inhibitors%2520using%2520fragment-based%2520screening%2520and%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2533%26epage%3D2551%26doi%3D10.1021%2Facs.jmedchem.7b01884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, R. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broggini-Tenzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Süssmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grünewald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span> <span> </span><span class="NLM_article-title">Novel TIE-2 inhibitor BAY-826 displays <i>in vivo</i> efficacy in experimental syngeneic murine glioma models</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1111/jnc.13877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1111%2Fjnc.13877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=27787897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGmt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=170-182&author=H.+Schneiderauthor=E.+Szaboauthor=R.+A.+C.+Machadoauthor=A.+Broggini-Tenzerauthor=A.+Walterauthor=M.+Lobellauthor=D.+Heldmannauthor=F.+S%C3%BCssmeierauthor=S.+Gr%C3%BCnewaldauthor=M.+Weller&title=Novel+TIE-2+inhibitor+BAY-826+displays+in+vivo+efficacy+in+experimental+syngeneic+murine+glioma+models&doi=10.1111%2Fjnc.13877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel TIE-2 inhibitor BAY-826 displays in vivo efficacy in experimental syngeneic murine glioma models</span></div><div class="casAuthors">Schneider, Hannah; Szabo, Emese; Machado, Raquel A. C.; Broggini-Tenzer, Angela; Walter, Alexander; Lobell, Mario; Heldmann, Dieter; Suessmeier, Frank; Gruenewald, Sylvia; Weller, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-182</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Targeting the vascular endothelial growth factor signaling axis in glioblastoma inevitably leads to tumor recurrence and a more aggressive phenotype.  Therefore, other angiogenic pathways, like the angiopoietin/tunica interna endothelial cell kinase (TIE) signaling axis, have become addnl. targets for therapeutic intervention.  Here, we explored whether targeting the receptor tyrosine kinase TIE-2 using a novel, highly potent, orally available small mol. TIE-2 inhibitor (BAY-826) improves tumor control in syngeneic mouse glioma models.  BAY-826 inhibits TIE-2 phosphorylation in vitro and in vivo as demonstrated by suppression of Angiopoietin-1- or Na3VO4-induced TIE-2 phosphorylation in glioma cells or exts. of lungs from BAY-826-treated mice.  There was a trend toward prolonged survival upon single-agent treatment in two of four models (SMA-497 and SMA-540) and there was a significant survival benefit in one model (SMA-560).  Co-treatment with BAY-826 and irradn. was ineffective in one model (SMA-497), but provided synergistic prolongation of survival in another (SMA-560).  Decreased vessel densities and increased leukocyte infiltration were obsd., but might be independent processes as the effect was also obsd. in single treatment modalities.  These data demonstrate that TIE-2 inhibition may improve tumor response to treatment in highly vascularized tumors such as glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSM7CpumxyGLVg90H21EOLACvtfcHk0lgFL0B8aEwL-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGmt7%252FK&md5=bd7b5a44b6c3c51f56e90f1e4f89f47d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13877%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DMachado%26aufirst%3DR.%2BA.%2BC.%26aulast%3DBroggini-Tenzer%26aufirst%3DA.%26aulast%3DWalter%26aufirst%3DA.%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DHeldmann%26aufirst%3DD.%26aulast%3DS%25C3%25BCssmeier%26aufirst%3DF.%26aulast%3DGr%25C3%25BCnewald%26aufirst%3DS.%26aulast%3DWeller%26aufirst%3DM.%26atitle%3DNovel%2520TIE-2%2520inhibitor%2520BAY-826%2520displays%2520in%2520vivo%2520efficacy%2520in%2520experimental%2520syngeneic%2520murine%2520glioma%2520models%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D140%26spage%3D170%26epage%3D182%26doi%3D10.1111%2Fjnc.13877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosmayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberspaecher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suelzle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesche, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Reppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nising, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebarth, A.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of the potent and highly selective (piperidin-4-yl)pyrido[3,2-<i>d</i>]pyrimidine based in vitro probe BAY-885 for the kinase ERK5</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01606</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01606" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFGisrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=928-940&author=D.+Nguyenauthor=C.+Lemosauthor=L.+Wortmannauthor=K.+Eisauthor=S.+J.+Holtonauthor=U.+Boemerauthor=D.+Moosmayerauthor=U.+Eberspaecherauthor=J.+Weiskeauthor=C.+Lechnerauthor=S.+Prechtlauthor=D.+Suelzleauthor=F.+Siegelauthor=F.+Prinzauthor=R.+Lescheauthor=B.+Nickeauthor=K.+Nowak-Reppelauthor=H.+Himmelauthor=D.+Mumbergauthor=F.+von+Nussbaumauthor=C.+F.+Nisingauthor=M.+Bauserauthor=A.+Haegebarth&title=Discovery+and+characterization+of+the+potent+and+highly+selective+%28piperidin-4-yl%29pyrido%5B3%2C2-d%5Dpyrimidine+based+in+vitro+probe+BAY-885+for+the+kinase+ERK5&doi=10.1021%2Facs.jmedchem.8b01606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5</span></div><div class="casAuthors">Nguyen, Duy; Lemos, Clara; Wortmann, Lars; Eis, Knut; Holton, Simon J.; Boemer, Ulf; Moosmayer, Dieter; Eberspaecher, Uwe; Weiske, Joerg; Lechner, Christian; Prechtl, Stefan; Suelzle, Detlev; Siegel, Franziska; Prinz, Florian; Lesche, Ralf; Nicke, Barbara; Nowak-Reppel, Katrin; Himmel, Herbert; Mumberg, Dominik; von Nussbaum, Franz; Nising, Carl F.; Bauser, Marcus; Haegebarth, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The availability of a chem. probe to study the role of a specific domain of a protein in a concn.- and time-dependent manner is of high value.  Herein, we report the identification of a highly potent and selective ERK5 inhibitor BAY-885(I) by high-throughput screening and subsequent structure-based optimization.  ERK5 is a key integrator of cellular signal transduction, and it has been shown to play a role in various cellular processes such as proliferation, differentiation, apoptosis, and cell survival.  We could demonstrate that inhibition of ERK5 kinase and transcriptional activity with a small mol. did not translate into antiproliferative activity in different relevant cell models, which is in contrast to the results obtained by RNAi technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkaBSl4bhkmrVg90H21EOLACvtfcHk0lgFL0B8aEwL-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFGisrjE&md5=0e7f25af7a066d31a69b6e4a291ff417</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01606%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DLemos%26aufirst%3DC.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DEberspaecher%26aufirst%3DU.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DLechner%26aufirst%3DC.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DSuelzle%26aufirst%3DD.%26aulast%3DSiegel%26aufirst%3DF.%26aulast%3DPrinz%26aufirst%3DF.%26aulast%3DLesche%26aufirst%3DR.%26aulast%3DNicke%26aufirst%3DB.%26aulast%3DNowak-Reppel%26aufirst%3DK.%26aulast%3DHimmel%26aufirst%3DH.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DNising%26aufirst%3DC.%2BF.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DHaegebarth%26aufirst%3DA.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520the%2520potent%2520and%2520highly%2520selective%2520%2528piperidin-4-yl%2529pyrido%255B3%252C2-d%255Dpyrimidine%2520based%2520in%2520vitro%2520probe%2520BAY-885%2520for%2520the%2520kinase%2520ERK5%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D928%26epage%3D940%26doi%3D10.1021%2Facs.jmedchem.8b01606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosmayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmann, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werbeck, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastouri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahmann, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhnke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1073/pnas.1812963116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.1812963116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=30683722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=2551-2560&author=R.+C.+Hilligauthor=B.+Sautierauthor=J.+Schroederauthor=D.+Moosmayerauthor=A.+Hilpmannauthor=C.+M.+Stegmannauthor=N.+D.+Werbeckauthor=H.+Briemauthor=U.+Boemerauthor=J.+Weiskeauthor=V.+Badockauthor=J.+Mastouriauthor=K.+Petersenauthor=G.+Siemeisterauthor=J.+D.+Kahmannauthor=D.+Wegenerauthor=N.+B%C3%B6hnkeauthor=K.+Eisauthor=K.+Grahamauthor=L.+Wortmannauthor=F.+von+Nussbaumauthor=B.+Bader&title=Discovery+of+potent+SOS1+inhibitors+that+block+RAS+activation+via+disruption+of+the+RAS-SOS1+interaction&doi=10.1073%2Fpnas.1812963116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction</span></div><div class="casAuthors">Hillig, Roman C.; Sautier, Brice; Schroeder, Jens; Moosmayer, Dieter; Hilpmann, AndrA; Stegmann, Christian M.; Werbeck, Nicolas D.; Briem, Hans; Boemer, Ulf; Weiske, Joerg; Badock, Volker; Mastouri, Julia; Petersen, Kirstin; Siemeister, Gerhard; Kahmann, Jan D.; Wegener, Dennis; Boehnke, Niels; Eis, Knut; Graham, Keith; Wortmann, Lars; von Nussbaum, Franz; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2551-2560</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Since the late 1980s, mutations in the RAS genes have been recognized as major oncogenes with a high occurrence rate in human cancers.  Such mutations reduce the ability of the small GTPase RAS to hydrolyze GTP, keeping this mol. switch in a constitutively active GTP-bound form that drives, unchecked, oncogenic downstream signaling.  One strategy to reduce the levels of active RAS is to target guanine nucleotide exchange factors, which allow RAS to cycle from the inactive GDP-bound state to the active GTP-bound form.  Here, we describe the identification of potent and cell-active small-mol. inhibitors which efficiently disrupt the interaction between KRAS and its exchange factor SOS1, a mode of action confirmed by a series of biophys. techniques.  The binding sites, mode of action, and selectivity were elucidated using crystal structures of KRASG12C-SOS1, SOS1, and SOS2.  By preventing formation of the KRAS-SOS1 complex, these inhibitors block reloading of KRAS with GTP, leading to antiproliferative activity.  The final compd. 23(I, BAY-293) selectively inhibits the KRAS-SOS1 interaction with an IC50 of 21 nM and is a valuable chem. probe for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTMAcBZFHkBrVg90H21EOLACvtfcHk0lirAaWHO6JExg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D&md5=f3150723049c15986cea1d7f93cb89af</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1812963116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1812963116%26sid%3Dliteratum%253Aachs%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DSautier%26aufirst%3DB.%26aulast%3DSchroeder%26aufirst%3DJ.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DHilpmann%26aufirst%3DA.%26aulast%3DStegmann%26aufirst%3DC.%2BM.%26aulast%3DWerbeck%26aufirst%3DN.%2BD.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DMastouri%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DK.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKahmann%26aufirst%3DJ.%2BD.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DB%25C3%25B6hnke%26aufirst%3DN.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520SOS1%2520inhibitors%2520that%2520block%2520RAS%2520activation%2520via%2520disruption%2520of%2520the%2520RAS-SOS1%2520interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2019%26volume%3D116%26spage%3D2551%26epage%3D2560%26doi%3D10.1073%2Fpnas.1812963116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manzar  Alam</span>, <span class="hlFld-ContribAuthor ">Gulam Mustafa  Hasan</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">A review on the role of TANK-binding kinase 1 signaling in cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>183 </em>, 2364-2375. <a href="https://doi.org/10.1016/j.ijbiomac.2021.06.022" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2021.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2021.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2021.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DA%252Breview%252Bon%252Bthe%252Brole%252Bof%252BTANK-binding%252Bkinase%252B1%252Bsignaling%252Bin%252Bcancer%26aulast%3DAlam%26aufirst%3DManzar%26date%3D2021%26volume%3D183%26spage%3D2364%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Xiang</span>, <span class="hlFld-ContribAuthor ">Shukai  Song</span>, <span class="hlFld-ContribAuthor ">Haotian  Tang</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Aiqun  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>18 </em><a href="https://doi.org/10.1016/j.drudis.2021.05.016" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTANK-binding%252Bkinase%252B1%252B%252528TBK1%252529%25253A%252BAn%252Bemerging%252Btherapeutic%252Btarget%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DXiang%26aufirst%3DShuang%26date%3D2021%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Huang</span>, <span class="hlFld-ContribAuthor ">Zexing  Li</span>, <span class="hlFld-ContribAuthor ">Zewen  Wu</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Minghang  Yu</span>, <span class="hlFld-ContribAuthor ">Mingjie  Wen</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">DDAH2 suppresses RLR-MAVS–mediated innate antiviral immunity by stimulating nitric oxide–activated, Drp1-induced mitochondrial fission. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2021,</strong> <em>14 </em>
                                    (678)
                                     , eabc7931. <a href="https://doi.org/10.1126/scisignal.abc7931" title="DOI URL">https://doi.org/10.1126/scisignal.abc7931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.abc7931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.abc7931%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DDDAH2%252Bsuppresses%252BRLR-MAVS%2525E2%252580%252593mediated%252Binnate%252Bantiviral%252Bimmunity%252Bby%252Bstimulating%252Bnitric%252Boxide%2525E2%252580%252593activated%25252C%252BDrp1-induced%252Bmitochondrial%252Bfission%26aulast%3DHuang%26aufirst%3DShan%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D678%26spage%3Deabc7931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas W.  Thomson</span>, <span class="hlFld-ContribAuthor ">Giovanna  Bergamini</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in small molecule TBK1 inhibitors: a patent review (2015– 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>9 </em>, 1-10. <a href="https://doi.org/10.1080/13543776.2021.1904893" title="DOI URL">https://doi.org/10.1080/13543776.2021.1904893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1904893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1904893%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bprogress%252Bin%252Bsmall%252Bmolecule%252BTBK1%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282015%2525E2%252580%252593%252B2020%252529%26aulast%3DThomson%26aufirst%3DDouglas%2BW.%26date%3D2021%26date%3D2021%26volume%3D9%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiasi  Wu</span>, <span class="hlFld-ContribAuthor ">Jiayi  Sun</span>, <span class="hlFld-ContribAuthor ">Xianli  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>165 </em>, 105408. <a href="https://doi.org/10.1016/j.phrs.2020.105408" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105408%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DPyroptosis%252Bby%252Bcaspase-11%252Binflammasome-Gasdermin%252BD%252Bpathway%252Bin%252Bautoimmune%252Bdiseases%26aulast%3DWu%26aufirst%3DJiasi%26date%3D2021%26volume%3D165%26spage%3D105408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina  Herhaus</span>. </span><span class="cited-content_cbyCitation_article-title">TBK1 (TANK-binding kinase 1)-mediated regulation of autophagy in health and disease. </span><span class="cited-content_cbyCitation_journal-name">Matrix Biology</span><span> <strong>2021,</strong> <em>3 </em><a href="https://doi.org/10.1016/j.matbio.2021.01.004" title="DOI URL">https://doi.org/10.1016/j.matbio.2021.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matbio.2021.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matbio.2021.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DMatrix%2520Biology%26atitle%3DTBK1%252B%252528TANK-binding%252Bkinase%252B1%252529-mediated%252Bregulation%252Bof%252Bautophagy%252Bin%252Bhealth%252Band%252Bdisease%26aulast%3DHerhaus%26aufirst%3DLina%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Compound <b>1</b> identified during our cellular HTS and compound <b>2</b> as an early variant. (B) Crystal structure of TBK1 in complex with <b>2</b> (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR">6RSR</a>). Left: the overall view of one TBK1 monomer with the kinase domain in cyan (N-terminal lobe) and blue (C-terminal lobe), the ULD in yellow, and the SDD in green. Right: <b>2</b> bound to the hinge region within the ATP site of the kinase domain. The 3.1 Å resolution mF<sub>o</sub>–DF<sub>c</sub> electron density omit map contoured at 2 σ is shown in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Conformational flexibility of the TBK1 gatekeeper Met86. Superimposition of the kinase domains of TBK1 in complex with <b>2</b> (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR">6RSR</a>, green carbon atoms) and BX-795 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EUU">4EUU</a>, orange carbon atoms). View into the hinge region of the ATP-binding site. Hydrogen-bond interactions between the inhibitors and TBK1 shown as yellow dotted lines. The gatekeeper residue Met86 can accommodate back-pocket binders such as <b>2</b> by adopting a new side-chain conformation (red arrow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. DiscoverX KINOME trees for compound <b>3</b>, <b>24</b>, and <b>34</b> at 100 nM. The red dots highlight the kinases that show an inhibition of 65% or more (for more complete list of the kinases, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf" class="ext-link">Tables S1–S3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of TBK1 in complex with <b>35</b> (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RST">6RST</a>). Left: view into the ATP site of TBK1, with the protein shown in surface representation (transparent). Right: view rotated and surface omitted for clarity. mF<sub>o</sub>–DF<sub>c</sub> electron density omit map contoured at 2σ shown around the ligand. Hydrogen-bond interactions between the inhibitor <b>35</b> and TBK1 shown as yellow dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overall profile for BAY-985 including pharmacological and physicochemical properties as well as in vitro DMPK properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antitumor efficacy of <b>34</b> as monotherapy in the SK-MEL-2 human melanoma xenograft model in female NMRI nude mice. Treatment schedule: <b>34</b> (200 mg/kg) applied twice daily (b.i.d.) for 35 days. (A) Tumor area (<i>n</i> = 10 mice/group). (B) Tumor weight at study end (day 111). Tumor areas and weights given as mean ± SD. (C) Body weight change (defined as the percentage change of the actual mean body weight compared to the maximal mean body weight after start of treatment).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/medium/jm9b01460_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01460/20200115/images/large/jm9b01460_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01460&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C; (b) 1<i>H</i>-imidazole, TCDI, DCM, 0 °C; (c) EDCI, DCM; (d) HCl, 1,4-dioxane, DCM; (e) 3,3,3-trifluoropropanoic acid, HATU, NaHCO<sub>3</sub>, DMF.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhirter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faia, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniatis, T.</span></span> <span> </span><span class="NLM_article-title">IKKε and TBK1 are essential components of the IRF3 signaling pathway</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1038/ni921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1038%2Fni921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=12692549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlakt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=491-496&author=K.+A.+Fitzgeraldauthor=S.+M.+McWhirterauthor=K.+L.+Faiaauthor=D.+C.+Roweauthor=E.+Latzauthor=D.+T.+Golenbockauthor=A.+J.+Coyleauthor=S.-M.+Liaoauthor=T.+Maniatis&title=IKK%CE%B5+and+TBK1+are+essential+components+of+the+IRF3+signaling+pathway&doi=10.1038%2Fni921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">IKKε and TBK1 are essential components of the IRF3 signaling pathway</span></div><div class="casAuthors">Fitzgerald, Katherine A.; McWhirter, Sarah M.; Faia, Kerrie L.; Rowe, Daniel C.; Latz, Eicke; Golenbock, Douglas T.; Coyle, Anthony J.; Liao, Sha-Mei; Maniatis, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transcription factors interferon regulatory factor 3 (IRF3) and NF-κB are required for the expression of many genes involved in the innate immune response.  Viral infection, or the binding of double-stranded RNA to Toll-like receptor 3, results in the coordinate activation of IRF3 and NF-κB.  Activation of IRF3 requires signal-dependent phosphorylation, but little is known about the signaling pathway or kinases involved.  Here the authors report that the noncanonical IκB kinase homologs, IκB kinase-ε (IKKε) and TANK-binding kinase-1 (TBK1), which were previously implicated in NF-κB activation, are also essential components of the IRF3 signaling pathway.  Thus, IKKε and TBK1 have a pivotal role in coordinating the activation of IRF3 and NF-κB in the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptsqPVRs3ofrVg90H21EOLACvtfcHk0lhvm51-NCecVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlakt7k%253D&md5=57ed4331a366ca6e1fff2af8e8505967</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni921%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DK.%2BA.%26aulast%3DMcWhirter%26aufirst%3DS.%2BM.%26aulast%3DFaia%26aufirst%3DK.%2BL.%26aulast%3DRowe%26aufirst%3DD.%2BC.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DCoyle%26aufirst%3DA.%2BJ.%26aulast%3DLiao%26aufirst%3DS.-M.%26aulast%3DManiatis%26aufirst%3DT.%26atitle%3DIKK%25CE%25B5%2520and%2520TBK1%2520are%2520essential%2520components%2520of%2520the%2520IRF3%2520signaling%2520pathway%26jtitle%3DNat.%2520Immunol.%26date%3D2003%26volume%3D4%26spage%3D491%26epage%3D496%26doi%3D10.1038%2Fni921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">tenOever, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandvaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiscott, J.</span></span> <span> </span><span class="NLM_article-title">Triggering the interferon antiviral response through an IKK-related pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">1148</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1126/science.1081315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1126%2Fscience.1081315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=12702806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=1148-1151&author=S.+Sharmaauthor=B.+R.+tenOeverauthor=N.+Grandvauxauthor=G.-P.+Zhouauthor=R.+Linauthor=J.+Hiscott&title=Triggering+the+interferon+antiviral+response+through+an+IKK-related+pathway&doi=10.1126%2Fscience.1081315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Triggering the Interferon Antiviral Response Through an IKK-Related Pathway</span></div><div class="casAuthors">Sharma, Sonia; ten Oever, Benjamin R.; Grandvaux, Nathalie; Zhou, Guo-Ping; Lin, Rongtuan; Hiscott, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">5622</span>),
    <span class="NLM_cas:pages">1148-1152</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Rapid induction of type I interferon expression, a central event in establishing the innate antiviral response, requires cooperative activation of numerous transcription factors.  Although signaling pathways that activate the transcription factors nuclear factor κB and ATF-2/c-Jun have been well characterized, activation of the interferon regulatory factors IRF-3 and IRF-7 has remained a crit. missing link in understanding interferon signaling.  We report here that the IκB kinase (IKK)-related kinases IKKε and TANK-binding kinase 1 (TBK1) are components of the virus-activated kinase that phosphorylate IRF-3 and IRF-7.  These studies illustrate an essential role for an IKK-related kinase pathway in triggering the host antiviral response to viral infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDrWALVOqi4rVg90H21EOLACvtfcHk0lhvm51-NCecVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGqtrs%253D&md5=239b55b61cedd911d80348f0bc822cb0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1081315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1081315%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DtenOever%26aufirst%3DB.%2BR.%26aulast%3DGrandvaux%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DG.-P.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DHiscott%26aufirst%3DJ.%26atitle%3DTriggering%2520the%2520interferon%2520antiviral%2520response%2520through%2520an%2520IKK-related%2520pathway%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D1148%26epage%3D1151%26doi%3D10.1126%2Fscience.1081315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholefield, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIver, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S.</span></span> <span> </span><span class="NLM_article-title">TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e50672</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0050672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1371%2Fjournal.pone.0050672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=23209807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A.+C.+Newmanauthor=C.+L.+Scholefieldauthor=A.+J.+Kempauthor=M.+Newmanauthor=E.+G.+McIverauthor=A.+Kamalauthor=S.+Wilkinson&title=TBK1+kinase+addiction+in+lung+cancer+cells+is+mediated+via+autophagy+of+Tax1bp1%2FNdp52+and+non-canonical+NF-%CE%BAB+signalling&doi=10.1371%2Fjournal.pone.0050672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling</span></div><div class="casAuthors">Newman, Alice C.; Scholefield, Caroline L.; Kemp, Alain J.; Newman, Michelle; McIver, Edward G.; Kamal, Ahmad; Wilkinson, Simon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e50672</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">K-Ras dependent non-small cell lung cancer (NSCLC) cells are 'addicted' to basal autophagy that reprograms cellular metab. in a lysosomal-sensitive manner.  Here we demonstrate that the xenophagy-assocd. kinase TBK1 drives basal autophagy, consistent with its known requirement in K-Ras-dependent NSCLC proliferation.  Furthermore, basal autophagy in this context is characterised by sequestration of the xenophagy cargo receptor Ndp52 and its paralogue Tax1bp1, which we demonstrate here to be a bona fide cargo receptor.  Autophagy of these cargo receptors promotes non-canonical NF-κB signalling.  We propose that this TBK1-dependent mechanism for NF-κB signalling contributes to autophagy addiction in K-Ras driven NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4GOMvvYu1HLVg90H21EOLACvtfcHk0lgQ9Ia3LBFCkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqsb%252FN&md5=fc67d5a03c51b7c79b9ab599a39b03d2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0050672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0050672%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BC.%26aulast%3DScholefield%26aufirst%3DC.%2BL.%26aulast%3DKemp%26aufirst%3DA.%2BJ.%26aulast%3DNewman%26aufirst%3DM.%26aulast%3DMcIver%26aufirst%3DE.%2BG.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DWilkinson%26aufirst%3DS.%26atitle%3DTBK1%2520kinase%2520addiction%2520in%2520lung%2520cancer%2520cells%2520is%2520mediated%2520via%2520autophagy%2520of%2520Tax1bp1%252FNdp52%2520and%2520non-canonical%2520NF-%25CE%25BAB%2520signalling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0050672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arko-Mensah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponpuak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Master, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornatowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradfute, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruun, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deretic, V.</span></span> <span> </span><span class="NLM_article-title">TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.immuni.2012.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=22921120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GksbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=223-234&author=M.+Pilliauthor=J.+Arko-Mensahauthor=M.+Ponpuakauthor=E.+Robertsauthor=S.+Masterauthor=M.+A.+Mandellauthor=N.+Dupontauthor=W.+Ornatowskiauthor=S.+Jiangauthor=S.+B.+Bradfuteauthor=J.-A.+Bruunauthor=T.+E.+Hansenauthor=T.+Johansenauthor=V.+Deretic&title=TBK-1+promotes+autophagy-mediated+antimicrobial+defense+by+controlling+autophagosome+maturation&doi=10.1016%2Fj.immuni.2012.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">TBK-1 Promotes Autophagy-Mediated Antimicrobial Defense by Controlling Autophagosome Maturation</span></div><div class="casAuthors">Pilli, Manohar; Arko-Mensah, John; Ponpuak, Marisa; Roberts, Esteban; Master, Sharon; Mandell, Michael A.; Dupont, Nicolas; Ornatowski, Wojciech; Jiang, Shanya; Bradfute, Steven B.; Bruun, Jack-Ansgar; Hansen, Tom Egil; Johansen, Terje; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-234</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Autophagy is a fundamental biol. process of the eukaryotic cell contributing to diverse cellular and physiol. functions including cell-autonomous defense against intracellular pathogens.  Here, we screened the Rab family of membrane trafficking regulators for effects on autophagic elimination of Mycobacterium tuberculosis var. bovis BCG and found that Rab8b and its downstream interacting partner, innate immunity regulator TBK-1, are required for autophagic elimination of mycobacteria in macrophages.  TBK-1 was necessary for autophagic maturation.  TBK-1 coordinated assembly and function of the autophagic machinery and phosphorylated the autophagic adaptor p62 (sequestosome 1) on Ser-403, a residue essential for its role in autophagic clearance.  A key proinflammatory cytokine, IL-1β, induced autophagy leading to autophagic killing of mycobacteria in macrophages, and this IL-1β activity was dependent on TBK-1.  Thus, TBK-1 is a key regulator of immunol. autophagy and is responsible for the maturation of autophagosomes into lytic bactericidal organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpa-L6h6ibrVg90H21EOLACvtfcHk0lgQ9Ia3LBFCkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GksbfN&md5=2bdcb1d8b65ca833a15c3f1fd48b0553</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DPilli%26aufirst%3DM.%26aulast%3DArko-Mensah%26aufirst%3DJ.%26aulast%3DPonpuak%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DMaster%26aufirst%3DS.%26aulast%3DMandell%26aufirst%3DM.%2BA.%26aulast%3DDupont%26aufirst%3DN.%26aulast%3DOrnatowski%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DBradfute%26aufirst%3DS.%2BB.%26aulast%3DBruun%26aufirst%3DJ.-A.%26aulast%3DHansen%26aufirst%3DT.%2BE.%26aulast%3DJohansen%26aufirst%3DT.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DTBK-1%2520promotes%2520autophagy-mediated%2520antimicrobial%2520defense%2520by%2520controlling%2520autophagosome%2520maturation%26jtitle%3DImmunity%26date%3D2012%26volume%3D37%26spage%3D223%26epage%3D234%26doi%3D10.1016%2Fj.immuni.2012.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span> <span> </span><span class="NLM_article-title">Autophagy in antimicrobial immunity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.molcel.2014.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24766886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=224-233&author=L.+C.+Gomesauthor=I.+Dikic&title=Autophagy+in+antimicrobial+immunity&doi=10.1016%2Fj.molcel.2014.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in Antimicrobial Immunity</span></div><div class="casAuthors">Gomes, Ligia C.; Dikic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-233</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Autophagy plays a key role in cellular homeostasis, responding to various environmental stresses.  In particular, pathogen invasion leads to rapid induction of autophagy, which is crit. for both innate and adaptive immune responses.  In this review, we focus on the emerging mol. mechanisms of pathogen elimination by autophagy (a process known as xenophagy) and on the strategies developed by pathogens to subvert autophagy.  We also address other functions of autophagy proteins in restricting pathogen invasion, independent of the formation of a canonical double-membrane autophagosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6oYcDQ219vrVg90H21EOLACvtfcHk0lgQ9Ia3LBFCkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGhtr0%253D&md5=5064824755c4175fac744640f19a4445</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DL.%2BC.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DAutophagy%2520in%2520antimicrobial%2520immunity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D224%26epage%3D233%26doi%3D10.1016%2Fj.molcel.2014.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, E.-L.</span></span> <span> </span><span class="NLM_article-title">Autophagy: Supporting cellular and organismal homeostasis by self-eating</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2019.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.biocel.2019.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=30940605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvFSntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2019&pages=1-10&author=E.-L.+Eskelinen&title=Autophagy%3A+Supporting+cellular+and+organismal+homeostasis+by+self-eating&doi=10.1016%2Fj.biocel.2019.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: Supporting cellular and organismal homeostasis by self-eating</span></div><div class="casAuthors">Eskelinen, Eeva-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Autophagy is a conserved catabolic process that delivers cytoplasmic components and organelles to lysosomes for degrdn. and recycling.  This pathway serves to degrade nonfunctional organelles and aggregate-prone proteins, as well as to produce substrates for energy prodn. and biosynthesis.  Autophagy is esp. important for the maintenance of stem cells, and for the survival and homeostasis of post-mitotic cells like neurons.  Functional autophagy promotes longevity in several model organisms.  Autophagy regulates immunity and inflammation at several levels and has both anti- and pro-tumorigenic roles in cancer.  This review provides a concise overview of autophagy and its importance in cellular and organismal homeostasis, with emphasis on aging, stem cells, neuronal cells, immunity, inflammation, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHCCCyu3Uh7Vg90H21EOLACvtfcHk0liW4uzT3W1C8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvFSntLw%253D&md5=06421829fb82b19eb024660a78a0708c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2019.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2019.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DEskelinen%26aufirst%3DE.-L.%26atitle%3DAutophagy%253A%2520Supporting%2520cellular%2520and%2520organismal%2520homeostasis%2520by%2520self-eating%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2019%26volume%3D111%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.biocel.2019.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span> <span> </span><span class="NLM_article-title">The roles of autophagy in cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3466</span>, <span class="refDoi"> DOI: 10.3390/ijms19113466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.3390%2Fijms19113466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVKksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3466&author=C.+Yunauthor=S.+Lee&title=The+roles+of+autophagy+in+cancer&doi=10.3390%2Fijms19113466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of autophagy in cancer</span></div><div class="casAuthors">Yun, Chul Won; Lee, Sang Hun</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3466/1-3466/18</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Autophagy is an intracellular degradative process that occurs under several stressful conditions, including organelle damage, the presence of abnormal proteins, and nutrient deprivation.  The mechanism of autophagy initiates the formation of autophagosomes that capture degraded components and then fuse with lysosomes to recycle these components.  The modulation of autophagy plays dual roles in tumor suppression and promotion in many cancers.  In addn., autophagy regulates the properties of cancer stem-cells by contributing to the maintenance of stemness, the induction of recurrence, and the development of resistance to anticancer reagents.  Although some autophagy modulators, such as rapamycin and chloroquine, are used to regulate autophagy in anticancer therapy, since this process also plays roles in both tumor suppression and promotion, the precise mechanism of autophagy in cancer requires further study.  In this review, we will summarize the mechanism of autophagy under stressful conditions and its roles in tumor suppression and promotion in cancer and in cancer stem-cells.  Furthermore, we discuss how autophagy is a promising potential therapeutic target in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq15OqSo4-izLVg90H21EOLACvtfcHk0liW4uzT3W1C8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVKksb0%253D&md5=f390920f25a16b47d16d0978b3b180e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fijms19113466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19113466%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DThe%2520roles%2520of%2520autophagy%2520in%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3466%26doi%3D10.3390%2Fijms19113466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacevic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungblut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terzic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1242/jcs.114926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1242%2Fjcs.114926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=23178947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntleksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=580-592&author=J.+Koracauthor=V.+Schaefferauthor=I.+Kovacevicauthor=A.+M.+Clementauthor=B.+Jungblutauthor=C.+Behlauthor=J.+Terzicauthor=I.+Dikic&title=Ubiquitin-independent+function+of+optineurin+in+autophagic+clearance+of+protein+aggregates&doi=10.1242%2Fjcs.114926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates</span></div><div class="casAuthors">Korac, Jelena; Schaeffer, Veronique; Kovacevic, Igor; Clement, Albrecht M.; Jungblut, Benno; Behl, Christian; Terzic, Janos; Dikic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">580-592</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Aggregation of misfolded proteins and the assocd. loss of neurons are considered a hallmark of numerous neurodegenerative diseases.  Optineurin is present in protein inclusions obsd. in various neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Huntington's disease, Alzheimer's disease, Parkinson's disease, Creutzfeld-Jacob disease and Pick's disease.  Optineurin deletion mutations have also been described in ALS patients.  However, the role of optineurin in mechanisms of protein aggregation remains unclear.  In this report, we demonstrate that optineurin recognizes various protein aggregates via its C-terminal coiled-coil domain in a ubiquitin-independent manner.  We also show that optineurin depletion significantly increases protein aggregation in HeLa cells and that morpholino-silencing of the optineurin ortholog in zebrafish causes the motor axonopathy phenotype similar to a zebrafish model of ALS.  A more severe phenotype is obsd. when optineurin is depleted in zebrafish carrying ALS mutations.  Furthermore, TANK1 binding kinase 1 (TBK1) is colocalized with optineurin on protein aggregates and is important in clearance of protein aggregates through the autophagy-lysosome pathway.  TBK1 phosphorylates optineurin at serine 177 and regulates its ability to interact with autophagy modifiers.  This study provides evidence for a ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates as well as addnl. relevance for TBK1 as an upstream regulator of the autophagic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdIVcoNUmRxbVg90H21EOLACvtfcHk0liW4uzT3W1C8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntleksLc%253D&md5=db386195406da3463d536e9ad4f95f8d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1242%2Fjcs.114926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.114926%26sid%3Dliteratum%253Aachs%26aulast%3DKorac%26aufirst%3DJ.%26aulast%3DSchaeffer%26aufirst%3DV.%26aulast%3DKovacevic%26aufirst%3DI.%26aulast%3DClement%26aufirst%3DA.%2BM.%26aulast%3DJungblut%26aufirst%3DB.%26aulast%3DBehl%26aufirst%3DC.%26aulast%3DTerzic%26aufirst%3DJ.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DUbiquitin-independent%2520function%2520of%2520optineurin%2520in%2520autophagic%2520clearance%2520of%2520protein%2520aggregates%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2013%26volume%3D126%26spage%3D580%26epage%3D592%26doi%3D10.1242%2Fjcs.114926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span> <span> </span><span class="NLM_article-title">Common traits spark the mitophagy/xenophagy interplay</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1172</span>, <span class="refDoi"> DOI: 10.3389/fphys.2018.01172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.3389%2Ffphys.2018.01172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=30294276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A280%3ADC%252BB3czms1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1172&author=A.+Singhauthor=S.+L.+Kendallauthor=M.+Campanella&title=Common+traits+spark+the+mitophagy%2Fxenophagy+interplay&doi=10.3389%2Ffphys.2018.01172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Common Traits Spark the Mitophagy/Xenophagy Interplay</span></div><div class="casAuthors">Singh Aarti; Campanella Michelangelo; Kendall Sharon L; Campanella Michelangelo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1172</span>
        ISSN:<span class="NLM_cas:issn">1664-042X</span>.
    </div><div class="casAbstract">Selective autophagy contributes to the wellbeing of eukaryotic cells by recycling cellular components, disposing damaged organelles, and removing pathogens, amongst others.  Both the quality control process of selective mitochondrial autophagy (Mitophagy) and the defensive process of intracellular pathogen-engulfment (Xenophagy) are facilitated via protein assemblies which have shared molecules, a prime example being the Tank-Binding Kinase 1 (TBK1).  TBK1 plays a central role in the immunity response driven by Xenophagy and was recently shown to be an amplifying mechanism in Mitophagy, bring to attention the potential cross talk between the two processes.  Here we draw parallels between Xenophagy and Mitophagy, speculating on the inhibitory mechanisms of specific proteins (e.g., the 18 kDa protein TSPO), how the preferential sequestering toward one of the two pathways may undermine the other, and in this way impair cellular response to pathogens and cellular immunity.  We believe that an in depth understanding of the commonalities may present an opportunity to design novel therapeutic strategies targeted at both the autonomous and non-autonomous processes of selective autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSa3S_UovOd7WPgL4LrC-0VfW6udTcc2easFZkZ0g4F2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czms1KnsQ%253D%253D&md5=fe34d3e87bacf70edc89a5f0044a4a5a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2018.01172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2018.01172%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKendall%26aufirst%3DS.%2BL.%26aulast%3DCampanella%26aufirst%3DM.%26atitle%3DCommon%2520traits%2520spark%2520the%2520mitophagy%252Fxenophagy%2520interplay%26jtitle%3DFront.%2520Physiol.%26date%3D2018%26volume%3D9%26spage%3D1172%26doi%3D10.3389%2Ffphys.2018.01172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watowich, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1084/jem.20161524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1084%2Fjem.20161524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=28356390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2017&pages=1493-1507&author=Y.+Xiaoauthor=Q.+Zouauthor=X.+Xieauthor=T.+Liuauthor=H.+S.+Liauthor=Z.+Jieauthor=J.+Jinauthor=H.+Huauthor=G.+Manyamauthor=L.+Zhangauthor=X.+Chengauthor=H.+Wangauthor=I.+Marieauthor=D.+E.+Levyauthor=S.+S.+Watowichauthor=S.-C.+Sun&title=The+kinase+TBK1+functions+in+dendritic+cells+to+regulate+T+cell+homeostasis%2C+autoimmunity%2C+and+antitumor+immunity&doi=10.1084%2Fjem.20161524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity</span></div><div class="casAuthors">Xiao, Yichuan; Zou, Qiang; Xie, Xiaoping; Liu, Ting; Li, Haiyan S.; Jie, Zuliang; Jin, Jin; Hu, Hongbo; Manyam, Ganiraju; Zhang, Li; Cheng, Xuhong; Wang, Hui; Marie, Isabelle; Levy, David E.; Watowich, Stephanie S.; Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1493-1507</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">1540-9538</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Dendritic cells (DCs) are crucial for mediating immune responses but, when deregulated, also contribute to immunol. disorders, such as autoimmunity.  The mol. mechanism underlying the function of DCs is incompletely understood.  In this study, we have identified TANK-binding kinase 1 (TBK1), a master innate immune kinase, as an important regulator of DC function.  DC-specific deletion of Tbk1 causes T cell activation and autoimmune symptoms and also enhances antitumor immunity in animal models of cancer immunotherapy.  The TBK1-deficient DCs have up-regulated expression of co-stimulatory mols. and increased T cell-priming activity.  We further demonstrate that TBK1 neg. regulates the induction of a subset of genes by type I interferon receptor (IFNAR).  Deletion of IFNAR1 could largely prevent aberrant T cell activation and autoimmunity in DC-conditional Tbk1 knockout mice.  These findings identify a DC-specific function of TBK1 in the maintenance of immune homeostasis and tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKZsWUz77p-LVg90H21EOLACvtfcHk0lg32LzQRFRQ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7jJ&md5=974f9b22ad3a2a1574452fa5151c9b27</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1084%2Fjem.20161524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20161524%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%2BS.%26aulast%3DJie%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DManyam%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMarie%26aufirst%3DI.%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DWatowich%26aufirst%3DS.%2BS.%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DThe%2520kinase%2520TBK1%2520functions%2520in%2520dendritic%2520cells%2520to%2520regulate%2520T%2520cell%2520homeostasis%252C%2520autoimmunity%252C%2520and%2520antitumor%2520immunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2017%26volume%3D214%26spage%3D1493%26epage%3D1507%26doi%3D10.1084%2Fjem.20161524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span> <span> </span><span class="NLM_article-title">TBK1 promote bladder cancer cell proliferation and migration via Akt signaling</span>. <i>J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1892</span>– <span class="NLM_lpage">1899</span>, <span class="refDoi"> DOI: 10.7150/jca.17638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.7150%2Fjca.17638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=28819387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A280%3ADC%252BC1cfpsVyqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1892-1899&author=W.+Chenauthor=K.+Luoauthor=Z.+Keauthor=B.+Kuaiauthor=S.+Heauthor=W.+Jiangauthor=W.+Huangauthor=Z.+Cai&title=TBK1+promote+bladder+cancer+cell+proliferation+and+migration+via+Akt+signaling&doi=10.7150%2Fjca.17638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling</span></div><div class="casAuthors">Chen Wei; Luo Kewang; Ke Zhiyi; He Shiyang; Jiang Wei; Huang Weiren; Cai Zhiming; Kuai Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1892-1899</span>
        ISSN:<span class="NLM_cas:issn">1837-9664</span>.
    </div><div class="casAbstract">Bladder cancer is a challenging and fatal malignancy and the improvement in prognosis is limited over years.  Deep understanding the mechanism of bladder cancer tumorigenesis and progression will help to discover novel and effective treatment strategies.  In this study, we identify non-canonical IkB kinase TBK1 is up-regulated in bladder cancer tissue and cell lines.  Knockdown of TBK1 markedly inhibits cell proliferation and migration.  Inhibition of TBK1 kinase activity by BX795 significantly attenuates bladder cancer cell proliferation and migration.  Mechanistic study shows that overexpression of TBK1 promoted the phosphorylation of Akt, whereas knockdown of TBK1 reverses this action.  Taken together, our data suggest that TBK1 modulates the malignant behaviors of bladder cancer cell via Akt signaling, revealing new insights in discovering new therapy target for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7Wv3q1vQF3UEgZCMqtRBifW6udTcc2easFZkZ0g4F2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfpsVyqsw%253D%253D&md5=8e71b429a5de279267f6a44fcda95479</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.7150%2Fjca.17638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fjca.17638%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DK.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DKuai%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DZ.%26atitle%3DTBK1%2520promote%2520bladder%2520cancer%2520cell%2520proliferation%2520and%2520migration%2520via%2520Akt%2520signaling%26jtitle%3DJ.%2520Cancer%26date%3D2017%26volume%3D8%26spage%3D1892%26epage%3D1899%26doi%3D10.7150%2Fjca.17638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, X.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span> <span> </span><span class="NLM_article-title">Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">E601</span>– <span class="NLM_lpage">E610</span>, <span class="refDoi"> DOI: 10.1073/pnas.1316255111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.1316255111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24449872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E601-E610&author=C.+Weiauthor=Y.+Caoauthor=X.+Yangauthor=Z.+Zhengauthor=K.+Guanauthor=Q.+Wangauthor=Y.+Taiauthor=Y.+Zhangauthor=S.+Maauthor=Y.+Caoauthor=X.+Geauthor=C.+Xuauthor=J.+Liauthor=H.+Yanauthor=Y.+Lingauthor=T.+Songauthor=L.+Zhuauthor=B.+Zhangauthor=Q.+Xuauthor=C.+Huauthor=X.-w.+Bianauthor=X.+Heauthor=H.+Zhong&title=Elevated+expression+of+TANK-binding+kinase+1+enhances+tamoxifen+resistance+in+breast+cancer&doi=10.1073%2Fpnas.1316255111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer</span></div><div class="casAuthors">Wei, Congwen; Cao, Yuan; Yang, Xiaoli; Zheng, Zirui; Guan, Kai; Wang, Qiang; Tai, Yanhong; Zhang, Yanhong; Ma, Shengli; Cao, Ye; Ge, Xiaoxing; Xu, Changzhi; Li, Jia; Yan, Hui; Ling, Youguo; Song, Ting; Zhu, Lin; Zhang, Buchang; Xu, Quanbin; Hu, Chengjin; Bian, Xiu-wu; He, Xiang; Zhong, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">E601-E610</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Resistance to antiestrogens is one of the major challenges in breast cancer treatment.  Although phosphorylation of estrogen receptor α (ERα) is an important factor in endocrine resistance, the contributions of specific kinases in endocrine resistance are still not fully understood.  Here, we report that an important innate immune response kinase, the IκB kinase-related TANK-binding kinase 1 (TBK1), is a crucial determinant of resistance to tamoxifen therapies.  We show that TBK1 increases ERα transcriptional activity through phosphorylation modification of ERα at the Ser-305 site.  Ectopic TBK1 expression impairs the responsiveness of breast cancer cells to tamoxifen.  By studying the specimens from patients with breast cancer, we find a strong pos. correlation of TBK1 with ERα, ERα Ser-305, and cyclin D1.  Notably, patients with tumors highly expressing TBK1 respond poorly to tamoxifen treatment and show high potential for relapse.  Therefore, our findings suggest that TBK1 contributes to tamoxifen resistance in breast cancer via phosphorylation modification of ERα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7g9UakTBLG7Vg90H21EOLACvtfcHk0lg5zfsalhKvNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyis7k%253D&md5=aab3413f2df8313a5425f67f94b1dfb9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1316255111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1316255111%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DGuan%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DTai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DBian%26aufirst%3DX.-w.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DH.%26atitle%3DElevated%2520expression%2520of%2520TANK-binding%2520kinase%25201%2520enhances%2520tamoxifen%2520resistance%2520in%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3DE601%26epage%3DE610%26doi%3D10.1073%2Fpnas.1316255111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korherr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig-Hoffmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixelius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egland, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, U.</span></span> <span> </span><span class="NLM_article-title">Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">4240</span>– <span class="NLM_lpage">4245</span>, <span class="refDoi"> DOI: 10.1073/pnas.0511319103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.0511319103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=16537515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFWhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=4240-4245&author=C.+Korherrauthor=H.+Gilleauthor=R.+Schaferauthor=K.+Koenig-Hoffmannauthor=J.+Dixeliusauthor=K.+A.+Eglandauthor=I.+Pastanauthor=U.+Brinkmann&title=Identification+of+proangiogenic+genes+and+pathways+by+high-throughput+functional+genomics%3A+TBK1+and+the+IRF3+pathway&doi=10.1073%2Fpnas.0511319103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway</span></div><div class="casAuthors">Korherr, Christian; Gille, Hendrik; Schaefer, Rolf; Koenig-Hoffmann, Kerstin; Dixelius, Johan; Egland, Kristi A.; Pastan, Ira; Brinkmann, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4240-4245</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A genome-wide phenotype screen was used to identify factors and pathways that induce proliferation of human umbilical vein endothelial cells (HUVEC).  HUVEC proliferation is a recognized marker for factors that modulate vascularization.  Screening "hits" included known proangiogenic factors, such as VEGF, FGF1, and FGF2 and addnl. factors for which a direct assocn. with angiogenesis was not previously described.  These include the kinase TBK1 as well as Toll-like receptor adaptor mol. and IFN regulatory factor 3.  All three proteins belong to one signaling pathway that mediates induction of gene expression, including a mixt. of secreted factors, which, in concert, mediate proliferative activity toward endothelial cells.  TBK1 as the "trigger" of this pathway is induced under hypoxic conditions and expressed at significant levels in many solid tumors.  This pattern of expression and the decreased expression of angiogenic factors in cultured cells upon RNA-interference-mediated ablation suggests that TBK1 is important for vascularization and subsequent tumor growth and a target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5bnKzf81bcbVg90H21EOLACvtfcHk0lg5zfsalhKvNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFWhsro%253D&md5=fac047c47cff388a9ef7e25bb5c8c7c9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0511319103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0511319103%26sid%3Dliteratum%253Aachs%26aulast%3DKorherr%26aufirst%3DC.%26aulast%3DGille%26aufirst%3DH.%26aulast%3DSchafer%26aufirst%3DR.%26aulast%3DKoenig-Hoffmann%26aufirst%3DK.%26aulast%3DDixelius%26aufirst%3DJ.%26aulast%3DEgland%26aufirst%3DK.%2BA.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DBrinkmann%26aufirst%3DU.%26atitle%3DIdentification%2520of%2520proangiogenic%2520genes%2520and%2520pathways%2520by%2520high-throughput%2520functional%2520genomics%253A%2520TBK1%2520and%2520the%2520IRF3%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D4240%26epage%3D4245%26doi%3D10.1073%2Fpnas.0511319103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbie, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meylan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiling, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadlow, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoersch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittner, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1038/nature08460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1038%2Fnature08460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=19847166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=108-112&author=D.+A.+Barbieauthor=P.+Tamayoauthor=J.+S.+Boehmauthor=S.+Y.+Kimauthor=S.+E.+Moodyauthor=I.+F.+Dunnauthor=A.+C.+Schinzelauthor=P.+Sandyauthor=E.+Meylanauthor=C.+Schollauthor=S.+Fr%C3%B6hlingauthor=E.+M.+Chanauthor=M.+L.+Sosauthor=K.+Michelauthor=C.+Mermelauthor=S.+J.+Silverauthor=B.+A.+Weirauthor=J.+H.+Reilingauthor=Q.+Shengauthor=P.+B.+Guptaauthor=R.+C.+Wadlowauthor=H.+Leauthor=S.+Hoerschauthor=B.+S.+Wittnerauthor=S.+Ramaswamyauthor=D.+M.+Livingstonauthor=D.+M.+Sabatiniauthor=M.+Meyersonauthor=R.+K.+Thomasauthor=E.+S.+Landerauthor=J.+P.+Mesirovauthor=D.+E.+Rootauthor=D.+G.+Gillilandauthor=T.+Jacksauthor=W.+C.+Hahn&title=Systematic+RNA+interference+reveals+that+oncogenic+KRAS-driven+cancers+require+TBK1&doi=10.1038%2Fnature08460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</span></div><div class="casAuthors">Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Sandy, Peter; Meylan, Etienne; Scholl, Claudia; Froehling, Stefan; Chan, Edmond M.; Sos, Martin L.; Michel, Kathrin; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Reiling, Jan H.; Sheng, Qing; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Hoersch, Sebastian; Wittner, Ben S.; Ramaswamy, Sridhar; Livingston, David M.; Sabatini, David M.; Meyerson, Matthew; Thomas, Roman K.; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7269</span>),
    <span class="NLM_cas:pages">108-112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to std. therapies.  Although the identification of specific oncogenes has led to the development of clin. effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach.  A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele.  Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IκB kinase TBK1 was selectively essential in cells that contain mutant KRAS.  Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression.  In these cells, TBK1 activated NF-κB anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction.  These observations indicate that TBK1 and NF-κB signaling are essential in KRAS mutant tumors, and establish a general approach for the rational identification of co-dependent pathways in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlw2rhGywK0bVg90H21EOLACvtfcHk0lg5zfsalhKvNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12gtrvL&md5=aab467de18805a08c3b1484f432ea64a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature08460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08460%26sid%3Dliteratum%253Aachs%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DDunn%26aufirst%3DI.%2BF.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMeylan%26aufirst%3DE.%26aulast%3DScholl%26aufirst%3DC.%26aulast%3DFr%25C3%25B6hling%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DMichel%26aufirst%3DK.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DSilver%26aufirst%3DS.%2BJ.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DReiling%26aufirst%3DJ.%2BH.%26aulast%3DSheng%26aufirst%3DQ.%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DWadlow%26aufirst%3DR.%2BC.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DHoersch%26aufirst%3DS.%26aulast%3DWittner%26aufirst%3DB.%2BS.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DSystematic%2520RNA%2520interference%2520reveals%2520that%2520oncogenic%2520KRAS-driven%2520cancers%2520require%2520TBK1%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D108%26epage%3D112%26doi%3D10.1038%2Fnature08460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumeister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakireva, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopelovich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeaman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camonis, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span> <span> </span><span class="NLM_article-title">RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.cell.2006.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17018283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSitrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=157-170&author=Y.+Chienauthor=S.+Kimauthor=R.+Bumeisterauthor=Y.-M.+Looauthor=S.+W.+Kwonauthor=C.+L.+Johnsonauthor=M.+G.+Balakirevaauthor=Y.+Romeoauthor=L.+Kopelovichauthor=M.+Galeauthor=C.+Yeamanauthor=J.+H.+Camonisauthor=Y.+Zhaoauthor=M.+A.+White&title=RalB+GTPase-mediated+activation+of+the+I%CE%BAB+family+kinase+TBK1+couples+innate+immune+signaling+to+tumor+cell+survival&doi=10.1016%2Fj.cell.2006.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival</span></div><div class="casAuthors">Chien, Yuchen; Kim, Sungchan; Bumeister, Ron; Loo, Yueh-Ming; Kwon, Sung Won; Johnson, Cynthia L.; Balakireva, Mirey G.; Romeo, Yves; Kopelovich, Levy; Gale, Michael, Jr.; Yeaman, Charles; Camonis, Jacques H.; Zhao, Yingming; White, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-170</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The monomeric RalGTPases, RalA and RalB are recognized as components of a regulatory framework supporting tumorigenic transformation.  Specifically, RalB is required to suppress apoptotic checkpoint activation, the mechanistic basis of which is unknown.  Reported effector proteins of RalB include the Sec5 component of the exocyst, an octameric protein complex implicated in tethering of vesicles to membranes.  Surprisingly, the authors find that the RalB/Sec5 effector complex directly recruits and activates the atypical IκB kinase family member TBK1.  In cancer cells, constitutive engagement of this pathway, via chronic RalB activation, restricts initiation of apoptotic programs typically engaged in the context of oncogenic stress.  Although dispensable for survival in a nontumorigenic context, this pathway helps mount an innate immune response to virus exposure.  These observations define the mechanistic contribution of RalGTPases to cancer cell survival and reveal the RalB/Sec5 effector complex as a component of TBK1-dependent innate immune signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsXgw7MqPab7Vg90H21EOLACvtfcHk0lik0yozppY3_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSitrzM&md5=b9c529423b1f96deec9c7069aa6964a9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DBumeister%26aufirst%3DR.%26aulast%3DLoo%26aufirst%3DY.-M.%26aulast%3DKwon%26aufirst%3DS.%2BW.%26aulast%3DJohnson%26aufirst%3DC.%2BL.%26aulast%3DBalakireva%26aufirst%3DM.%2BG.%26aulast%3DRomeo%26aufirst%3DY.%26aulast%3DKopelovich%26aufirst%3DL.%26aulast%3DGale%26aufirst%3DM.%26aulast%3DYeaman%26aufirst%3DC.%26aulast%3DCamonis%26aufirst%3DJ.%2BH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DRalB%2520GTPase-mediated%2520activation%2520of%2520the%2520I%25CE%25BAB%2520family%2520kinase%2520TBK1%2520couples%2520innate%2520immune%2520signaling%2520to%2520tumor%2520cell%2520survival%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D157%26epage%3D170%26doi%3D10.1016%2Fj.cell.2006.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aref, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohoon, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbie, T. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinzel, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfrey, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silkworth, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labowsky, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozhansky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillanders, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacohen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbie, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.cd-13-0646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1158%2F2159-8290.cd-13-0646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24444711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFSmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=452-465&author=Z.+Zhuauthor=A.+R.+Arefauthor=T.+J.+Cohoonauthor=T.+U.+Barbieauthor=Y.+Imamuraauthor=S.+Yangauthor=S.+E.+Moodyauthor=R.+R.+Shenauthor=A.+C.+Schinzelauthor=T.+C.+Thaiauthor=J.+B.+Reibelauthor=P.+Tamayoauthor=J.+T.+Godfreyauthor=Z.+R.+Qianauthor=A.+N.+Pageauthor=K.+Maciagauthor=E.+M.+Chanauthor=W.+Silkworthauthor=M.+T.+Labowskyauthor=L.+Rozhanskyauthor=J.+P.+Mesirovauthor=W.+E.+Gillandersauthor=S.+Oginoauthor=N.+Hacohenauthor=S.+Gaudetauthor=M.+J.+Eckauthor=J.+A.+Engelmanauthor=R.+B.+Corcoranauthor=K.-K.+Wongauthor=W.+C.+Hahnauthor=D.+A.+Barbie&title=Inhibition+of+KRAS-driven+tumorigenicity+by+interruption+of+an+autocrine+cytokine+circuit&doi=10.1158%2F2159-8290.cd-13-0646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of KRAS-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit</span></div><div class="casAuthors">Zhu, Zehua; Aref, Amir R.; Cohoon, Travis J.; Barbie, Thanh U.; Imamura, Yu; Yang, Shenghong; Moody, Susan E.; Shen, Rhine R.; Schinzel, Anna C.; Thai, Tran C.; Reibel, Jacob B.; Tamayo, Pablo; Godfrey, Jason T.; Qian, Zhi Rong; Page, Asher N.; Maciag, Karolina; Chan, Edmond M.; Silkworth, Whitney; Labowsky, Mary T.; Rozhansky, Lior; Mesirov, Jill P.; Gillanders, William E.; Ogino, Shuji; Hacohen, Nir; Gaudet, Suzanne; Eck, Michael J.; Engelman, Jeffrey A.; Corcoran, Ryan B.; Wong, Kwok-Kin; Hahn, William C.; Barbie, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">452-465</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the roles of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling in KRAS-driven tumorigenesis are well established, KRAS activates addnl. pathways required for tumor maintenance, the inhibition of which are likely to be necessary for effective KRAS-directed therapy.  Here, we show that the IκB kinase (IKK)- related kinases Tank-binding kinase-1 (TBK1) and IKKε promote KRAS-driven tumorigenesis by regulating autocrine CCL5 and interleukin (IL)-6 and identify CYT387 as a potent JAK/TBK1/IKKε inhibitor.  CYT387 treatment ablates RAS-assocd. cytokine signaling and impairs Kras-driven murine lung cancer growth.  Combined CYT387 treatment and MAPK pathway inhibition induces regression of aggressive murine lung adenocarcinomas driven by Kras mutation and p53 loss.  These observations reveal that TBK1/IKKε promote tumor survival by activating CCL5 and IL-6 and identify concurrent inhibition of TBK1/IKKε, Janus-activated kinase (JAK), and MEK signaling as an effective approach to inhibit the actions of oncogenic KRAS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHKh9hy-iqZ7Vg90H21EOLACvtfcHk0lik0yozppY3_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFSmu70%253D&md5=e218c1228786d6b72e122a349007964a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.cd-13-0646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.cd-13-0646%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DAref%26aufirst%3DA.%2BR.%26aulast%3DCohoon%26aufirst%3DT.%2BJ.%26aulast%3DBarbie%26aufirst%3DT.%2BU.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DShen%26aufirst%3DR.%2BR.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DThai%26aufirst%3DT.%2BC.%26aulast%3DReibel%26aufirst%3DJ.%2BB.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DGodfrey%26aufirst%3DJ.%2BT.%26aulast%3DQian%26aufirst%3DZ.%2BR.%26aulast%3DPage%26aufirst%3DA.%2BN.%26aulast%3DMaciag%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DSilkworth%26aufirst%3DW.%26aulast%3DLabowsky%26aufirst%3DM.%2BT.%26aulast%3DRozhansky%26aufirst%3DL.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DGillanders%26aufirst%3DW.%2BE.%26aulast%3DOgino%26aufirst%3DS.%26aulast%3DHacohen%26aufirst%3DN.%26aulast%3DGaudet%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520KRAS-driven%2520tumorigenicity%2520by%2520interruption%2520of%2520an%2520autocrine%2520cytokine%2520circuit%26jtitle%3DCancer%2520Discovery%26date%3D2014%26volume%3D4%26spage%3D452%26epage%3D465%26doi%3D10.1158%2F2159-8290.cd-13-0646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formstecher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polverino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span> <span> </span><span class="NLM_article-title">TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.molcel.2011.01.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=21329883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Ggsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=458-470&author=Y.-H.+Ouauthor=M.+Torresauthor=R.+Ramauthor=E.+Formstecherauthor=C.+Rolandauthor=T.+Chengauthor=R.+Brekkenauthor=R.+Wurzauthor=A.+Taskerauthor=T.+Polverinoauthor=S.-L.+Tanauthor=M.+A.+White&title=TBK1+directly+engages+Akt%2FPKB+survival+signaling+to+support+oncogenic+transformation&doi=10.1016%2Fj.molcel.2011.01.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic Transformation</span></div><div class="casAuthors">Ou, Yi-Hung; Torres, Michael; Ram, Rosalyn; Formstecher, Etienne; Roland, Christina; Cheng, Tzuling; Brekken, Rolf; Wurz, Ryan; Tasker, Andrew; Polverino, Tony; Tan, Seng-Lai; White, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-470</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The innate immune-signaling kinase, TBK1, couples pathogen surveillance to induction of host defense mechanisms.  Pathol. activation of TBK1 in cancer can overcome programmed cell death cues, enabling cells to survive oncogenic stress.  The mechanistic basis of TBK1 prosurvival signaling, however, has been enigmatic.  Here, we show that TBK1 directly activates AKT by phosphorylation of the canonical activation loop and hydrophobic motif sites independently of PDK1 and mTORC2.  Upon mitogen stimulation, triggering of the innate immune response, re-exposure to glucose, or oncogene activation, TBK1 is recruited to the exocyst, where it activates AKT.  In cells lacking TBK1, insulin activates AKT normally, but AKT activation by exocyst-dependent mechanisms is impaired.  Discovery and characterization of a 6-aminopyrazolopyrimidine deriv., as a selective low-nanomolar TBK1 inhibitor, indicates that this regulatory arm can be pharmacol. perturbed independently of canonical PI3K/PDK1 signaling.  Thus, AKT is a direct TBK1 substrate that connects TBK1 to prosurvival signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMc_xy4O_x6rVg90H21EOLACvtfcHk0lj3NHnPujZE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Ggsb8%253D&md5=0a85a5612ab6e13b899081994679abc9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DY.-H.%26aulast%3DTorres%26aufirst%3DM.%26aulast%3DRam%26aufirst%3DR.%26aulast%3DFormstecher%26aufirst%3DE.%26aulast%3DRoland%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DBrekken%26aufirst%3DR.%26aulast%3DWurz%26aufirst%3DR.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DPolverino%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DS.-L.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DTBK1%2520directly%2520engages%2520Akt%252FPKB%2520survival%2520signaling%2520to%2520support%2520oncogenic%2520transformation%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D41%26spage%3D458%26epage%3D470%26doi%3D10.1016%2Fj.molcel.2011.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebsbach, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiozawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taichman, R. S.</span></span> <span> </span><span class="NLM_article-title">TBK1 regulates prostate cancer dormancy through mTOR inhibition</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1593/neo.13402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1593%2Fneo.13402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24027431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1064-1074&author=J.+K.+Kimauthor=Y.+Jungauthor=J.+Wangauthor=J.+Josephauthor=A.+Mishraauthor=E.+E.+Hillauthor=P.+H.+Krebsbachauthor=K.+J.+Pientaauthor=Y.+Shiozawaauthor=R.+S.+Taichman&title=TBK1+regulates+prostate+cancer+dormancy+through+mTOR+inhibition&doi=10.1593%2Fneo.13402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 regulates prostate cancer dormancy through mTOR inhibition</span></div><div class="casAuthors">Kim, Jin Koo; Jung, Younghun; Wang, Jingcheng; Joseph, Jeena; Mishra, Anjali; Hill, Elliott E.; Krebsbach, Paul H.; Pienta, Kenneth J.; Shiozawa, Yusuke; Taichman, Russell S.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1064-1074</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">The mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are well established and are largely dependent on signals emanating from the HSC niche.  Recently, we found that prostate cancer (PCa) cells target the HSC niche in mouse bone marrow (BM) during metastasis.  Little is known, however, as to how the HSC niche may regulate dormancy in cancer cells.  In this study, we investigated the effects of TANK binding kinase 1 (TBK1) on PCa dormancy in the BM niche.  We found that binding with niche osteoblasts induces the expression of TBK1 in PCa cells PC3 and C4-2B.  Interestingly, TBK1 interacts with mammalian target of rapamycin (mTOR) and inhibits its function.  Rapamycin, an mTOR inhibitor, induces cell cycle arrest of PCa cells and enhances chemotherapeutic resistance of PCa cells.  As a result, the knockdown of TBK1 decreases PCa stem-like cells and drug resistance in vitro and in vivo.  Taken together, these results strongly indicate that TBK1 plays an important role in the dormancy and drug resistance of PCa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDMSl7htIPXrVg90H21EOLACvtfcHk0lj3NHnPujZE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCnur8%253D&md5=1f1f2327dae079362bed0c1463bcf8ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1593%2Fneo.13402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.13402%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BK.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DE.%2BE.%26aulast%3DKrebsbach%26aufirst%3DP.%2BH.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DShiozawa%26aufirst%3DY.%26aulast%3DTaichman%26aufirst%3DR.%2BS.%26atitle%3DTBK1%2520regulates%2520prostate%2520cancer%2520dormancy%2520through%2520mTOR%2520inhibition%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D1064%26epage%3D1074%26doi%3D10.1593%2Fneo.13402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muvaffak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolinski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strack, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jánne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel-Dugan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschmeier, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Evaluating TBK1 as a therapeutic target in cancers with activated IRF3</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.mcr-13-0642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1158%2F1541-7786.mcr-13-0642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=24752990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1055-1066&author=A.+Muvaffakauthor=Q.+Panauthor=H.+Yanauthor=R.+Fernandezauthor=J.+Limauthor=B.+Dolinskiauthor=T.+T.+Nguyenauthor=P.+Strackauthor=S.+Wuauthor=R.+Chungauthor=W.+Zhangauthor=C.+Hultonauthor=S.+Ripleyauthor=H.+Hirschauthor=K.+Nagashimaauthor=K.-K.+Wongauthor=P.+A.+J%C3%A1nneauthor=C.+Seidel-Duganauthor=L.+Zawelauthor=P.+T.+Kirschmeierauthor=R.+E.+Middletonauthor=E.+J.+Morrisauthor=Y.+Wang&title=Evaluating+TBK1+as+a+therapeutic+target+in+cancers+with+activated+IRF3&doi=10.1158%2F1541-7786.mcr-13-0642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3</span></div><div class="casAuthors">Muvaffak, Asli; Pan, Qi; Yan, Haiyan; Fernandez, Rafael; Lim, Jongwon; Dolinski, Brian; Nguyen, Thi T.; Strack, Peter; Wu, Stephen; Chung, Rossana; Zhang, Weiqun; Hulton, Chris; Ripley, Steven; Hirsch, Heather; Nagashima, Kumiko; Wong, Kwok-Kin; Janne, Pasi A.; Seidel-Dugan, Cynthia; Zawel, Leigh; Kirschmeier, Paul T.; Middleton, Richard E.; Morris, Erick J.; Wang, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1055-1066</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">TBK1 (TANK-binding kinase 1) is a noncanonical IκB protein kinase that phosphorylates and activates downstream targets such as IRF3 and c-Rel and, mediates NF-κB activation in cancer.  Previous reports demonstrated synthetic lethality of TBK1 with mutant KRAS in non-small cell lung cancer (NSCLC); thus, TBK1 could be a novel target for treatment of KRAS-mutant NSCLC.  Here, the effect of TBK1 on proliferation in a panel of cancer cells by both genetic and pharmacol. approaches was evaluated.  In KRAS-mutant cancer cells, redn. of TBK1 activity by knockdown or treatment with TBK1 inhibitors did not correlate with reduced proliferation in a two-dimensional viability assay.  Verification of target engagement via reduced phosphorylation of S386 of IRF3 (pIRF3S386) was difficult to assess in NSCLC cells due to low protein expression.  However, several cell lines were identified with high pIRF3S386 levels after screening a large panel of cell lines, many of which also harbor KRAS mutations.  Specifically, a large subset of KRAS-mutant pancreatic cancer cell lines was uncovered with high constitutive pIRF3S386 levels, which correlated with high levels of phosphorylated S172 of TBK1 (pTBK1S172).  Finally, TBK1 inhibitors dose-dependently inhibited pIRF3S386 in these cell lines, but this did not correlate with inhibition of cell growth.  Taken together, these data demonstrate that the regulation of pathways important for cell proliferation in some NSCLC, pancreatic, and colorectal cell lines is not solely dependent on TBK1 activity.  Implications: TBK1 has therapeutic potential under certain contexts and phosphorylation of its downstream target IRF3 is a biomarker of TBK1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1SJhITnpZLVg90H21EOLACvtfcHk0lj3NHnPujZE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbjJ&md5=556bb9b1f3a33fc7a84f5ba3b8485acd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.mcr-13-0642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.mcr-13-0642%26sid%3Dliteratum%253Aachs%26aulast%3DMuvaffak%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DDolinski%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DStrack%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DHulton%26aufirst%3DC.%26aulast%3DRipley%26aufirst%3DS.%26aulast%3DHirsch%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DJ%25C3%25A1nne%26aufirst%3DP.%2BA.%26aulast%3DSeidel-Dugan%26aufirst%3DC.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DKirschmeier%26aufirst%3DP.%2BT.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMorris%26aufirst%3DE.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEvaluating%2520TBK1%2520as%2520a%2520therapeutic%2520target%2520in%2520cancers%2520with%2520activated%2520IRF3%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2014%26volume%3D12%26spage%3D1055%26epage%3D1066%26doi%3D10.1158%2F1541-7786.mcr-13-0642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebrenik, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamman, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neklesa, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of von Hippel-Lindau-recruiting proteolysis targeting chimeras (PROTACs) of TANK-binding kinase 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFelu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=583-598&author=A.+P.+Crewauthor=K.+Rainaauthor=H.+Dongauthor=Y.+Qianauthor=J.+Wangauthor=D.+Vigilauthor=Y.+V.+Serebrenikauthor=B.+D.+Hammanauthor=A.+Morganauthor=C.+Ferraroauthor=K.+Siuauthor=T.+K.+Neklesaauthor=J.+D.+Winklerauthor=K.+G.+Colemanauthor=C.+M.+Crews&title=Identification+and+characterization+of+von+Hippel-Lindau-recruiting+proteolysis+targeting+chimeras+%28PROTACs%29+of+TANK-binding+kinase+1&doi=10.1021%2Facs.jmedchem.7b00635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1</span></div><div class="casAuthors">Crew, Andrew P.; Raina, Kanak; Dong, Hanqing; Qian, Yimin; Wang, Jing; Vigil, Dominico; Serebrenik, Yevgeniy V.; Hamman, Brian D.; Morgan, Alicia; Ferraro, Caterina; Siu, Kam; Neklesa, Taavi K.; Winkler, James D.; Coleman, Kevin G.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">583-598</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteolysis Targeting Chimeras (PROTACs) are bifunctional mols. that recruit an E3 ligase to a target protein to facilitate ubiquitination and subsequent degrdn. of that protein.  While the field of targeted degraders is still relatively young, the potential for this modality to become a differentiated and therapeutic reality is strong, such that both academic and pharmaceutical institutions are now entering this interesting area of research.  In this paper, the authors describe a broadly applicable process for identifying degrader hits based around the serine/threonine kinase TANK-binding kinase 1 (TBK1), and have generalized the key structural elements assocd. with degrdn. activities.  Compd. I is a potent hit (TBK1 DC50 = 12 nM, Dmax = 96%) with excellent selectivity against a related kinase IKKε, which was further used as a chem. tool to assess TBK1 as a target in mutant K-Ras cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJWCnFncQRLVg90H21EOLACvtfcHk0lhu8OEJuBLl8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFelu7rK&md5=41c3627e05ca31aee3ba85815685fcb2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00635%26sid%3Dliteratum%253Aachs%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DSerebrenik%26aufirst%3DY.%2BV.%26aulast%3DHamman%26aufirst%3DB.%2BD.%26aulast%3DMorgan%26aufirst%3DA.%26aulast%3DFerraro%26aufirst%3DC.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DNeklesa%26aufirst%3DT.%2BK.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DColeman%26aufirst%3DK.%2BG.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520von%2520Hippel-Lindau-recruiting%2520proteolysis%2520targeting%2520chimeras%2520%2528PROTACs%2529%2520of%2520TANK-binding%2520kinase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D583%26epage%3D598%26doi%3D10.1021%2Facs.jmedchem.7b00635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span> <span> </span><span class="NLM_article-title">Assessment of TANK-binding kinase 1 as a therapeutic target in cancer</span>. <i>J. Cell. Commun. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1007/s12079-017-0438-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1007%2Fs12079-017-0438-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=29218456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A280%3ADC%252BC1M3pt1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=83-90&author=V.+H.+Cruzauthor=R.+A.+Brekken&title=Assessment+of+TANK-binding+kinase+1+as+a+therapeutic+target+in+cancer&doi=10.1007%2Fs12079-017-0438-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of TANK-binding kinase 1 as a therapeutic target in cancer</span></div><div class="casAuthors">Cruz Victoria H; Brekken Rolf A; Brekken Rolf A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cell communication and signaling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-90</span>
        ISSN:<span class="NLM_cas:issn">1873-9601</span>.
    </div><div class="casAbstract">TANK-binding kinase 1 (TBK1) is central to multiple biological processes that promote tumorigenesis including cell division, autophagy, innate immune response and AKT-pro survival signaling.  TBK1 is well studied and most known for its function in innate immunity.  However, the serine threonine protein kinase received significant attention as a synthetic lethal partner and effector of the major oncogene, RAS.  This review summarizes newly identified cancer promoting functions of TBK1 and evaluates the therapeutic potential of targeting TBK1 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQR8mq8uPtuWXl8icjszYl0fW6udTcc2eb1nzaCBp1eLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3pt1Kktg%253D%253D&md5=563940aeb57006e79070bfac8e4e0419</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs12079-017-0438-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12079-017-0438-y%26sid%3Dliteratum%253Aachs%26aulast%3DCruz%26aufirst%3DV.%2BH.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26atitle%3DAssessment%2520of%2520TANK-binding%2520kinase%25201%2520as%2520a%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Commun.%2520Signal.%26date%3D2018%26volume%3D12%26spage%3D83%26epage%3D90%26doi%3D10.1007%2Fs12079-017-0438-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeckel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duempelfeld, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanjulu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesiridis, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muelbaier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of GSK8612, a highly selective and potent TBK1 inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFensr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=780-785&author=D.+W.+Thomsonauthor=D.+Poeckelauthor=N.+Zinnauthor=C.+Rauauthor=K.+Strohmerauthor=A.+J.+Wagnerauthor=A.+P.+Gravesauthor=J.+Perrinauthor=M.+Bantscheffauthor=B.+Duempelfeldauthor=V.+Kasparcovaauthor=J.+M.+Ramanjuluauthor=G.+S.+Pesiridisauthor=M.+Muelbaierauthor=G.+Bergamini&title=Discovery+of+GSK8612%2C+a+highly+selective+and+potent+TBK1+inhibitor&doi=10.1021%2Facsmedchemlett.9b00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor</span></div><div class="casAuthors">Thomson, Douglas W.; Poeckel, Daniel; Zinn, Nico; Rau, Christina; Strohmer, Katrin; Wagner, Anne J.; Graves, Alan P.; Perrin, Jessica; Bantscheff, Marcus; Duempelfeld, Birgit; Kasparcova, Viera; Ramanjulu, Joshi M.; Pesiridis, G. Scott; Muelbaier, Marcel; Bergamini, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">780-785</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The serine/threonine protein kinase TBK1 (Tank-binding Kinase-1) is a noncanonical member of the IkB kinase (IKK) family.  This kinase regulates signaling pathways in innate immunity, oncogenesis, energy homeostasis, autophagy, and neuroinflammation.  Herein, we report the discovery and characterization of a novel potent and highly selective TBK1 inhibitor, GSK8612.  In cellular assays, this small mol. inhibited Toll-like receptor (TLR)3-induced interferon regulatory factor (IRF)3 phosphorylation in Ramos cells and type I interferon (IFN) secretion in primary human mononuclear cells.  In THP1 cells, GSK8612 was able to inhibit secretion of interferon beta (IFNβ) in response to dsDNA and cGAMP, the natural ligand for STING.  GSK8612 is a TBK1 small mol. inhibitor displaying an excellent selectivity profile and therefore represents an ideal probe to further dissect the biol. of TBK1 in models of immunity, neuroinflammation, obesity, or cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSGssfttyOLVg90H21EOLACvtfcHk0lhu8OEJuBLl8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFensr0%253D&md5=d9b3a1d565707a6c0cfb9f8a78a178e2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00027%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DPoeckel%26aufirst%3DD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DStrohmer%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDuempelfeld%26aufirst%3DB.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DRamanjulu%26aufirst%3DJ.%2BM.%26aulast%3DPesiridis%26aufirst%3DG.%2BS.%26aulast%3DMuelbaier%26aufirst%3DM.%26aulast%3DBergamini%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520GSK8612%252C%2520a%2520highly%2520selective%2520and%2520potent%2520TBK1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D780%26epage%3D785%26doi%3D10.1021%2Facsmedchemlett.9b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. Y.</span></span> <span> </span><span class="NLM_article-title">TBK1 inhibitors: a review of patent literature (2011 - 2014)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1385</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1517/13543776.2015.1081168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1517%2F13543776.2015.1081168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=26293650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVajsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1385-1396&author=T.+Yuauthor=Y.+Yangauthor=D.+Q.+Yinauthor=S.+Hongauthor=Y.-J.+Sonauthor=J.-H.+Kimauthor=J.+Y.+Cho&title=TBK1+inhibitors%3A+a+review+of+patent+literature+%282011+-+2014%29&doi=10.1517%2F13543776.2015.1081168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">TBK1 inhibitors: a review of patent literature (2011 - 2014)</span></div><div class="casAuthors">Yu, Tao; Yang, Yanyan; Yin, De Qing; Hong, Sungyoul; Son, Young-Jin; Kim, Jong-Hoon; Cho, Jae Youl</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1385-1396</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">TANK-binding kinase 1 (TBK1) is a noncanonical IκB kinase family member that regulates the innate immune response.  Misregulation of TBK1 activity can promote inflammatory disorders and oncogenesis; therefore, TBK1 inhibitors are considered a promising therapy for inflammation and cancer.  In this review, the authors provide information on the role of TBK1 in human health and on recently developed inhibitors from patents granted from 2011 to 2014.  The reader will gain an understanding of the mechanisms of TBK1 function as well as the structure and biol. activity of recently developed TBK1 inhibitors.  Google and NCBI search engines were used to find relevant patents and clin. information using "TBK1 inhibitor" as the search term.  The role of TBK1 in various diseases has prompted the further investigation of significant targets.  Although research on TBK1 inhibitors has increased over the last few years, only a few inhibitors of this kinase have been identified.  In addn., almost all of the chem. inhibitors are modified from different scaffolds and/or chemotypes of pyrimidine.  Specifically, compd. BX795 is the representative one, which was first patented as a potent TBK1 inhibitor.  Even though some compds. have displayed interesting potential inhibition and selectivity of TBK1 in vitro and in in vivo trials, the development of more efficient and selective TBK1 inhibitors is still required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsxegMOo9h-LVg90H21EOLACvtfcHk0lg0wfACuqudYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVajsrbF&md5=19c818f20a1b43c64d056da910398a80</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F13543776.2015.1081168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2015.1081168%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DD.%2BQ.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DSon%26aufirst%3DY.-J.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26atitle%3DTBK1%2520inhibitors%253A%2520a%2520review%2520of%2520patent%2520literature%2520%25282011%2520-%25202014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26spage%3D1385%26epage%3D1396%26doi%3D10.1517%2F13543776.2015.1081168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larabi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Round, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniatis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panne, D.</span></span> <span> </span><span class="NLM_article-title">Crystal structure and mechanism of activation of TANK-binding kinase 1</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.celrep.2013.01.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=23453971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlyrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=734-746&author=A.+Larabiauthor=J.+M.+Devosauthor=S.-L.+Ngauthor=M.+H.+Nanaoauthor=A.+Roundauthor=T.+Maniatisauthor=D.+Panne&title=Crystal+structure+and+mechanism+of+activation+of+TANK-binding+kinase+1&doi=10.1016%2Fj.celrep.2013.01.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure and Mechanism of Activation of TANK-Binding Kinase 1</span></div><div class="casAuthors">Larabi, Amede; Devos, Juliette M.; Ng, Sze-Ling; Nanao, Max H.; Round, Adam; Maniatis, Tom; Panne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">734-746</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tank-binding kinase I (TBK1) plays a key role in the innate immune system by integrating signals from pattern-recognition receptors.  Here, we report the x-ray crystal structures of inhibitor-bound inactive and active TBK1 detd. to 2.6 Å and 4.0 Å resoln., resp.  The structures reveal a compact dimer made up of trimodular subunits contg. an N-terminal kinase domain (KD), a ubiquitin-like domain (ULD), and an α-helical scaffold dimerization domain (SDD).  Activation rearranges the KD into an active conformation while maintaining the overall dimer conformation.  Low-resoln. SAXS studies reveal that the missing C-terminal domain (CTD) extends away from the main body of the kinase dimer.  Mutants that interfere with TBK1 dimerization show significantly reduced trans-autophosphorylation but retain the ability to bind adaptor proteins through the CTD.  Our results provide detailed insights into the architecture of TBK1 and the mol. mechanism of activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp47I973peWE7Vg90H21EOLACvtfcHk0lg0wfACuqudYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlyrsro%253D&md5=aacfaf521342d3f642cac21a4f92c60e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DLarabi%26aufirst%3DA.%26aulast%3DDevos%26aufirst%3DJ.%2BM.%26aulast%3DNg%26aufirst%3DS.-L.%26aulast%3DNanao%26aufirst%3DM.%2BH.%26aulast%3DRound%26aufirst%3DA.%26aulast%3DManiatis%26aufirst%3DT.%26aulast%3DPanne%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520and%2520mechanism%2520of%2520activation%2520of%2520TANK-binding%2520kinase%25201%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D734%26epage%3D746%26doi%3D10.1016%2Fj.celrep.2013.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, M.</span></span> <span> </span><span class="NLM_article-title">Identification of NAP1, a regulatory subunit of IκB kinase-related kinases that potentiates NF-κB signaling</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7780</span>– <span class="NLM_lpage">7793</span>, <span class="refDoi"> DOI: 10.1128/mcb.23.21.7780-7793.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1128%2Fmcb.23.21.7780-7793.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=14560022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7780-7793&author=F.+Fujitaauthor=Y.+Taniguchiauthor=T.+Katoauthor=Y.+Naritaauthor=A.+Furuyaauthor=T.+Ogawaauthor=H.+Sakuraiauthor=T.+Johauthor=M.+Itohauthor=M.+Delhaseauthor=M.+Karinauthor=M.+Nakanishi&title=Identification+of+NAP1%2C+a+regulatory+subunit+of+I%CE%BAB+kinase-related+kinases+that+potentiates+NF-%CE%BAB+signaling&doi=10.1128%2Fmcb.23.21.7780-7793.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NAP1, a regulatory subunit of IκB kinase-related kinases that potentiates NF-κB signaling</span></div><div class="casAuthors">Fujita, Fumitaka; Taniguchi, Yuko; Kato, Takashi; Narita, Yasuko; Furuya, Akiko; Ogawa, Tatsuhiro; Sakurai, Hiroaki; Joh, Takashi; Itoh, Makoto; Delhase, Mireille; Karin, Michael; Nakanishi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7780-7793</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The IκB kinase (IKK)-related kinase NAK (also known as TBK or T2K) contributes to the activation of NF-κB-dependent gene expression.  Here we identify NAP1 (for NAK-assocd. protein 1), a protein that interacts with NAK and its relative IKKε (also known as IKKi).  NAP1 activates NAK and facilitates its oligomerization.  Interestingly, the NAK-NAP1 complex itself effectively phosphorylated serine 536 of the p65/RelA subunit of NF-κB, and this activity was stimulated by tumor necrosis factor alpha (TNF-α).  Overexpression of NAP1 specifically enhanced cytokine induction of an NF-κB-dependent, but not an AP-1-dependent, reporter.  Depletion of NAP1 reduced NF-κB-dependent reporter gene expression and sensitized cells to TNF-α-induced apoptosis.  These results define NAP1 as an activator of IKK-related kinases and suggest that the NAK-NAP1 complex may protect cells from TNF-α-induced apoptosis by promoting NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRPtpVJzwFfLVg90H21EOLACvtfcHk0lg0wfACuqudYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOgt7g%253D&md5=dc35c4a46a7dee37d2d73de7520c680c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2Fmcb.23.21.7780-7793.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmcb.23.21.7780-7793.2003%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DNarita%26aufirst%3DY.%26aulast%3DFuruya%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DH.%26aulast%3DJoh%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DM.%26aulast%3DDelhase%26aufirst%3DM.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NAP1%252C%2520a%2520regulatory%2520subunit%2520of%2520I%25CE%25BAB%2520kinase-related%2520kinases%2520that%2520potentiates%2520NF-%25CE%25BAB%2520signaling%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D7780%26epage%3D7793%26doi%3D10.1128%2Fmcb.23.21.7780-7793.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatot, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gioia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, T.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrascu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Close, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapelle, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraille, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebenlist, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejardin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chariot, A.</span></span> <span> </span><span class="NLM_article-title">Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKε-dependent Lys<sup>63</sup>-linked polyubiquitination and phosphorylation of TANK/I-TRAF</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">31131</span>– <span class="NLM_lpage">31146</span>, <span class="refDoi"> DOI: 10.1074/jbc.m701690200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1074%2Fjbc.m701690200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17823124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFykurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=31131-31146&author=J.-S.+Gatotauthor=R.+Gioiaauthor=T.-L.+Chauauthor=F.+Patrascuauthor=M.+Warnierauthor=P.+Closeauthor=J.-P.+Chapelleauthor=E.+Murailleauthor=K.+Brownauthor=U.+Siebenlistauthor=J.+Pietteauthor=E.+Dejardinauthor=A.+Chariot&title=Lipopolysaccharide-mediated+interferon+regulatory+factor+activation+involves+TBK1-IKK%CE%B5-dependent+Lys63-linked+polyubiquitination+and+phosphorylation+of+TANK%2FI-TRAF&doi=10.1074%2Fjbc.m701690200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide-mediated Interferon Regulatory Factor Activation Involves TBK1-IKKε-dependent Lys63-linked Polyubiquitination and Phosphorylation of TANK/I-TRAF</span></div><div class="casAuthors">Gatot, Jean-Stephane; Gioia, Romain; Chau, Tieu-Lan; Patrascu, Felicia; Warnier, Michael; Close, Pierre; Chapelle, Jean-Paul; Muraille, Eric; Brown, Keith; Siebenlist, Ulrich; Piette, Jacques; Dejardin, Emmanuel; Chariot, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">31131-31146</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Type I interferon gene induction relies on IKK-related kinase TBK1 and IKKε-mediated phosphorylations of IRF3/7 through the Toll-like receptor-dependent signaling pathways.  The scaffold proteins that assemble these kinase complexes are poorly characterized.  We show here that TANK/I-TRAF is required for the TBK1- and IKKε-mediated IRF3/7 phosphorylations through some Toll-like receptor-dependent pathways and is part of a TRAF3-contg. complex.  Moreover, TANK is dispensable for the early phase of double-stranded RNA-mediated IRF3 phosphorylation.  Interestingly, TANK is heavily phosphorylated by TBK1-IKKε upon lipopolysaccharide stimulation and is also subject to lipopolysaccharide- and TBK1-IKKε-mediated Lys63-linked polyubiquitination, a mechanism that does not require TBK1-IKKε kinase activity.  Thus, we have identified TANK as a scaffold protein that assembles some but not all IRF3/7-phosphorylating TBK1-IKKε complexes and demonstrated that these kinases possess two functions, namely the phosphorylation of both IRF3/7 and TANK as well as the recruitment of an E3 ligase for Lys63-linked polyubiquitination of their scaffold protein, TANK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7yx4SPWko1LVg90H21EOLACvtfcHk0ljsQnN2F7Vcqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFykurrO&md5=10cb598f48055bb2ffc97a2f4bbd7c4d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m701690200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m701690200%26sid%3Dliteratum%253Aachs%26aulast%3DGatot%26aufirst%3DJ.-S.%26aulast%3DGioia%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DT.-L.%26aulast%3DPatrascu%26aufirst%3DF.%26aulast%3DWarnier%26aufirst%3DM.%26aulast%3DClose%26aufirst%3DP.%26aulast%3DChapelle%26aufirst%3DJ.-P.%26aulast%3DMuraille%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DSiebenlist%26aufirst%3DU.%26aulast%3DPiette%26aufirst%3DJ.%26aulast%3DDejardin%26aufirst%3DE.%26aulast%3DChariot%26aufirst%3DA.%26atitle%3DLipopolysaccharide-mediated%2520interferon%2520regulatory%2520factor%2520activation%2520involves%2520TBK1-IKK%25CE%25B5-dependent%2520Lys63-linked%2520polyubiquitination%2520and%2520phosphorylation%2520of%2520TANK%252FI-TRAF%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D31131%26epage%3D31146%26doi%3D10.1074%2Fjbc.m701690200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryzhakov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randow, F.</span></span> <span> </span><span class="NLM_article-title">SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3180</span>– <span class="NLM_lpage">3190</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1038%2Fsj.emboj.7601743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17568778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFejtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3180-3190&author=G.+Ryzhakovauthor=F.+Randow&title=SINTBAD%2C+a+novel+component+of+innate+antiviral+immunity%2C+shares+a+TBK1-binding+domain+with+NAP1+and+TANK&doi=10.1038%2Fsj.emboj.7601743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK</span></div><div class="casAuthors">Ryzhakov, Grigory; Randow, Felix</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3180-3190</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The expression of antiviral genes during infection is controlled by inducible transcription factors such as IRF3 (interferon regulatory factor).  Activation of IRF3 requires its phosphorylation by TBK1 (TANK-binding kinase) or IKKi (inhibitor of nuclear factor κB kinase, inducible).  The authors have identified a new and essential component of this pathway, the adaptor protein SINTBAD (similar to NAP1 TBK1 adaptor).  SINTBAD constitutively binds TBK1 and IKKi but not related kinases.  Upon infection with Sendai virus, SINTBAD is essential for the efficient induction of IRF-dependent transcription, as are two further TBK1 adaptors, TANK and NAP1.  The authors identified a conserved TBK1/IKKi-binding domain (TBD) in the three adaptors, predicted to form an α-helix with residues essential for kinase binding clustering on one side.  Isolated TBDs compete with adaptor binding to TBK1 and prevent poly(I:C)-induced IRF-dependent transcription.  The results suggest that efficient signal transduction upon viral infection requires SINTBAD, TANK and NAP1 because they link TBK1 and IKKi to virus-activated signaling cascades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-HD2rNbqMBrVg90H21EOLACvtfcHk0ljsQnN2F7Vcqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFejtr4%253D&md5=35fbfb07c129d1c555dc7307aed62ae5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601743%26sid%3Dliteratum%253Aachs%26aulast%3DRyzhakov%26aufirst%3DG.%26aulast%3DRandow%26aufirst%3DF.%26atitle%3DSINTBAD%252C%2520a%2520novel%2520component%2520of%2520innate%2520antiviral%2520immunity%252C%2520shares%2520a%2520TBK1-binding%2520domain%2520with%2520NAP1%2520and%2520TANK%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D3180%26epage%3D3190%26doi%3D10.1038%2Fsj.emboj.7601743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackloo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baryza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttcher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damerell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dötsch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pande, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh Saikatendu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, A. Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span> <span> </span><span class="NLM_article-title">Donated chemical probes for open science</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e34311</span> <span class="refDoi"> DOI: 10.7554/elife.34311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.7554%2Felife.34311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=29676732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSisr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=S.+M%C3%BCllerauthor=S.+Acklooauthor=C.+H.+Arrowsmithauthor=M.+Bauserauthor=J.+L.+Baryzaauthor=J.+Blaggauthor=J.+B%C3%B6ttcherauthor=C.+Bountraauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=A.+J.+Carterauthor=D.+Damerellauthor=V.+D%C3%B6tschauthor=D.+H.+Drewryauthor=A.+M.+Edwardsauthor=J.+Edwardsauthor=J.+M.+Elkinsauthor=C.+Fischerauthor=S.+V.+Fryeauthor=A.+Gollnerauthor=C.+E.+Grimshawauthor=A.+IJzermanauthor=T.+Hankeauthor=I.+V.+Hartungauthor=S.+Hitchcockauthor=T.+Howeauthor=T.+V.+Hughesauthor=S.+Lauferauthor=V.+M.+J.+Liauthor=S.+Lirasauthor=B.+D.+Marsdenauthor=H.+Matsuiauthor=J.+Mathiasauthor=R.+C.+O%E2%80%99Haganauthor=D.+R.+Owenauthor=V.+Pandeauthor=D.+Rauhauthor=S.+H.+Rosenbergauthor=B.+L.+Rothauthor=N.+S.+Schneiderauthor=C.+Scholtenauthor=K.+Singh+Saikatenduauthor=A.+Simeonovauthor=M.+Takizawaauthor=C.+Tseauthor=P.+R.+Thompsonauthor=D.+K.+Treiberauthor=A.+Y.+I.+Vianaauthor=C.+I.+Wellsauthor=T.+M.+Willsonauthor=W.+J.+Zuercherauthor=S.+Knappauthor=A.+Mueller-Fahrnow&title=Donated+chemical+probes+for+open+science&doi=10.7554%2Felife.34311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Donated chemical probes for open science</span></div><div class="casAuthors">Mueller, Susanne; Ackloo, Suzanne; Arrowsmith, Cheryl H.; Bauser, Marcus; Baryza, Jeremy L.; Blagg, Julian; Boettcher, Jark; Bountra, Chas; Brown, Peter J.; Bunnage, Mark E.; Carter, Adrian J.; Damerell, David; Doetsch, Volker; Drewry, David H.; Edwards, Aled M.; Edwards, James; Elkins, Jon M.; Fischer, Christian; Frye, Stephen V.; Gollner, Andreas; Grimshaw, Charles E.; Ijzerman, Adriaan; Hanke, Thomas; Hartung, Ingo V.; Hitchcock, Steve; Howe, Trevor; Hughes, Terry V.; Laufer, Stefan; Li, Volkhart MJ; Liras, Spiros; Marsden, Brian D.; Matsui, Hisanori; Mathias, John; O'Hagan, Ronan C.; Owen, Dafydd R.; Pande, Vineet; Rauh, Daniel; Rosenberg, Saul H.; Roth, Bryan L.; Schneider, Natalie S.; Scholten, Cora; Saikatendu, Kumar Singh; Simeonov, Anton; Takizawa, Masayuki; Tse, Chris; Thompson, Paul R.; Treiber, Daniel K.; Viana, Amelia YI; Wells, Carrow I.; Willson, Timothy M.; Zuercher, William J.; Knapp, Stefan; Mueller-Fahrnow, Anke</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e34311/1-e34311/15</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Potent, selective and broadly characterized small mol. modulators of protein function (chem. probes) are powerful research reagents.  The pharmaceutical industry has generated many high-quality chem. probes and several of these have been made available to academia.  However, probe-assocd. data and control compds., such as inactive structurally related mols. and their assocd. data, are generally not accessible.  The lack of data and guidance makes it difficult for researchers to decide which chem. tools to choose.  Several pharmaceutical companies (AbbVie, Bayer, Boehringer Ingelheim, Janssen, MSD, Pfizer, and Takeda) have therefore entered into a pre-competitive collaboration to make available a large no. of innovative high-quality probes, including all probe-assocd. data, control compds. and recommendations on use.  Here we describe the chem. tools and target-related knowledge that have been made available, and encourage others to join the project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRaiuCjk4Ny7Vg90H21EOLACvtfcHk0ljN00BwTYpLMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSisr3F&md5=18e66627d15b9fa650b83bb96564757c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.7554%2Felife.34311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252Felife.34311%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DAckloo%26aufirst%3DS.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBaryza%26aufirst%3DJ.%2BL.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DDamerell%26aufirst%3DD.%26aulast%3DD%25C3%25B6tsch%26aufirst%3DV.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGollner%26aufirst%3DA.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DIJzerman%26aufirst%3DA.%26aulast%3DHanke%26aufirst%3DT.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DT.%2BV.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DV.%2BM.%2BJ.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%2BD.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMathias%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPande%26aufirst%3DV.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSchneider%26aufirst%3DN.%2BS.%26aulast%3DScholten%26aufirst%3DC.%26aulast%3DSingh%2BSaikatendu%26aufirst%3DK.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DTakizawa%26aufirst%3DM.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DP.%2BR.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DViana%26aufirst%3DA.%2BY.%2BI.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26atitle%3DDonated%2520chemical%2520probes%2520for%2520open%2520science%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26doi%3D10.7554%2Felife.34311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercede, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. W.</span></span> <span> </span><span class="NLM_article-title">2-Phenylamino-6-cyano-1<i>H</i>-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5392</span>– <span class="NLM_lpage">5395</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.bmcl.2012.07.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=22877629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGhtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5392-5395&author=Z.+Huaauthor=X.+Huangauthor=H.+Bregmanauthor=N.+Chakkaauthor=E.+F.+DiMauroauthor=E.+M.+Dohertyauthor=J.+Goldsteinauthor=H.+Gunaydinauthor=H.+Huangauthor=S.+Mercedeauthor=J.+Newcombauthor=V.+F.+Patelauthor=S.+M.+Turciauthor=J.+Yanauthor=C.+Wilsonauthor=M.+W.+Martin&title=2-Phenylamino-6-cyano-1H-benzimidazole-based+isoform+selective+casein+kinase+1+gamma+%28CK1%CE%B3%29+inhibitors&doi=10.1016%2Fj.bmcl.2012.07.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">2-(Phenylamino)-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors</span></div><div class="casAuthors">Hua, Zihao; Huang, Xin; Bregman, Howard; Chakka, Nagasree; DiMauro, Erin F.; Doherty, Elizabeth M.; Goldstein, Jon; Gunaydin, Hakan; Huang, Hongbing; Mercede, Stephanie; Newcomb, John; Patel, Vinod F.; Turci, Susan M.; Yan, Jie; Wilson, Cindy; Martin, Matthew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5392-5395</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Screening of the amgen compd. library led to the identification of 2-(phenylamino)-6-cyano-1H-benzimidazole, I, as a potential CK1 gamma inhibitor (CK1γ) with excellent kinase selectivity and unprecedented CK1 isoform selectivity.  Further structure-based optimization of this series resulted in the discovery of II, which possessed good enzymic and cellular potency, excellent CK1 isoform and kinase selectivity, and acceptable pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HobtFUhBBLVg90H21EOLACvtfcHk0ljN00BwTYpLMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGhtb%252FL&md5=05de8c976d9a1cb21c5d1a0f6cc2ea75</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.046%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDoherty%26aufirst%3DE.%2BM.%26aulast%3DGoldstein%26aufirst%3DJ.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DMercede%26aufirst%3DS.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26atitle%3D2-Phenylamino-6-cyano-1H-benzimidazole-based%2520isoform%2520selective%2520casein%2520kinase%25201%2520gamma%2520%2528CK1%25CE%25B3%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5392%26epage%3D5395%26doi%3D10.1016%2Fj.bmcl.2012.07.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plobeck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.11.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.bmcl.2005.11.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=16337120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28Xosl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1397-1401&author=B.-M.+Swahnauthor=Y.+Xueauthor=E.+Arzelauthor=E.+Kallinauthor=A.+Magnusauthor=N.+Plobeckauthor=J.+Viklund&title=Design+and+synthesis+of+2%E2%80%B2-anilino-4%2C4%E2%80%B2-bipyridines+as+selective+inhibitors+of+c-Jun+N-terminal+kinase-3&doi=10.1016%2Fj.bmcl.2005.11.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3</span></div><div class="casAuthors">Swahn, Britt-Marie; Xue, Yafeng; Arzel, Erwan; Kallin, Elisabet; Magnus, Angelika; Plobeck, Niklas; Viklund, Jenny</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1397-1401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The design and synthesis of a new series of c-Jun N-terminal kinase-3 (JNK3) inhibitors with selectivity against JNK1 are reported.  Substituted 2'-anilino-4,4'-bipyridines I (R1 = R2 = 4-FC6H4, 2-MeOC6H4, 3-F3CC6H4, etc.; R1 = Ph, 4-FC6H4, R2 = MeOCH2CH2CO, 4-methoxycyclohexylcarbonyl, nicotinoyl, 2-furoyl, etc.) were designed based on a combination of hits from high throughput screening and X-ray crystal structure information of compds. crystd. into the JNK3 ATP binding active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxU6m3U6EDrVg90H21EOLACvtfcHk0ljN00BwTYpLMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xosl2gtw%253D%253D&md5=ddb516dc2c8b520c119c52ef3e8aac27</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.11.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.11.039%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DArzel%26aufirst%3DE.%26aulast%3DKallin%26aufirst%3DE.%26aulast%3DMagnus%26aufirst%3DA.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DViklund%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202%25E2%2580%25B2-anilino-4%252C4%25E2%2580%25B2-bipyridines%2520as%2520selective%2520inhibitors%2520of%2520c-Jun%2520N-terminal%2520kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1397%26epage%3D1401%26doi%3D10.1016%2Fj.bmcl.2005.11.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichy-Knight, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hightower, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkakorpi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musgrave, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1016%2Fj.bmcl.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17194588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1296-1301&author=R.+M.+Angellauthor=F.+L.+Atkinsonauthor=M.+J.+Brownauthor=T.+T.+Chuangauthor=J.+A.+Christopherauthor=M.+Cichy-Knightauthor=A.+K.+Dunnauthor=K.+E.+Hightowerauthor=S.+Malkakorpiauthor=J.+R.+Musgraveauthor=M.+Neuauthor=P.+Rowlandauthor=R.+L.+Sheaauthor=J.+L.+Smithauthor=D.+O.+Somersauthor=S.+A.+Thomasauthor=G.+Thompsonauthor=R.+Wang&title=N-%283-Cyano-4%2C5%2C6%2C7-tetrahydro-1-benzothien-2-yl%29amides+as+potent%2C+selective%2C+inhibitors+of+JNK2+and+JNK3&doi=10.1016%2Fj.bmcl.2006.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3</span></div><div class="casAuthors">Angell, Richard M.; Atkinson, Francis L.; Brown, Murray J.; Chuang, Tsu Tshen; Christopher, John A.; Cichy-Knight, Maria; Dunn, Allison K.; Hightower, Kendra E.; Malkakorpi, Susanna; Musgrave, James R.; Neu, Margarete; Rowland, Paul; Shea, Robyn L.; Smith, Jeffery L.; Somers, Donald O.; Thomas, Sonia A.; Thompson, Gladstone; Wang, Ruolan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1296-1301</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The identification and exploration of a novel, potent and selective series of N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amide inhibitors of JNK2 and JNK3 kinases is described.  Compds. 5a and 11a were identified as potent inhibitors of JNK3 (pIC50 6.7 and 6.6, resp.), with essentially equal potency against JNK2 (pIC50 6.5).  Selectivity within the mitogen-activated protein kinase (MAPK) family, against JNK1, p38α and ERK2, was obsd. for the series.  X-ray crystallog. of 5e and 8a in JNK3 revealed a unique binding mode, with the 3-cyano substituent forming an H-bond acceptor interaction with the hinge region of the ATP-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr271b_UF6qQLVg90H21EOLACvtfcHk0li-puACMSX0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsbk%253D&md5=2c9f4aaea1a10f2c2fd143555f756f2c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAtkinson%26aufirst%3DF.%2BL.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26aulast%3DChuang%26aufirst%3DT.%2BT.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DCichy-Knight%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DA.%2BK.%26aulast%3DHightower%26aufirst%3DK.%2BE.%26aulast%3DMalkakorpi%26aufirst%3DS.%26aulast%3DMusgrave%26aufirst%3DJ.%2BR.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DR.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DThomas%26aufirst%3DS.%2BA.%26aulast%3DThompson%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DN-%25283-Cyano-4%252C5%252C6%252C7-tetrahydro-1-benzothien-2-yl%2529amides%2520as%2520potent%252C%2520selective%252C%2520inhibitors%2520of%2520JNK2%2520and%2520JNK3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1296%26epage%3D1301%26doi%3D10.1016%2Fj.bmcl.2006.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frackowiak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">12853</span>– <span class="NLM_lpage">12861</span>, <span class="refDoi"> DOI: 10.1074/jbc.m809430200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1074%2Fjbc.m809430200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=19261605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlemsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=12853-12861&author=T.+Kameneckaauthor=J.+Habelauthor=D.+Duckettauthor=W.+Chenauthor=Y.+Y.+Lingauthor=B.+Frackowiakauthor=R.+Jiangauthor=Y.+Shinauthor=X.+Songauthor=P.+LoGrasso&title=Structure-activity+relationships+and+X-ray+structures+describing+the+selectivity+of+aminopyrazole+inhibitors+for+c-Jun+N-terminal+kinase+3+%28JNK3%29+over+p38&doi=10.1074%2Fjbc.m809430200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38</span></div><div class="casAuthors">Kamenecka, Ted; Habel, Jeff; Duckett, Derek; Chen, Weimin; Ling, Yuan Yuan; Frackowiak, Bozena; Jiang, Rong; Shin, Youseung; Song, Xinyi; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12853-12861</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">C-Jun N-terminal kinase 3α1 (JNK3α1) is a mitogen-activated protein kinase family member expressed primarily in the brain that phosphorylates protein transcription factors, including c-Jun and activating transcription factor-2 (ATF-2) upon activation by a variety of stress-based stimuli.  In this study, we set out to design JNK3-selective inhibitors that had >1000-fold selectivity over p38, another closely related mitogen-activated protein kinase family member.  To do this we employed traditional medicinal chem. principles coupled with structure-based drug design.  Inhibitors from the aminopyrazole class, such as SR-3576, were found to be very potent JNK3 inhibitors (IC50 = 7 nM) with >2800-fold selectivity over p38 (p38 IC50 > 20 μM) and had cell-based potency of ∼1 μM.  In contrast, indazole-based inhibitors exemplified by SR-3737 were potent inhibitors of both JNK3 (IC50 = 12 nM) and p38 (IC50 = 3 nM).  These selectivity differences between the indazole class and the aminopyrazole class came despite nearly identical binding (root mean square deviation = 0.33 Å) of these two compd. classes to JNK3.  The structural features within the compds. giving rise to the selectivity in the aminopyrazole class include the highly planar nature of the pyrazole, N-linked Ph structures, which better occupied the smaller active site of JNK3 compared with the larger active site of p38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAnr4BDk9xp7Vg90H21EOLACvtfcHk0li-puACMSX0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlemsrs%253D&md5=fe7a266891521ca6526dd8738441fcee</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m809430200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m809430200%26sid%3Dliteratum%253Aachs%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DHabel%26aufirst%3DJ.%26aulast%3DDuckett%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLing%26aufirst%3DY.%2BY.%26aulast%3DFrackowiak%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DStructure-activity%2520relationships%2520and%2520X-ray%2520structures%2520describing%2520the%2520selectivity%2520of%2520aminopyrazole%2520inhibitors%2520for%2520c-Jun%2520N-terminal%2520kinase%25203%2520%2528JNK3%2529%2520over%2520p38%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D12853%26epage%3D12861%26doi%3D10.1074%2Fjbc.m809430200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helgason, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueber, E. C.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">9378</span>– <span class="NLM_lpage">9383</span>, <span class="refDoi"> DOI: 10.1073/pnas.1121552109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.1121552109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=22619329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptlaiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=9378-9383&author=X.+Maauthor=E.+Helgasonauthor=Q.+T.+Phungauthor=C.+L.+Quanauthor=R.+S.+Iyerauthor=M.+W.+Leeauthor=K.+K.+Bowmanauthor=M.+A.+Starovasnikauthor=E.+C.+Dueber&title=Molecular+basis+of+Tank-binding+kinase+1+activation+by+transautophosphorylation&doi=10.1073%2Fpnas.1121552109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation</span></div><div class="casAuthors">Ma, Xiaolei; Helgason, Elizabeth; Phung, Qui T.; Quan, Clifford L.; Lyer, Rekha S.; Lee, Michelle W.; Bowman, Krista K.; Starovasnik, Melissa A.; Dueber, Erin C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9378-9383, S9378/1-S9378/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tank-binding kinase (TBK)1 plays a central role in innate immunity; it serves as an integrator of multiple signals induced by receptor-mediated pathogen detection and as a modulator of IFN levels.  Efforts to better understand the biol. of this key immunol. factor have intensified recently as growing evidence implicates aberrant TBK1 activity in a variety of autoimmune diseases and cancers.  Nevertheless, key mol. details of TBK1 regulation and substrate selection remain unanswered.  Here, structures of phosphorylated and unphosphorylated human TBK1 kinase domain (KD) and ubiquitin-like domain (ULD), combined with biochem. studies, indicate a mol. mechanism of activation via transautophosphorylation.  These TBK1 structures are consistent with the tripartite architecture obsd. recently for the related kinase IKKβ, but domain contributions toward target recognition appear to differ for the two enzymes.  In particular, both TBK1 autoactivation and substrate specificity are likely driven by signal-dependent colocalization events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHhXS8bOS9LVg90H21EOLACvtfcHk0liAHujnB1L8Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptlaiurc%253D&md5=fa6ff15e25a04066c1a54f5d5072d651</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121552109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121552109%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHelgason%26aufirst%3DE.%26aulast%3DPhung%26aufirst%3DQ.%2BT.%26aulast%3DQuan%26aufirst%3DC.%2BL.%26aulast%3DIyer%26aufirst%3DR.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BW.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DDueber%26aufirst%3DE.%2BC.%26atitle%3DMolecular%2520basis%2520of%2520Tank-binding%2520kinase%25201%2520activation%2520by%2520transautophosphorylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D9378%26epage%3D9383%26doi%3D10.1073%2Fpnas.1121552109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikediobi, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bignell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarius, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barthorpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brackenbury, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicks, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hills, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmidou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mironenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tofts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhold, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futreal, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooster, R.</span></span> <span> </span><span class="NLM_article-title">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2606</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-06-0433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1158%2F1535-7163.mct-06-0433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=17088437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2606-2612&author=O.+N.+Ikediobiauthor=H.+Daviesauthor=G.+Bignellauthor=S.+Edkinsauthor=C.+Stevensauthor=S.+O%E2%80%99Mearaauthor=T.+Santariusauthor=T.+Avisauthor=S.+Barthorpeauthor=L.+Brackenburyauthor=G.+Buckauthor=A.+Butlerauthor=J.+Clementsauthor=J.+Coleauthor=E.+Dicksauthor=S.+Forbesauthor=K.+Grayauthor=K.+Hallidayauthor=R.+Harrisonauthor=K.+Hillsauthor=J.+Hintonauthor=C.+Hunterauthor=A.+Jenkinsonauthor=D.+Jonesauthor=V.+Kosmidouauthor=R.+Luggauthor=A.+Menziesauthor=T.+Mironenkoauthor=A.+Parkerauthor=J.+Perryauthor=K.+Raineauthor=D.+Richardsonauthor=R.+Shepherdauthor=A.+Smallauthor=R.+Smithauthor=H.+Solomonauthor=P.+Stephensauthor=J.+Teagueauthor=C.+Toftsauthor=J.+Varianauthor=T.+Webbauthor=S.+Westauthor=S.+Widaaauthor=A.+Yatesauthor=W.+Reinholdauthor=J.+N.+Weinsteinauthor=M.+R.+Strattonauthor=P.+A.+Futrealauthor=R.+Wooster&title=Mutation+analysis+of+24+known+cancer+genes+in+the+NCI-60+cell+line+set&doi=10.1158%2F1535-7163.mct-06-0433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span></div><div class="casAuthors">Ikediobi, Ogechi N.; Davies, Helen; Bignell, Graham; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Santarius, Thomas; Avis, Tim; Barthorpe, Syd; Brackenbury, Lisa; Buck, Gemma; Butler, Adam; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kristian; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jonathan; Hunter, Chris; Jenkinson, Andy; Jones, David; Kosmidou, Vivienne; Lugg, Richard; Menzies, Andrew; Mironenko, Tatiana; Parker, Adrian; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alex; Smith, Raffaella; Solomon, Helen; Stephens, Philip; Teague, Jon; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Reinhold, William; Weinstein, John N.; Stratton, Michael R.; Futreal, P. Andrew; Wooster, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2606-2612</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer Institute for anticancer drug discovery is a widely used resource.  The NCI-60 has been characterized pharmacol. and at the mol. level more extensively than any other set of cell lines.  However, no systematic mutation anal. of genes causally implicated in oncogenesis has been reported.  This study reports the sequence anal. of 24 known cancer genes in the NCI-60 and an assessment of 4 of the 24 genes for homozygous deletions.  One hundred thirty-seven oncogenic mutations were identified in 14 (APC, BRAF, CDKN2, CTNNB1, HRAS, KRAS, NRAS, SMAD4, PIK3CA, PTEN, RB1, STK11, TP53, and VHL) of the 24 genes.  All lines have at least one mutation among the cancer genes examd., with most lines (73%) having more than one.  Identification of those cancer genes mutated in the NCI-60, in combination with pharmacol. and mol. profiles of the cells, will allow for more informed interpretation of anticancer agent screening and will enhance the use of the NCI-60 cell lines for molecularly targeted screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1IovOJtJWDbVg90H21EOLACvtfcHk0liAHujnB1L8Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK&md5=f943d16d3e147357815de0ec3c29c30d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.mct-06-0433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.mct-06-0433%26sid%3Dliteratum%253Aachs%26aulast%3DIkediobi%26aufirst%3DO.%2BN.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DBignell%26aufirst%3DG.%26aulast%3DEdkins%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DS.%26aulast%3DSantarius%26aufirst%3DT.%26aulast%3DAvis%26aufirst%3DT.%26aulast%3DBarthorpe%26aufirst%3DS.%26aulast%3DBrackenbury%26aufirst%3DL.%26aulast%3DBuck%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DA.%26aulast%3DClements%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DJ.%26aulast%3DDicks%26aufirst%3DE.%26aulast%3DForbes%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DHalliday%26aufirst%3DK.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHills%26aufirst%3DK.%26aulast%3DHinton%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DC.%26aulast%3DJenkinson%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKosmidou%26aufirst%3DV.%26aulast%3DLugg%26aufirst%3DR.%26aulast%3DMenzies%26aufirst%3DA.%26aulast%3DMironenko%26aufirst%3DT.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DRaine%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DR.%26aulast%3DSmall%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DSolomon%26aufirst%3DH.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DTofts%26aufirst%3DC.%26aulast%3DVarian%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWidaa%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DA.%26aulast%3DReinhold%26aufirst%3DW.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26atitle%3DMutation%2520analysis%2520of%252024%2520known%2520cancer%2520genes%2520in%2520the%2520NCI-60%2520cell%2520line%2520set%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2606%26epage%3D2612%26doi%3D10.1158%2F1535-7163.mct-06-0433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meibom, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbeck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrenga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittendorf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schamberger, J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective human neutrophil elastase inhibitors with novel equatorial ring topology: in vivo efficacy of the polar pyrimidopyridazine BAY-8040 in a pulmonary arterial hypertension rat model</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1002%2Fcmdc.201500269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=26333652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGntL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=199-206&author=F.+von%0ANussbaumauthor=V.+M.+Liauthor=D.+Meibomauthor=S.+Anlaufauthor=M.+Bechemauthor=M.+Delbeckauthor=M.+Gerischauthor=A.+Harrengaauthor=D.+Karthausauthor=D.+Langauthor=K.+Lustigauthor=J.+Mittendorfauthor=M.+Sch%C3%A4ferauthor=S.+Sch%C3%A4ferauthor=J.+Schamberger&title=Potent+and+selective+human+neutrophil+elastase+inhibitors+with+novel+equatorial+ring+topology%3A+in+vivo+efficacy+of+the+polar+pyrimidopyridazine+BAY-8040+in+a+pulmonary+arterial+hypertension+rat+model&doi=10.1002%2Fcmdc.201500269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat Model</span></div><div class="casAuthors">von Nussbaum, Franz; Li, Volkhart M.; Meibom, Daniel; Anlauf, Sonja; Bechem, Martin; Delbeck, Martina; Gerisch, Michael; Harrenga, Axel; Karthaus, Dagmar; Lang, Dieter; Lustig, Klemens; Mittendorf, Joachim; Schaefer, Martina; Schaefer, Stefan; Schamberger, Jens</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Human neutrophil elastase (HNE) is a key driver of inflammation in many cardiopulmonary and systemic inflammatory and autoimmune conditions.  Overshooting high HNE activity is the consequence of a disrupted protease-antiprotease balance.  Accordingly, there has been an intensive search for potent and selective HNE inhibitors with suitable pharmacokinetics that would allowing oral administration in patients.  Based on the chem. probe BAY-678 and the clin. candidate BAY 85-8501 we explored further ring topologies along the equator of the parent pyrimidinone lead series.  Novel ring systems were annulated in the east, yielding imidazolo-, triazolo-, and tetrazolopyrimidines in order to ensure addnl. inhibitor-HNE contacts beyond the S1 and the S2 pocket of HNE.  The western annulation of pyridazines led to the polar pyrimidopyridazine BAY-8040, which combines excellent potency and selectivity with a promising pharmacokinetic profile.  In vivo efficacy with regard to decreasing cardiac remodeling and amelioration of cardiac function was shown in a monocrotaline-induced rat model for pulmonary arterial hypertension.  This demonstrated in vivo proof of concept in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_7hken5xnLVg90H21EOLACvtfcHk0lhEQOsVS_KrOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGntL3I&md5=a649307980cdcb9f1994e6675ff9d509</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500269%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DV.%2BM.%26aulast%3DMeibom%26aufirst%3DD.%26aulast%3DAnlauf%26aufirst%3DS.%26aulast%3DBechem%26aufirst%3DM.%26aulast%3DDelbeck%26aufirst%3DM.%26aulast%3DGerisch%26aufirst%3DM.%26aulast%3DHarrenga%26aufirst%3DA.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DLustig%26aufirst%3DK.%26aulast%3DMittendorf%26aufirst%3DJ.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26aulast%3DSchamberger%26aufirst%3DJ.%26atitle%3DPotent%2520and%2520selective%2520human%2520neutrophil%2520elastase%2520inhibitors%2520with%2520novel%2520equatorial%2520ring%2520topology%253A%2520in%2520vivo%2520efficacy%2520of%2520the%2520polar%2520pyrimidopyridazine%2520BAY-8040%2520in%2520a%2520pulmonary%2520arterial%2520hypertension%2520rat%2520model%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D199%26epage%3D206%26doi%3D10.1002%2Fcmdc.201500269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brumby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ter Laak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Montalvan, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsyte-Lovejoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhakumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellfeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stresemann, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a highly potent and selective aminopyrazoline-based in vivo probe (BAY-598) for the protein lysine methyltransferase SMYD2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4578</span>– <span class="NLM_lpage">4600</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01890</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4578-4600&author=E.+Eggertauthor=R.+C.+Hilligauthor=S.+Koehrauthor=D.+St%C3%B6ckigtauthor=J.+Weiskeauthor=N.+Barakauthor=J.+Mowatauthor=T.+Brumbyauthor=C.+D.+Christauthor=A.+ter+Laakauthor=T.+Langauthor=A.+E.+Fernandez-Montalvanauthor=V.+Badockauthor=H.+Weinmannauthor=I.+V.+Hartungauthor=D.+Barsyte-Lovejoyauthor=M.+Szewczykauthor=S.+Kennedyauthor=F.+Liauthor=M.+Vedadiauthor=P.+J.+Brownauthor=V.+Santhakumarauthor=C.+H.+Arrowsmithauthor=T.+Stellfeldauthor=C.+Stresemann&title=Discovery+and+characterization+of+a+highly+potent+and+selective+aminopyrazoline-based+in+vivo+probe+%28BAY-598%29+for+the+protein+lysine+methyltransferase+SMYD2&doi=10.1021%2Facs.jmedchem.5b01890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2</span></div><div class="casAuthors">Eggert, Erik; Hillig, Roman C.; Koehr, Silke; Stoeckigt, Detlef; Weiske, Joerg; Barak, Naomi; Mowat, Jeffrey; Brumby, Thomas; Christ, Clara D.; ter Laak, Antonius; Lang, Tina; Fernandez-Montalvan, Amaury E.; Badock, Volker; Weinmann, Hilmar; Hartung, Ingo V.; Barsyte-Lovejoy, Dalia; Szewczyk, Magdalena; Kennedy, Steven; Li, Fengling; Vedadi, Masoud; Brown, Peter J.; Santhakumar, Vijayaratnam; Arrowsmith, Cheryl H.; Stellfeld, Timo; Stresemann, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4578-4600</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein lysine methyltransferases have recently emerged as a new target class for the development of inhibitors that modulate gene transcription or signaling pathways.  SET and MYND domain contg. protein 2 (SMYD2) is a catalytic SET domain contg. methyltransferase reported to monomethylate lysine residues on histone and nonhistone proteins.  Although several studies have uncovered an important role of SMYD2 in promoting cancer by protein methylation, the biol. of SMYD2 is far from being fully understood.  Utilization of highly potent and selective chem. probes for target validation has emerged as a concept which circumvents possible limitations of knockdown expts. and, in particular, could result in an improved exploration of drug targets with a complex underlying biol.  Here, we report the development of a potent, selective, and cell-active, substrate-competitive inhibitor of SMYD2, which is the first reported inhibitor suitable for in vivo target validation studies in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuNehWDd3N7Vg90H21EOLACvtfcHk0lhEQOsVS_KrOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsLc%253D&md5=d0944b0a6870b9790f9f4c429290f81e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01890%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DE.%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DKoehr%26aufirst%3DS.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DBarak%26aufirst%3DN.%26aulast%3DMowat%26aufirst%3DJ.%26aulast%3DBrumby%26aufirst%3DT.%26aulast%3DChrist%26aufirst%3DC.%2BD.%26aulast%3Dter%2BLaak%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DT.%26aulast%3DFernandez-Montalvan%26aufirst%3DA.%2BE.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DSzewczyk%26aufirst%3DM.%26aulast%3DKennedy%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSanthakumar%26aufirst%3DV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DStellfeld%26aufirst%3DT.%26aulast%3DStresemann%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520potent%2520and%2520selective%2520aminopyrazoline-based%2520in%2520vivo%2520probe%2520%2528BAY-598%2529%2520for%2520the%2520protein%2520lysine%2520methyltransferase%2520SMYD2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4578%26epage%3D4600%26doi%3D10.1021%2Facs.jmedchem.5b01890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouché, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Montalván, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ter Laak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Sáez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siejka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pütter, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haendler, B.</span></span> <span> </span><span class="NLM_article-title">Benzoisoquinolinediones as potent and selective inhibitors of BRPF2 and TAF1/TAF1L bromodomains</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4002</span>– <span class="NLM_lpage">4022</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4002-4022&author=L.+Bouch%C3%A9author=C.+D.+Christauthor=S.+Siegelauthor=A.+E.+Fern%C3%A1ndez-Montalv%C3%A1nauthor=S.+J.+Holtonauthor=O.+Fedorovauthor=A.+ter+Laakauthor=T.+Sugawaraauthor=D.+St%C3%B6ckigtauthor=C.+Tallantauthor=J.+Bennettauthor=O.+Monteiroauthor=L.+D%C3%ADaz-S%C3%A1ezauthor=P.+Siejkaauthor=J.+Meierauthor=V.+P%C3%BCtterauthor=J.+Weiskeauthor=S.+M%C3%BCllerauthor=K.+V.+M.+Huberauthor=I.+V.+Hartungauthor=B.+Haendler&title=Benzoisoquinolinediones+as+potent+and+selective+inhibitors+of+BRPF2+and+TAF1%2FTAF1L+bromodomains&doi=10.1021%2Facs.jmedchem.7b00306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains</span></div><div class="casAuthors">Bouche, Lea; Christ, Clara D.; Siegel, Stephan; Fernandez-Montalvan, Amaury E.; Holton, Simon J.; Fedorov, Oleg; ter Laak, Antonius; Sugawara, Tatsuo; Stoeckigt, Detlef; Tallant, Cynthia; Bennett, James; Monteiro, Octovia; Diaz-Saez, Laura; Siejka, Paulina; Meier, Julia; Puetter, Vera; Weiske, Joerg; Mueller, Susanne; Huber, Kilian V. M.; Hartung, Ingo V.; Haendler, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4002-4022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains (BD) are readers of lysine acetylation marks present in numerous proteins assocd. with chromatin.  Here we describe a dual inhibitor of the bromodomain and PHD finger (BRPF) family member BRPF2 and the TATA box binding protein-assocd. factors TAF1 and TAF1L.  These proteins are found in large chromatin complexes and play important roles in transcription regulation.  The substituted benzoisoquinolinedione series was identified by high-throughput screening, and subsequent structure-activity relationship optimization allowed generation of low nanomolar BRPF2 BD inhibitors with strong selectivity against BRPF1 and BRPF3 BDs.  In addn., a strong inhibition of TAF1/TAF1L BD2 was measured for most derivs.  The best compd. of the series was BAY-299, which is a very potent, dual inhibitor with an IC50 of 67 nM for BRPF2 BD, 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2.  Importantly, no activity was measured for BRD4 BDs.  Furthermore, cellular activity was evidenced using a BRPF2- or TAF1-histone H3.3 or H4 interaction assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWg-Bg5eiC-bVg90H21EOLACvtfcHk0lgiDxz-HboYiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvFWhsLk%253D&md5=3012fd7ce265b23bfc6c354425112e2a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00306%26sid%3Dliteratum%253Aachs%26aulast%3DBouch%25C3%25A9%26aufirst%3DL.%26aulast%3DChrist%26aufirst%3DC.%2BD.%26aulast%3DSiegel%26aufirst%3DS.%26aulast%3DFern%25C3%25A1ndez-Montalv%25C3%25A1n%26aufirst%3DA.%2BE.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3Dter%2BLaak%26aufirst%3DA.%26aulast%3DSugawara%26aufirst%3DT.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DMonteiro%26aufirst%3DO.%26aulast%3DD%25C3%25ADaz-S%25C3%25A1ez%26aufirst%3DL.%26aulast%3DSiejka%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DJ.%26aulast%3DP%25C3%25BCtter%26aufirst%3DV.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DHaendler%26aufirst%3DB.%26atitle%3DBenzoisoquinolinediones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520BRPF2%2520and%2520TAF1%252FTAF1L%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4002%26epage%3D4022%26doi%3D10.1021%2Facs.jmedchem.7b00306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Montalván, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuropka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puetter, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ter Laak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troast, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodeschini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Sáez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorjánácz, M.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective ATAD2 chemical probe with novel chemical structure and unusual mode of action</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2730</span>– <span class="NLM_lpage">2736</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2730-2736&author=A.+E.+Fern%C3%A1ndez-Montalv%C3%A1nauthor=M.+Bergerauthor=B.+Kuropkaauthor=S.+J.+Kooauthor=V.+Badockauthor=J.+Weiskeauthor=V.+Puetterauthor=S.+J.+Holtonauthor=D.+St%C3%B6ckigtauthor=A.+ter+Laakauthor=P.+A.+Centrellaauthor=M.+A.+Clarkauthor=C.+E.+Dumelinauthor=E.+A.+Sigelauthor=H.+H.+Soutterauthor=D.+M.+Troastauthor=Y.+Zhangauthor=J.+W.+Cuozzoauthor=A.+D.+Keefeauthor=D.+Rocheauthor=V.+Rodeschiniauthor=A.+Chaikuadauthor=L.+D%C3%ADaz-S%C3%A1ezauthor=J.+M.+Bennettauthor=O.+Fedorovauthor=K.+V.+M.+Huberauthor=J.+H%C3%BCbnerauthor=H.+Weinmannauthor=I.+V.+Hartungauthor=M.+Gorj%C3%A1n%C3%A1cz&title=Isoform-selective+ATAD2+chemical+probe+with+novel+chemical+structure+and+unusual+mode+of+action&doi=10.1021%2Facschembio.7b00708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action</span></div><div class="casAuthors">Fernandez-Montalvan, Amaury E.; Berger, Markus; Kuropka, Benno; Koo, Seong Joo; Badock, Volker; Weiske, Joerg; Puetter, Vera; Holton, Simon J.; Stoeckigt, Detlef; ter Laak, Antonius; Centrella, Paolo A.; Clark, Matthew A.; Dumelin, Christoph E.; Sigel, Eric A.; Soutter, Holly H.; Troast, Dawn M.; Zhang, Ying; Cuozzo, John W.; Keefe, Anthony D.; Roche, Didier; Rodeschini, Vincent; Chaikuad, Apirat; Diaz-Saez, Laura; Bennett, James M.; Fedorov, Oleg; Huber, Kilian V. M.; Huebner, Jan; Weinmann, Hilmar; Hartung, Ingo V.; Gorjanacz, Matyas</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2730-2736</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types.  Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells.  These features qualify BAY-850 as a chem. probe to explore ATAD2 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCB3nyG9YvubVg90H21EOLACvtfcHk0lgiDxz-HboYiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KqsrrL&md5=1f09000a7d7e60e30540fbbae117acfe</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00708%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Montalv%25C3%25A1n%26aufirst%3DA.%2BE.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DKuropka%26aufirst%3DB.%26aulast%3DKoo%26aufirst%3DS.%2BJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DPuetter%26aufirst%3DV.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3Dter%2BLaak%26aufirst%3DA.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DSigel%26aufirst%3DE.%2BA.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DTroast%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26aulast%3DRoche%26aufirst%3DD.%26aulast%3DRodeschini%26aufirst%3DV.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DD%25C3%25ADaz-S%25C3%25A1ez%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DJ.%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DGorj%25C3%25A1n%25C3%25A1cz%26aufirst%3DM.%26atitle%3DIsoform-selective%2520ATAD2%2520chemical%2520probe%2520with%2520novel%2520chemical%2520structure%2520and%2520unusual%2520mode%2520of%2520action%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D2730%26epage%3D2736%26doi%3D10.1021%2Facschembio.7b00708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siebeneicher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehwinkel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmann, B.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2261</span>– <span class="NLM_lpage">2271</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1002%2Fcmdc.201600276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=27552707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2261-2271&author=H.+Siebeneicherauthor=A.+Cleveauthor=H.+Rehwinkelauthor=R.+Neuhausauthor=I.+Heislerauthor=T.+M%C3%BCllerauthor=M.+Bauserauthor=B.+Buchmann&title=Identification+and+optimization+of+the+first+highly+selective+GLUT1+inhibitor+BAY-876&doi=10.1002%2Fcmdc.201600276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876</span></div><div class="casAuthors">Siebeneicher, Holger; Cleve, Arwed; Rehwinkel, Hartmut; Neuhaus, Roland; Heisler, Iring; Mueller, Thomas; Bauser, Marcus; Buchmann, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2261-2271</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Despite the long-known fact that the facilitative glucose transporter GLUT1 is one of the key players safeguarding the increase in glucose consumption of many tumor entities even under conditions of normal oxygen supply (known as the Warburg effect), only few endeavors have been undertaken to find a GLUT1-selective small-mol. inhibitor.  Because other transporters of the GLUT1 family are involved in crucial processes, these transporters should not be addressed by such an inhibitor.  A high-throughput screen against a library of ∼3 million compds. was performed to find a small mol. with this challenging potency and selectivity profile.  The N-(1H-pyrazol-4-yl)quinoline-4-carboxamides were identified as an excellent starting point for further compd. optimization.  After extensive structure-activity relationship explorations, single-digit nanomolar inhibitors with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4 were obtained.  The most promising compd., BAY-876 [N4-[1-(4-cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide], showed good metabolic stability in vitro and high oral bioavailability in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFnF7Pnmxup7Vg90H21EOLACvtfcHk0liXXJurnL7OWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyktr3L&md5=bcad707900882f937d137dc3925862a7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600276%26sid%3Dliteratum%253Aachs%26aulast%3DSiebeneicher%26aufirst%3DH.%26aulast%3DCleve%26aufirst%3DA.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DHeisler%26aufirst%3DI.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520the%2520first%2520highly%2520selective%2520GLUT1%2520inhibitor%2520BAY-876%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2261%26epage%3D2271%26doi%3D10.1002%2Fcmdc.201600276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trésaugues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talagas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Sáez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panagakou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siejka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorjánácz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, M.</span></span> <span> </span><span class="NLM_article-title">Creation of a novel class of potent and selective MutT homologue 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2533</span>– <span class="NLM_lpage">2551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2533-2551&author=F.+Rahmauthor=J.+Viklundauthor=L.+Tr%C3%A9sauguesauthor=M.+Ellermannauthor=A.+Gieseauthor=U.+Ericssonauthor=R.+Forsblomauthor=T.+Ginmanauthor=J.+G%C3%BCntherauthor=K.+Hallbergauthor=J.+Lindstr%C3%B6mauthor=L.+B.+Perssonauthor=C.+Silvanderauthor=A.+Talagasauthor=L.+D%C3%ADaz-S%C3%A1ezauthor=O.+Fedorovauthor=K.+V.+M.+Huberauthor=I.+Panagakouauthor=P.+Siejkaauthor=M.+Gorj%C3%A1n%C3%A1czauthor=M.+Bauserauthor=M.+Andersson&title=Creation+of+a+novel+class+of+potent+and+selective+MutT+homologue+1+%28MTH1%29+inhibitors+using+fragment-based+screening+and+structure-based+drug+design&doi=10.1021%2Facs.jmedchem.7b01884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design</span></div><div class="casAuthors">Rahm, Fredrik; Viklund, Jenny; Tresaugues, Lionel; Ellermann, Manuel; Giese, Anja; Ericsson, Ulrika; Forsblom, Rickard; Ginman, Tobias; Gunther, Judith; Hallberg, Kenth; Lindstroem, Johan; Persson, Lars Boukharta; Silvander, Camilla; Talagas, Antoine; Diaz-Saez, Laura; Fedorov, Oleg; Huber, Kilian V. M.; Panagakou, Ioanna; Siejka, Paulina; Gorjanacz, Matyas; Bauser, Marcus; Andersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2533-2551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent literature has both suggested and questioned MTH1 as a novel cancer target.  BAY-707 was just published as a target validation small mol. probe for assessing the effects of pharmacol. inhibition of MTH1 on tumor cell survival, both in vitro and in vivo.  In this report, the authors describe the medicinal chem. program creating BAY-707, where fragment-based methods were used to develop a series of highly potent and selective MTH1 inhibitors.  Using structure-based drug design and rational medicinal chem. approaches, the potency was increased over 10,000 times from the fragment starting point while maintaining high ligand efficiency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7pMr__ory7Vg90H21EOLACvtfcHk0liXXJurnL7OWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku7o%253D&md5=5500fe330efef6fdbe5eae95b3d88ab1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01884%26sid%3Dliteratum%253Aachs%26aulast%3DRahm%26aufirst%3DF.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DTr%25C3%25A9saugues%26aufirst%3DL.%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DA.%26aulast%3DEricsson%26aufirst%3DU.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DG%25C3%25BCnther%26aufirst%3DJ.%26aulast%3DHallberg%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPersson%26aufirst%3DL.%2BB.%26aulast%3DSilvander%26aufirst%3DC.%26aulast%3DTalagas%26aufirst%3DA.%26aulast%3DD%25C3%25ADaz-S%25C3%25A1ez%26aufirst%3DL.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DPanagakou%26aufirst%3DI.%26aulast%3DSiejka%26aufirst%3DP.%26aulast%3DGorj%25C3%25A1n%25C3%25A1cz%26aufirst%3DM.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DM.%26atitle%3DCreation%2520of%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520MutT%2520homologue%25201%2520%2528MTH1%2529%2520inhibitors%2520using%2520fragment-based%2520screening%2520and%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2533%26epage%3D2551%26doi%3D10.1021%2Facs.jmedchem.7b01884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, R. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broggini-Tenzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Süssmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grünewald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span> <span> </span><span class="NLM_article-title">Novel TIE-2 inhibitor BAY-826 displays <i>in vivo</i> efficacy in experimental syngeneic murine glioma models</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1111/jnc.13877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1111%2Fjnc.13877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=27787897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGmt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=170-182&author=H.+Schneiderauthor=E.+Szaboauthor=R.+A.+C.+Machadoauthor=A.+Broggini-Tenzerauthor=A.+Walterauthor=M.+Lobellauthor=D.+Heldmannauthor=F.+S%C3%BCssmeierauthor=S.+Gr%C3%BCnewaldauthor=M.+Weller&title=Novel+TIE-2+inhibitor+BAY-826+displays+in+vivo+efficacy+in+experimental+syngeneic+murine+glioma+models&doi=10.1111%2Fjnc.13877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel TIE-2 inhibitor BAY-826 displays in vivo efficacy in experimental syngeneic murine glioma models</span></div><div class="casAuthors">Schneider, Hannah; Szabo, Emese; Machado, Raquel A. C.; Broggini-Tenzer, Angela; Walter, Alexander; Lobell, Mario; Heldmann, Dieter; Suessmeier, Frank; Gruenewald, Sylvia; Weller, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-182</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Targeting the vascular endothelial growth factor signaling axis in glioblastoma inevitably leads to tumor recurrence and a more aggressive phenotype.  Therefore, other angiogenic pathways, like the angiopoietin/tunica interna endothelial cell kinase (TIE) signaling axis, have become addnl. targets for therapeutic intervention.  Here, we explored whether targeting the receptor tyrosine kinase TIE-2 using a novel, highly potent, orally available small mol. TIE-2 inhibitor (BAY-826) improves tumor control in syngeneic mouse glioma models.  BAY-826 inhibits TIE-2 phosphorylation in vitro and in vivo as demonstrated by suppression of Angiopoietin-1- or Na3VO4-induced TIE-2 phosphorylation in glioma cells or exts. of lungs from BAY-826-treated mice.  There was a trend toward prolonged survival upon single-agent treatment in two of four models (SMA-497 and SMA-540) and there was a significant survival benefit in one model (SMA-560).  Co-treatment with BAY-826 and irradn. was ineffective in one model (SMA-497), but provided synergistic prolongation of survival in another (SMA-560).  Decreased vessel densities and increased leukocyte infiltration were obsd., but might be independent processes as the effect was also obsd. in single treatment modalities.  These data demonstrate that TIE-2 inhibition may improve tumor response to treatment in highly vascularized tumors such as glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSM7CpumxyGLVg90H21EOLACvtfcHk0lhIyDFIiUXPQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGmt7%252FK&md5=bd7b5a44b6c3c51f56e90f1e4f89f47d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13877%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DMachado%26aufirst%3DR.%2BA.%2BC.%26aulast%3DBroggini-Tenzer%26aufirst%3DA.%26aulast%3DWalter%26aufirst%3DA.%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DHeldmann%26aufirst%3DD.%26aulast%3DS%25C3%25BCssmeier%26aufirst%3DF.%26aulast%3DGr%25C3%25BCnewald%26aufirst%3DS.%26aulast%3DWeller%26aufirst%3DM.%26atitle%3DNovel%2520TIE-2%2520inhibitor%2520BAY-826%2520displays%2520in%2520vivo%2520efficacy%2520in%2520experimental%2520syngeneic%2520murine%2520glioma%2520models%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D140%26spage%3D170%26epage%3D182%26doi%3D10.1111%2Fjnc.13877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosmayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberspaecher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suelzle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesche, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Reppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nising, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegebarth, A.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of the potent and highly selective (piperidin-4-yl)pyrido[3,2-<i>d</i>]pyrimidine based in vitro probe BAY-885 for the kinase ERK5</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01606</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01606" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFGisrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=928-940&author=D.+Nguyenauthor=C.+Lemosauthor=L.+Wortmannauthor=K.+Eisauthor=S.+J.+Holtonauthor=U.+Boemerauthor=D.+Moosmayerauthor=U.+Eberspaecherauthor=J.+Weiskeauthor=C.+Lechnerauthor=S.+Prechtlauthor=D.+Suelzleauthor=F.+Siegelauthor=F.+Prinzauthor=R.+Lescheauthor=B.+Nickeauthor=K.+Nowak-Reppelauthor=H.+Himmelauthor=D.+Mumbergauthor=F.+von+Nussbaumauthor=C.+F.+Nisingauthor=M.+Bauserauthor=A.+Haegebarth&title=Discovery+and+characterization+of+the+potent+and+highly+selective+%28piperidin-4-yl%29pyrido%5B3%2C2-d%5Dpyrimidine+based+in+vitro+probe+BAY-885+for+the+kinase+ERK5&doi=10.1021%2Facs.jmedchem.8b01606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5</span></div><div class="casAuthors">Nguyen, Duy; Lemos, Clara; Wortmann, Lars; Eis, Knut; Holton, Simon J.; Boemer, Ulf; Moosmayer, Dieter; Eberspaecher, Uwe; Weiske, Joerg; Lechner, Christian; Prechtl, Stefan; Suelzle, Detlev; Siegel, Franziska; Prinz, Florian; Lesche, Ralf; Nicke, Barbara; Nowak-Reppel, Katrin; Himmel, Herbert; Mumberg, Dominik; von Nussbaum, Franz; Nising, Carl F.; Bauser, Marcus; Haegebarth, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The availability of a chem. probe to study the role of a specific domain of a protein in a concn.- and time-dependent manner is of high value.  Herein, we report the identification of a highly potent and selective ERK5 inhibitor BAY-885(I) by high-throughput screening and subsequent structure-based optimization.  ERK5 is a key integrator of cellular signal transduction, and it has been shown to play a role in various cellular processes such as proliferation, differentiation, apoptosis, and cell survival.  We could demonstrate that inhibition of ERK5 kinase and transcriptional activity with a small mol. did not translate into antiproliferative activity in different relevant cell models, which is in contrast to the results obtained by RNAi technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkaBSl4bhkmrVg90H21EOLACvtfcHk0lhIyDFIiUXPQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFGisrjE&md5=0e7f25af7a066d31a69b6e4a291ff417</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01606%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DLemos%26aufirst%3DC.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DEberspaecher%26aufirst%3DU.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DLechner%26aufirst%3DC.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DSuelzle%26aufirst%3DD.%26aulast%3DSiegel%26aufirst%3DF.%26aulast%3DPrinz%26aufirst%3DF.%26aulast%3DLesche%26aufirst%3DR.%26aulast%3DNicke%26aufirst%3DB.%26aulast%3DNowak-Reppel%26aufirst%3DK.%26aulast%3DHimmel%26aufirst%3DH.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DNising%26aufirst%3DC.%2BF.%26aulast%3DBauser%26aufirst%3DM.%26aulast%3DHaegebarth%26aufirst%3DA.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520the%2520potent%2520and%2520highly%2520selective%2520%2528piperidin-4-yl%2529pyrido%255B3%252C2-d%255Dpyrimidine%2520based%2520in%2520vitro%2520probe%2520BAY-885%2520for%2520the%2520kinase%2520ERK5%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D928%26epage%3D940%26doi%3D10.1021%2Facs.jmedchem.8b01606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosmayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmann, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werbeck, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastouri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahmann, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhnke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1073/pnas.1812963116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=10.1073%2Fpnas.1812963116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=30683722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=2551-2560&author=R.+C.+Hilligauthor=B.+Sautierauthor=J.+Schroederauthor=D.+Moosmayerauthor=A.+Hilpmannauthor=C.+M.+Stegmannauthor=N.+D.+Werbeckauthor=H.+Briemauthor=U.+Boemerauthor=J.+Weiskeauthor=V.+Badockauthor=J.+Mastouriauthor=K.+Petersenauthor=G.+Siemeisterauthor=J.+D.+Kahmannauthor=D.+Wegenerauthor=N.+B%C3%B6hnkeauthor=K.+Eisauthor=K.+Grahamauthor=L.+Wortmannauthor=F.+von+Nussbaumauthor=B.+Bader&title=Discovery+of+potent+SOS1+inhibitors+that+block+RAS+activation+via+disruption+of+the+RAS-SOS1+interaction&doi=10.1073%2Fpnas.1812963116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction</span></div><div class="casAuthors">Hillig, Roman C.; Sautier, Brice; Schroeder, Jens; Moosmayer, Dieter; Hilpmann, AndrA; Stegmann, Christian M.; Werbeck, Nicolas D.; Briem, Hans; Boemer, Ulf; Weiske, Joerg; Badock, Volker; Mastouri, Julia; Petersen, Kirstin; Siemeister, Gerhard; Kahmann, Jan D.; Wegener, Dennis; Boehnke, Niels; Eis, Knut; Graham, Keith; Wortmann, Lars; von Nussbaum, Franz; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2551-2560</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Since the late 1980s, mutations in the RAS genes have been recognized as major oncogenes with a high occurrence rate in human cancers.  Such mutations reduce the ability of the small GTPase RAS to hydrolyze GTP, keeping this mol. switch in a constitutively active GTP-bound form that drives, unchecked, oncogenic downstream signaling.  One strategy to reduce the levels of active RAS is to target guanine nucleotide exchange factors, which allow RAS to cycle from the inactive GDP-bound state to the active GTP-bound form.  Here, we describe the identification of potent and cell-active small-mol. inhibitors which efficiently disrupt the interaction between KRAS and its exchange factor SOS1, a mode of action confirmed by a series of biophys. techniques.  The binding sites, mode of action, and selectivity were elucidated using crystal structures of KRASG12C-SOS1, SOS1, and SOS2.  By preventing formation of the KRAS-SOS1 complex, these inhibitors block reloading of KRAS with GTP, leading to antiproliferative activity.  The final compd. 23(I, BAY-293) selectively inhibits the KRAS-SOS1 interaction with an IC50 of 21 nM and is a valuable chem. probe for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTMAcBZFHkBrVg90H21EOLACvtfcHk0li8qau4UWXEVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D&md5=f3150723049c15986cea1d7f93cb89af</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1812963116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1812963116%26sid%3Dliteratum%253Aachs%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DSautier%26aufirst%3DB.%26aulast%3DSchroeder%26aufirst%3DJ.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DHilpmann%26aufirst%3DA.%26aulast%3DStegmann%26aufirst%3DC.%2BM.%26aulast%3DWerbeck%26aufirst%3DN.%2BD.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DMastouri%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DK.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKahmann%26aufirst%3DJ.%2BD.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DB%25C3%25B6hnke%26aufirst%3DN.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520SOS1%2520inhibitors%2520that%2520block%2520RAS%2520activation%2520via%2520disruption%2520of%2520the%2520RAS-SOS1%2520interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2019%26volume%3D116%26spage%3D2551%26epage%3D2560%26doi%3D10.1073%2Fpnas.1812963116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR','PDB','6RSR'); return false;">PDB: 6RSR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EUU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EUU','PDB','4EUU'); return false;">PDB: 4EUU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RST" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RST','PDB','6RST'); return false;">PDB: 6RST</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSU','PDB','6RSU'); return false;">PDB: 6RSU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01460">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53206"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01460?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01460</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_001.csv">CSV</a>)</p></li><li><p class="inline">Detailed descriptions of methods for the HTS; all biochemical and cellular assays, pharmacokinetics assays; synthesis of compounds <b>1</b> to <b>36</b>; crystallization and structure determination; tables containing IC<sub>50</sub> values with standard deviation; kinase selectivity results; crystallographic data collection and refinement statistics; and additional crystallography result figure (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_001.csv">jm9b01460_si_001.csv (6.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01460/suppl_file/jm9b01460_si_002.pdf">jm9b01460_si_002.pdf (710.1 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors for the described crystal structures have been deposited with the Protein Data Bank (PDB). The PDB accession codes are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSR">6RSR</a> (compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RST">6RST</a> (compound <b>24</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RSU">6RSU</a> (compound <b>35</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01460&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01460%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01460" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a86020fb83285","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
